Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3006270	fb-folaat	nmol/l (nmol/l)	2574	2988	0.00%
3006270	fb-folaat	— (—)	533	581	100.00%	Distribution not available
3006270	fb-folat	nmol/l (nmol/l)	218	247	0.00%
3006270	fb-folaatti	nmol/l (nmol/l)	42	43	0.00%
3006270	fb-folat	— (—)	11	11	100.00%	Distribution not available
3006270	fb-folaatti(k-pks:n)(ko)	nmol/l (nmol/l)	9	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Speech therapy

372

856

4.45

147.29

1.2

281.54

359.40

nmol/l

9.64

271

726

Anaemias

195

249

5.07

77.50

1.2

1.1

391.70

403.17

nmol/l

0.27

175

240

Other anaemias

435

1537

2.68

77.16

1.3

1.2

328.92

336.30

nmol/l

0.27

345

1217

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

753

2371

2.15

76.90

1.2

1.1

357.67

373.91

nmol/l

1.10

615

2025

Aplastic and other anaemias

452

1598

2.62

76.14

1.3

1.2

326.41

339.77

nmol/l

0.60

360

1272

Other and unspecified anaemias

425

1530

2.64

73.13

1.2

327.77

336.74

nmol/l

0.34

336

1211

Diseases of oesophagus, stomach and duodenum

771

2280

2.01

63.63

1.2

1.1

346.86

380.20

nmol/l

3.68

651

1931

Fitting and adjustment of other devices

345

1170

2.62

58.20

1.2

293.62

336.64

nmol/l

3.16

246

987

Dementia, including avohilmo

399

1119

2.45

55.25

1.3

1.2

317.96

319.94

nmol/l

0.06

314

856

Bacterial infection, other or unspecified, including avohilmo

473

1759

2.22

54.55

1.2

316.82

358.10

nmol/l

3.73

365

1474

Other antidepressants

705

1832

1.97

53.69

1.2

1.1

378.28

356.49

nmol/l

1.69

608

1548

Malaise and fatigue

419

1449

2.29

51.80

1.2

1.1

343.46

355.26

nmol/l

0.48

312

1249

Dementia

378

1078

2.42

50.88

1.3

1.2

316.88

317.00

nmol/l

0.00

302

818

Bacterial infection, other or unspecified

436

1670

2.22

50.62

1.2

322.33

353.14

nmol/l

2.08

331

1393

Dipeptidyl peptidase 4 (DPP-4) inhibitors

422

1502

2.22

48.31

1.2

314.96

349.67

nmol/l

2.26

274

1309

Nutritional anaemias

423

1876

2.17

47.41

1.3

1.2

353.48

347.14

nmol/l

0.22

349

1526

Organic, including symptomatic, mental disorders

406

1280

2.25

46.78

1.3

1.2

321.41

329.15

nmol/l

0.28

327

1003

Recurrent or chronic depression

259

683

2.65

42.32

1.2

1.1

394.47

370.95

nmol/l

0.97

237

602

Iron deficiency anaemia

360

1646

2.16

40.49

1.2

353.51

350.30

nmol/l

0.10

295

1340

Other and unspecified iron deficiency

299

1300

2.32

39.86

1.2

363.16

346.95

nmol/l

0.65

245

1056

Medical observation and evaluation for suspected diseases and conditions

436

1062

2.11

39.79

1.2

1.1

341.28

394.28

nmol/l

4.85

353

905

Unspecific neurodegenerative disorder

355

1114

2.20

38.70

1.3

1.2

319.43

305.95

nmol/l

0.53

286

826

Gastro-oesophageal reflux disease

464

2029

1.94

37.88

1.3

1.1

340.57

378.95

nmol/l

3.83

403

1706

Covid-19 suspected case

186

665

2.83

37.57

1.1

392.35

382.96

nmol/l

0.17

615

Type 2 diabetes, wide definition

526

1769

1.88

37.15

1.2

338.75

367.88

nmol/l

2.08

370

1572

Presence of cardiac and vascular implants and grafts

330

1127

2.17

35.43

1.3

1.2

315.26

341.51

nmol/l

1.34

242

899

Care involving use of rehabilitation procedures

433

2034

1.92

35.02

1.1

360.89

372.65

nmol/l

0.46

283

1792

Other special examinations and investigations of persons without complaint or reported diagnosis

423

1064

2.02

34.70

1.2

1.1

353.33

394.02

nmol/l

3.13

357

906

Unspecified dementia

141

401

3.21

34.44

1.3

1.2

292.92

313.24

nmol/l

0.46

296

Autoimmune diseases

689

2041

1.72

34.41

1.2

1.1

368.93

374.22

nmol/l

0.24

592

1750

Other functional intestinal disorders

333

1471

2.07

33.15

1.2

1.1

334.83

362.44

nmol/l

1.52

265

1222

Autoimmune diseases excluding thyroid diseases

643

2031

1.72

32.84

1.2

1.1

362.70

373.85

nmol/l

0.65

531

1740

Any dementia, excluding more controls

293

917

2.21

32.49

1.3

1.2

299.38

321.32

nmol/l

0.92

228

712

Other nutritional deficiencies

437

2148

1.87

32.39

1.2

1.1

391.24

377.73

nmol/l

0.65

349

1902

Any dementia

323

1064

2.12

32.16

1.3

1.2

301.86

314.78

nmol/l

0.47

248

802

Other diseases of intestines

647

2124

1.70

31.97

1.2

1.1

357.31

382.43

nmol/l

2.11

557

1824

Symptoms and signs involving cognition, perception, emotional state and behaviour

625

2467

1.70

31.85

1.2

1.1

373.19

368.79

nmol/l

0.19

521

2109

Depression or dysthymia

384

1048

2.01

31.67

1.2

1.1

373.08

354.64

nmol/l

0.87

330

877

Autoimmune diseases excluding thyroid diseases, strict definition

620

1971

1.72

31.41

1.2

1.1

360.96

374.89

nmol/l

0.87

512

1693

Used for control exclusion in common control thyroid runs

637

1887

1.71

31.11

1.2

1.1

371.41

374.72

nmol/l

0.13

539

1622

Biguanides

611

2171

1.71

30.93

1.2

350.87

369.82

nmol/l

1.27

442

1944

Endocrine, nutritional and metabolic diseases

446

1189

1.90

30.81

1.2

1.1

378.05

384.54

nmol/l

0.24

390

1095

Psychiatric diseases

574

1646

1.75

30.65

1.2

1.1

371.08

369.00

nmol/l

0.08

491

1405

Combinations of oral blood glucose lowering drugs

204

846

2.43

30.58

1.1

1.2

346.41

354.70

nmol/l

0.20

141

749

Constipation

587

2344

1.70

30.30

1.2

1.1

365.67

361.13

nmol/l

0.19

465

2006

Persons encountering health services for specific procedures and health care

647

2302

1.66

29.81

1.2

1.1

354.53

379.79

nmol/l

2.13

517

2040

Diaphragmatic hernia

272

1295

2.12

29.29

1.2

322.64

352.94

nmol/l

1.69

236

1039

Use of memantine

258

956

2.19

29.07

1.3

1.2

330.62

304.89

nmol/l

1.02

203

700

Use of other anti-dementia drugs

258

956

2.19

29.07

1.3

1.2

330.62

304.89

nmol/l

1.02

203

700

Hypothyroidism, levothyroxine purchases

142

258

3.10

28.91

1.1

398.98

403.18

nmol/l

0.08

130

249

Hypothyroidism and >3 levothyroxin purchases

142

258

3.10

28.91

1.1

398.98

403.18

nmol/l

0.08

130

249

Other infectious diseases, including avohilmo

282

3.54

28.79

1.2

311.68

361.75

nmol/l

1.30

237

Any mental disorder

652

1976

1.66

28.57

1.2

1.1

357.94

375.11

nmol/l

1.15

553

1704

Codes for special purposes

371

1971

1.88

28.39

1.2

342.65

361.97

nmol/l

0.87

225

1713

Continuous positive airway pressure

132

372

2.98

28.31

1.2

1.1

343.31

378.12

nmol/l

0.96

104

332

Provisional assignment of new diseases of uncertain etiology

370

1968

1.87

28.22

1.2

342.65

362.15

nmol/l

0.88

225

1710

Hyperlipidaemia, other/unspecified

283

1239

2.07

28.12

1.3

1.2

307.12

338.44

nmol/l

1.64

192

1021

Insulin medication

386

1728

1.86

28.02

1.2

322.18

360.22

nmol/l

2.76

267

1536

Other degenerative diseases of the nervous system

207

636

2.39

27.98

1.2

320.61

345.79

nmol/l

0.85

172

513

Other (not insulin) diabetes medications

610

2163

1.66

27.92

1.2

355.10

371.10

nmol/l

0.96

447

1941

Undefined dementia

144

483

2.79

27.91

1.3

289.51

305.93

nmol/l

0.37

367

Selective serotonin reuptake inhibitors

593

1835

1.69

27.91

1.2

1.1

378.00

356.13

nmol/l

1.58

508

1551

Hypothyroidism (congenital or acquired)

140

258

3.05

27.83

1.1

396.20

403.18

nmol/l

0.14

128

249

Pain in throat and chest

525

1818

1.72

27.15

1.2

1.1

344.77

376.06

nmol/l

2.61

433

1569

Diverticular disease of intestine

468

1656

1.77

27.09

1.3

1.1

351.86

368.76

nmol/l

0.85

379

1379

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

548

2214

1.68

26.76

1.2

1.1

355.30

373.95

nmol/l

1.18

454

1902

Obesity due to excess calories

306

1576

1.95

26.52

1.2

1.1

376.62

379.67

nmol/l

0.09

234

1411

Gastrointestinal diseases

335

846

1.99

26.51

1.1

389.01

392.52

nmol/l

0.10

303

752

Hypothyroidism, strict autoimmune

461

1732

1.75

26.33

1.2

1.1

367.01

371.17

nmol/l

0.14

395

1486

Alzheimer disease, excluding more controls

135

300

2.94

26.31

1.2

327.18

316.72

nmol/l

0.19

114

228

Use of donepezil

206

873

2.28

26.28

1.3

1.2

332.13

314.72

nmol/l

0.51

168

636

Use of anticholinesterases

295

1148

2.00

25.92

1.3

1.2

332.66

303.43

nmol/l

1.42

237

849

N06DA Anticholinesterases

295

1148

2.00

25.92

1.3

1.2

332.66

303.43

nmol/l

1.42

237

849

Other gastritis (incl. Duodenitis)

169

695

2.45

25.91

1.2

1.1

322.79

358.13

nmol/l

1.35

153

560

Alzheimer’s disease (Late onset), excluding more controls

122

259

3.09

25.90

1.3

1.2

310.12

315.32

nmol/l

0.09

101

189

Obesity and other hyperalimentation

397

2102

1.78

25.64

1.2

1.1

384.26

377.37

nmol/l

0.26

314

1868

Depression medications

149

264

2.85

25.50

1.1

413.06

402.46

nmol/l

0.22

140

255

Dizziness and giddiness

486

2242

1.69

25.29

1.2

1.1

363.40

361.76

nmol/l

0.06

393

1899

Obesity

392

2096

1.77

24.64

1.2

1.1

385.23

377.39

nmol/l

0.30

309

1863

Diseases of the digestive system

327

1751

1.86

24.61

1.2

341.08

346.01

nmol/l

0.16

259

1423

Insulin, intermediate and long-acting

361

1946

1.80

24.13

1.2

318.73

357.84

nmol/l

2.80

251

1646

Complications of medical and surgical care

475

2574

1.66

23.83

1.2

352.82

365.42

nmol/l

0.63

386

2180

General symptoms and signs

619

1947

1.60

23.57

1.2

1.1

371.05

376.25

nmol/l

0.22

516

1713

Type 2 diabetes

579

2109

1.59

22.61

1.2

1.1

369.79

373.74

nmol/l

0.16

441

1899

Diabetes, insulin treatment (Kela reimbursement)

603

2283

1.58

22.60

1.2

350.73

370.73

nmol/l

1.34

431

2030

Condition for Implicit Sepsis (Organ dysfunction codes)

517

2213

1.62

22.55

1.2

1.1

346.79

369.33

nmol/l

1.50

412

1894

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

553

2049

1.61

22.39

1.2

351.65

370.55

nmol/l

1.16

402

1840

Type 2 diabetes, definitions combined, including avohilmo

560

2026

1.60

22.38

1.2

1.1

364.86

372.98

nmol/l

0.36

436

1819

Neurological diseases

471

1404

1.69

22.35

1.1

367.68

382.05

nmol/l

0.71

420

1202

Diabetes medication

609

2276

1.57

22.20

1.2

356.72

373.62

nmol/l

1.06

449

2053

Infections, IBD-co-morbidities

209

3.22

22.17

1.1

326.76

399.20

nmol/l

2.61

197

Persons encountering health services in other circumstances, wide

693

2336

1.53

22.04

1.2

1.1

368.55

367.95

nmol/l

0.02

576

1976

Non-invasive ventilation

151

542

2.42

21.95

1.2

1.1

339.42

393.54

nmol/l

2.82

129

494

Other bacterial diseases

560

2348

1.58

21.92

1.2

1.1

337.01

371.33

nmol/l

3.13

440

2018

Other soft tissue disorders, not elsewhere classified

551

1963

1.60

21.87

1.2

1.1

357.13

376.53

nmol/l

1.28

454

1666

Diabetes mellitus

588

2164

1.57

21.77

1.2

1.1

369.11

374.07

nmol/l

0.21

451

1954

Diabetes, varying definitions

586

2164

1.57

21.77

1.2

1.1

370.33

373.89

nmol/l

0.14

450

1953

Type 2 diabetes, definitions combined

557

2046

1.59

21.51

1.2

1.1

365.73

371.77

nmol/l

0.25

426

1837

Abnormalities of heart beat

247

1232

1.95

21.50

1.2

354.05

356.16

nmol/l

0.05

196

1034

Obesity, other/unspecified

221

1102

2.02

21.16

1.2

1.1

402.98

384.27

nmol/l

0.66

178

996

Parasetamol

408

1198

1.73

21.01

1.2

1.1

372.23

390.86

nmol/l

0.83

357

1032

Intracranial trauma

319

1187

1.82

20.98

1.2

1.1

348.87

385.97

nmol/l

2.37

260

1029

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

566

2289

1.57

20.97

1.2

1.1

348.22

383.46

nmol/l

3.22

472

1979

Type 2 diabetes, strict (exclude DM1)

556

2055

1.58

20.95

1.2

1.1

364.73

371.80

nmol/l

0.30

424

1845

Insulin, combination of fast acting with intermediate-acting or long-acting

390

2101

1.69

20.86

1.2

322.84

356.06

nmol/l

2.27

269

1773

Hypothyreosis and Thyroxine purchase for inclusion criteria

562

2361

1.56

20.80

1.2

370.11

368.10

nmol/l

0.07

474

2008

Persons encountering health services for other counselling and medical advice, not elsewhere classified

656

2295

1.52

20.67

1.2

1.1

365.80

369.23

nmol/l

0.14

547

1946

Inflammatory bowel disease treatment related agents

678

2501

1.51

20.58

1.2

376.50

369.50

nmol/l

0.35

571

2121

Persons encountering health services for examination and investigation

372

1064

1.76

20.40

1.2

1.1

340.90

394.02

nmol/l

4.14

319

906

Disorders of the thyroid gland

569

2384

1.55

20.39

1.2

366.33

367.97

nmol/l

0.06

480

2029

Hypothyroidism, other/unspecified

538

2263

1.57

20.16

1.2

369.71

368.81

nmol/l

0.03

456

1927

Other and unspecified polyneuropathies, also in other diseases

148

645

2.32

20.07

1.2

351.12

341.56

nmol/l

0.22

129

522

Hypothyroidism, strict autoimmune, 3 medication purchases required

518

2215

1.58

19.97

1.2

367.66

367.21

nmol/l

0.01

439

1880

Metabolic disorders

561

2170

1.56

19.97

1.2

1.1

359.42

371.41

nmol/l

0.62

452

1884

Nerve, nerve root and plexus disorders

641

2558

1.51

19.89

1.2

1.1

363.18

368.23

nmol/l

0.24

545

2157

Oral corticosteroids

634

2465

1.51

19.76

1.2

372.87

367.57

nmol/l

0.23

532

2087

Benign neoplasm of colon, rectum, anus and anal canal

406

2093

1.65

19.47

1.2

322.62

355.91

nmol/l

2.52

317

1725

Disorders of gallbladder, biliary tract and pancreas

596

2442

1.52

19.46

1.2

1.1

353.14

370.66

nmol/l

1.18

491

2073

Anxiety disorders, excluding more controls

455

1803

1.62

19.34

1.2

1.1

378.72

382.45

nmol/l

0.14

398

1566

Implicit Sepsis, including avohilmo

487

2205

1.58

19.33

1.2

1.1

345.54

366.74

nmol/l

1.30

381

1876

Abnormalities of breathing

510

1851

1.58

19.29

1.2

1.1

363.98

376.88

nmol/l

0.68

437

1603

Autoimmune diseases related-to ILD

508

2734

1.56

19.25

1.2

354.68

373.50

nmol/l

1.20

416

2333

Examination and observation for other reasons

328

1045

1.78

19.17

1.2

1.1

371.52

396.70

nmol/l

1.23

286

892

Presence of other devices

185

890

2.06

18.75

1.3

1.2

298.79

335.93

nmol/l

1.92

178

697

Implicit Sepsis

453

2098

1.60

18.74

1.2

1.1

338.99

362.47

nmol/l

1.40

345

1769

Complications of surgical and medical care, not elsewhere classified

595

2642

1.51

18.73

1.2

1.1

355.90

368.99

nmol/l

0.75

491

2244

Episodal and paroxysmal disorders

624

2105

1.51

18.65

1.2

1.1

354.03

372.44

nmol/l

1.32

536

1779

Symptoms and signs involving the urinary system

462

2221

1.57

18.13

1.2

339.04

361.54

nmol/l

1.45

362

1869

Mood disorders, excluding more controls

508

1924

1.56

18.11

1.2

1.1

367.94

378.80

nmol/l

0.52

438

1657

Benign neoplasm: Colon

345

1941

1.68

18.03

1.3

1.2

319.86

350.61

nmol/l

2.01

274

1585

Disorders of thyroid, IBD co-morbidities

246

2.77

17.92

1.1

379.87

407.62

nmol/l

0.64

234

Presence of other functional implants

358

1467

1.68

17.82

1.2

334.25

358.57

nmol/l

1.12

275

1208

Chronic gastritis

185

924

2.02

17.76

1.3

1.2

323.70

348.84

nmol/l

0.66

152

711

ILD medications: prednisolone, methylprednisolone, prednisone

633

2382

1.48

17.74

1.2

380.34

368.45

nmol/l

0.66

535

2012

Symptoms and signs involving the circulatory and respiratory systems

562

1854

1.52

17.61

1.2

1.1

373.69

376.82

nmol/l

0.12

485

1604

Sleep disorders (combined)

633

2237

1.48

17.57

1.2

368.91

363.83

nmol/l

0.23

552

1870

Sensorineural hearing loss

460

1959

1.57

17.51

1.2

312.90

368.24

nmol/l

7.05

358

1629

Conductive and sensorineural hearing loss

475

2030

1.56

17.48

1.2

1.1

317.49

370.10

nmol/l

6.61

375

1696

Oxycodone

258

1228

1.80

17.31

1.3

1.1

337.33

348.42

nmol/l

0.34

204

996

Opioids

548

1866

1.52

17.18

1.2

1.1

386.03

374.58

nmol/l

0.57

475

1592

Hypertensive Heart Disease

162

581

2.13

17.08

1.2

285.54

334.78

nmol/l

2.35

133

485

Headache

378

1804

1.62

17.02

1.2

1.1

385.77

378.71

nmol/l

0.26

322

1593

ILD medications

649

2398

1.46

16.99

1.2

1.1

373.27

369.12

nmol/l

0.18

557

2028

Polyneuropathies and other disorders of the peripheral nervous system

157

755

2.10

16.76

1.2

354.77

342.50

nmol/l

0.30

136

608

Sleep apnoea, including avohilmo

566

2301

1.49

16.73

1.2

1.1

361.38

370.70

nmol/l

0.47

488

1953

Soft tissue disorders

577

1985

1.49

16.56

1.2

1.1

356.15

375.50

nmol/l

1.34

492

1681

Other bacterial diseases, including avohilmo

570

2404

1.48

16.55

1.2

1.1

339.52

377.78

nmol/l

4.03

465

2073

Renal failure

316

1608

1.68

16.54

1.3

1.2

311.94

334.34

nmol/l

0.85

230

1290

First line medication for Crohn's disease

631

2328

1.46

16.50

1.2

1.1

378.89

370.02

nmol/l

0.45

538

1968

Benign neoplasms

558

2033

1.50

16.50

1.2

1.1

368.17

376.28

nmol/l

0.35

481

1722

Syncope and collapse

275

1321

1.74

16.44

1.2

341.26

351.26

nmol/l

0.31

207

1130

Non-selective monoamine reuptake inhibitors

224

1172

1.84

16.43

1.2

358.92

349.08

nmol/l

0.26

182

975

Dyspnoea

533

2588

1.49

16.25

1.2

1.1

352.03

368.58

nmol/l

1.00

437

2193

Bacterial Sepsis

306

1509

1.68

16.04

1.2

306.38

344.44

nmol/l

2.31

222

1231

Pain in limb

466

1936

1.53

15.91

1.2

1.1

354.60

376.61

nmol/l

1.40

382

1644

Implicit bacterial Sepsis, including avohilmo

296

1465

1.69

15.70

1.2

307.41

342.20

nmol/l

1.95

220

1190

Codeine

512

1843

1.50

15.53

1.2

1.1

377.11

374.50

nmol/l

0.10

447

1574

Neurological diseases, wide definition

138

305

2.28

15.53

1.1

398.19

408.94

nmol/l

0.23

129

291

Sleep apnoea

531

2263

1.48

15.45

1.2

1.1

360.54

369.97

nmol/l

0.45

450

1924

Abdominal and pelvic pain

554

1883

1.48

15.31

1.2

1.1

359.47

373.97

nmol/l

0.84

475

1594

Complications of procedures, not elsewhere classified

477

2571

1.50

15.25

1.2

1.1

358.79

368.71

nmol/l

0.45

389

2184

Fall on same level

629

2334

1.44

15.24

1.2

1.1

355.70

382.31

nmol/l

2.19

526

2014

Functional dyspepsia

167

851

1.97

15.22

1.2

1.1

330.55

378.93

nmol/l

2.60

136

720

Other disorders of ear

524

2300

1.48

14.99

1.2

1.1

333.38

374.11

nmol/l

4.51

435

1952

Sulfonylureas

217

951

1.82

14.91

1.2

336.86

320.97

nmol/l

0.44

146

801

Symptoms and signs involving the digestive system and abdomen

552

1883

1.47

14.85

1.2

1.1

362.30

373.97

nmol/l

0.61

472

1594

Hypertensive heart and/or renal disease

165

606

2.00

14.73

1.2

285.26

338.09

nmol/l

2.67

133

508

Polycystic ovarian syndrome, consortium definition

415

1538

1.55

14.72

1.2

1.1

366.32

388.20

nmol/l

1.33

371

1336

Gastroduodenal ulcer

172

895

1.93

14.63

1.3

1.2

303.97

343.93

nmol/l

1.90

141

689

Concussion

260

1177

1.72

14.61

1.2

1.1

347.66

385.67

nmol/l

2.23

213

1019

Pain (limb, back, neck, head abdominally)

409

1314

1.56

14.56

1.2

1.1

361.66

372.39

nmol/l

0.40

352

1109

Disorders of lipoprotein metabolism and other lipidaemias

473

1921

1.50

14.55

1.2

1.1

356.99

366.55

nmol/l

0.41

377

1649

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

362

2280

1.56

14.45

1.2

349.80

361.89

nmol/l

0.49

292

1919

Misadventures to patients during surgical and medical care

110

489

2.27

14.40

1.2

378.62

361.59

nmol/l

0.34

414

Gastric ulcer

121

559

2.18

14.40

1.2

312.71

347.02

nmol/l

1.14

106

427

Tramadol

438

1737

1.52

14.28

1.2

1.1

376.40

369.68

nmol/l

0.26

383

1470

Other dorsopathies, not elsewhere classified

560

2005

1.45

14.26

1.2

1.1

369.76

375.71

nmol/l

0.24

481

1697

Degenerative diseases of the nervous system

268

1140

1.70

14.26

1.2

303.22

311.68

nmol/l

0.26

209

846

Parkinson's disease, strict definition, excluding more controls

292

2.61

14.18

1.2

306.78

331.25

nmol/l

0.48

223

Parkinson's disease, excluding more controls

305

2.55

14.04

1.2

301.16

334.90

nmol/l

0.78

235

Other infectious diseases

245

2.81

13.90

1.2

327.35

365.10

nmol/l

0.64

205

Alzheimer disease, including avohilmo

272

1124

1.68

13.89

1.2

312.12

307.11

nmol/l

0.14

215

832

All chronic kidney diseases

328

1646

1.59

13.89

1.2

333.44

349.54

nmol/l

0.54

243

1383

Dorsopathies

570

2007

1.44

13.82

1.2

1.1

372.96

375.57

nmol/l

0.10

494

1698

Benzodiazepine use

574

2725

1.42

13.81

1.2

1.1

365.65

369.72

nmol/l

0.17

494

2303

Chronic kidney disease

224

1242

1.74

13.77

1.3

1.2

316.43

327.89

nmol/l

0.27

167

984

Neurotic, stress-related and somatoform disorders

477

2240

1.47

13.61

1.2

1.1

383.29

379.49

nmol/l

0.15

419

1937

Polyarthropathies

370

1533

1.55

13.56

1.2

1.1

347.50

373.08

nmol/l

1.49

297

1302

Other CVD (FINNGEN)

217

2.69

13.53

1.2

1.1

352.05

360.01

nmol/l

0.10

188

Implicit bacterial Sepsis

267

1384

1.66

13.49

1.2

300.98

337.64

nmol/l

1.96

194

1114

Somatoform disorder

111

510

2.19

13.43

1.2

1.1

385.92

385.76

nmol/l

0.00

101

454

Certain infectious and parasitic diseases

530

1831

1.45

13.40

1.2

1.1

367.29

376.90

nmol/l

0.44

450

1601

Other disorders of urethra and urinary system

418

1938

1.50

13.40

1.2

353.34

369.54

nmol/l

0.79

351

1629

Acute gastritis

201

2.97

13.35

1.4

1.1

298.88

377.90

nmol/l

2.11

170

GASTRO-related operations

432

1435

1.51

13.35

1.2

1.1

352.85

388.58

nmol/l

2.72

386

1202

Any gastric operation

432

1435

1.51

13.35

1.2

1.1

352.85

388.58

nmol/l

2.72

386

1202

Certain infectious and parasitic diseases, including avohilmo

407

1334

1.53

13.31

1.2

1.1

366.67

373.11

nmol/l

0.23

349

1141

Dysphagia

165

878

1.89

13.30

1.2

337.19

343.74

nmol/l

0.15

133

711

General examination and investigation of persons without complaint and reported diagnosis

327

1058

1.61

13.27

1.2

1.1

349.14

394.85

nmol/l

3.03

307

902

Intracranial injury

345

2083

1.55

13.21

1.2

338.28

361.17

nmol/l

1.22

272

1750

Depression

520

2422

1.44

13.20

1.2

1.1

372.68

375.64

nmol/l

0.11

450

2079

Hypothyroidism, drug reimbursement

195

2.70

13.15

1.1

1.0

343.72

395.86

nmol/l

1.49

187

Other symptoms and signs involving cognitive functions and awareness

287

1580

1.62

13.11

1.2

358.08

341.70

nmol/l

0.64

236

1289

Anxiety disorders

480

2267

1.46

13.04

1.2

1.1

383.06

378.47

nmol/l

0.19

422

1956

Codeine or tramadol medication

630

2458

1.39

12.96

1.2

373.41

366.41

nmol/l

0.36

542

2066

Accidents

449

1512

1.49

12.95

1.2

1.1

365.82

381.62

nmol/l

0.72

384

1299

All kidney diseases

538

2537

1.42

12.91

1.2

1.1

358.14

376.21

nmol/l

1.01

428

2209

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

336

2176

1.55

12.91

1.2

354.06

356.14

nmol/l

0.06

269

1821

Renal tubulo-interstitial diseases

485

2462

1.45

12.89

1.2

1.1

346.95

370.79

nmol/l

1.40

380

2121

Other external causes of accidental injury

447

1512

1.48

12.63

1.2

1.1

364.74

381.62

nmol/l

0.78

381

1299

Bleeding

468

2266

1.45

12.59

1.2

351.43

359.24

nmol/l

0.31

371

1898

Heart failure, not strict

397

1782

1.50

12.55

1.2

1.1

316.41

370.43

nmol/l

6.09

314

1500

Migraine

270

1293

1.63

12.54

1.1

404.08

393.47

nmol/l

0.36

245

1152

Other disorders of fluid, electrolyte and acid-base balance

200

1080

1.75

12.52

1.2

331.83

339.29

nmol/l

0.17

153

886

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

176

469

1.89

12.34

1.1

388.87

395.15

nmol/l

0.14

166

430

Spondylopathies

444

1792

1.47

12.32

1.2

340.76

369.80

nmol/l

2.18

370

1494

Other diseases of the digestive system

211

1241

1.71

12.19

1.2

328.07

340.10

nmol/l

0.35

162

990

Arthropathies

479

1670

1.45

12.18

1.2

1.1

381.43

378.87

nmol/l

0.09

416

1432

Unspecified misadventure during surgical and medical care

164

3.09

12.14

1.1

1.2

346.49

379.41

nmol/l

0.47

144

Other heart diseases, wide

471

1975

1.45

12.13

1.2

1.1

385.22

381.09

nmol/l

0.16

409

1732

Pain, not elsewhere classified

164

900

1.83

12.04

1.3

1.1

349.75

371.51

nmol/l

0.63

138

789

Noninfective enteritis and colitis

261

1632

1.60

11.81

1.2

357.03

365.89

nmol/l

0.31

224

1391

Cardiac arrhythmias

298

1213

1.58

11.77

1.2

1.1

411.48

392.55

nmol/l

0.86

270

1121

Angina pectoris

317

1358

1.55

11.74

1.2

326.03

352.34

nmol/l

1.29

232

1137

Other neurological diseases

417

2223

1.46

11.73

1.2

329.87

356.88

nmol/l

1.83

333

1835

Diseases of arteries, arterioles and capillaries (FINNGEN)

126

431

2.03

11.65

1.1

344.11

385.40

nmol/l

1.26

389

Irritable bowel syndrome

159

876

1.82

11.55

1.2

1.1

349.57

381.79

nmol/l

1.23

138

767

Cholelithiasis, broad definition with cholecystitis

496

2340

1.41

11.52

1.2

347.63

367.67

nmol/l

1.30

406

1980

Alzheimer disease

241

1052

1.65

11.48

1.2

311.78

307.99

nmol/l

0.09

187

771

Heart failure,strict

293

1309

1.57

11.39

1.3

1.2

298.98

350.15

nmol/l

4.02

236

1062

Triptan medication for migraine, single purchase ok

374

1709

1.49

11.33

1.1

424.06

383.40

nmol/l

3.50

344

1518

Migraine, single triptan purchase ok & required. ICD-code if available is included

374

1709

1.49

11.33

1.1

424.06

383.40

nmol/l

3.50

344

1518

Follow-up examination after treatment for conditions other than malignant neoplasms

229

920

1.66

11.24

1.2

1.1

348.21

398.33

nmol/l

3.04

195

784

Traumatic subdural haemorrhage

381

2.22

11.23

1.3

1.2

320.16

332.07

nmol/l

0.20

295

Injuries to the head

612

2668

1.36

11.23

1.2

1.1

353.79

373.89

nmol/l

1.51

498

2287

Other abnormal uterine and vaginal bleeding

140

527

1.92

11.21

1.2

1.1

345.48

376.80

nmol/l

1.04

124

417

Adjustment and management of implanted device

125

649

1.94

10.97

1.2

351.16

328.89

nmol/l

0.48

532

Falls/tendency to fall

561

2034

1.38

10.96

1.2

1.1

356.95

386.73

nmol/l

2.33

482

1767

Rotator cuff syndrome

345

1591

1.50

10.90

1.2

1.1

359.47

366.68

nmol/l

0.26

301

1323

Hernia

508

2429

1.39

10.85

1.2

349.79

373.42

nmol/l

1.68

432

2031

Myalgia

139

750

1.86

10.83

1.2

1.1

370.43

380.54

nmol/l

0.23

117

646

Polyuria

143

779

1.85

10.83

1.3

1.2

341.77

344.95

nmol/l

0.06

111

632

Hypokalaemia

423

2.17

10.81

1.2

1.1

349.87

349.45

nmol/l

0.01

352

Fever of other and unknown origin

298

1693

1.53

10.79

1.2

1.1

338.17

366.87

nmol/l

1.52

241

1479

Non-rheumatic valve diseases

250

1116

1.60

10.79

1.2

1.1

328.24

351.65

nmol/l

1.03

214

923

Shoulder lesions

412

1708

1.45

10.77

1.2

1.1

346.15

370.00

nmol/l

1.56

357

1430

Valvular heart disease excluding rheumatic fever

251

1123

1.60

10.77

1.2

1.1

327.83

352.62

nmol/l

1.12

215

929

Benign neoplasm: Ascending colon

464

2.11

10.71

1.2

335.02

342.38

nmol/l

0.14

378

Other diseases of urinary system

538

2190

1.38

10.65

1.2

1.1

363.91

372.71

nmol/l

0.38

453

1855

Other arrhythmias

337

1691

1.49

10.63

1.2

1.1

365.87

372.05

nmol/l

0.21

284

1462

Oedema, not elsewhere classified

193

1124

1.68

10.62

1.3

1.2

328.12

357.91

nmol/l

1.12

147

959

All-cause Heart Failure

331

1539

1.50

10.60

1.3

1.2

299.56

340.59

nmol/l

2.45

263

1219

Septicaemia

248

1433

1.58

10.57

1.2

320.28

346.74

nmol/l

1.21

201

1182

Cholelithiasis

474

2314

1.40

10.56

1.2

349.29

366.88

nmol/l

1.02

388

1957

Cardiovascular diseases

279

946

1.57

10.39

1.1

411.73

411.72

nmol/l

0.00

259

890

Explicit Sepsis, including avohilmo

265

1558

1.55

10.22

1.2

321.29

346.61

nmol/l

1.17

215

1282

Diseases of the eye and adnexa

404

1402

1.45

10.16

1.2

1.1

377.42

389.54

nmol/l

0.55

360

1234

Dorsalgia

521

2004

1.38

10.16

1.2

1.1

365.54

375.69

nmol/l

0.46

452

1695

Other septicaemia, including avohilmo

228

1345

1.60

10.14

1.2

322.04

346.69

nmol/l

1.02

187

1100

Mood [affective] disorders

542

2552

1.36

10.13

1.2

373.35

373.39

nmol/l

0.00

469

2175

Diabetic neuropathy

426

2.12

10.12

1.2

350.03

329.35

nmol/l

0.39

300

Paralytic ileus and intestinal obstruction

158

905

1.75

10.11

1.2

1.1

336.93

351.92

nmol/l

0.41

121

730

Heart failure, strict

332

1561

1.48

10.06

1.3

1.2

298.67

341.95

nmol/l

2.70

265

1239

Migraine without aura

108

550

1.97

10.04

1.1

443.85

400.23

nmol/l

1.34

517

Alzheimer’s disease, strict definition

192

931

1.67

10.02

1.3

1.2

320.64

311.23

nmol/l

0.25

155

683

Alzheimer’s disease (Late onset)

180

877

1.70

9.97

1.3

1.2

310.86

308.72

nmol/l

0.05

145

640

Excessive, frequent and irregular menstruation

205

655

1.68

9.96

1.1

371.55

385.34

nmol/l

0.38

184

537

Migraine without aura and triptan purchases

437

2.09

9.96

1.1

459.76

400.25

nmol/l

1.88

409

Mood disorders

542

2555

1.36

9.95

1.2

372.85

373.30

nmol/l

0.02

469

2176

Rheumatoid arthritis

189

1008

1.67

9.90

1.2

1.1

340.63

365.01

nmol/l

0.86

153

834

Other septicaemia

223

1324

1.59

9.87

1.2

319.89

344.97

nmol/l

1.04

182

1080

External causes of morbidity and mortality

352

1197

1.48

9.86

1.2

1.1

366.61

381.96

nmol/l

0.59

306

1039

Other joint disorders

449

1666

1.41

9.84

1.2

1.1

378.18

379.37

nmol/l

0.04

399

1429

Soft tissue disorders related to use, overuse and pressure

157

907

1.74

9.80

1.3

1.1

379.96

365.81

nmol/l

0.35

134

752

Antihypertensive medication - note that there are other indications

283

961

1.54

9.79

1.1

397.75

395.58

nmol/l

0.06

264

882

Menorrhagia

187

614

1.70

9.76

1.2

1.1

355.84

381.62

nmol/l

0.89

166

499

Other intervertebral disc disorders

446

1902

1.40

9.75

1.2

353.07

373.37

nmol/l

1.27

386

1603

Pure hypercholesterolaemia

406

1818

1.42

9.73

1.2

352.33

364.58

nmol/l

0.53

328

1556

Coxarthrosis

284

1206

1.52

9.72

1.2

1.1

351.86

361.59

nmol/l

0.32

227

993

Diseases of the ear and mastoid process

604

2262

1.34

9.71

1.2

1.1

347.43

384.04

nmol/l

3.98

514

1948

Explicit Sepsis

258

1536

1.53

9.64

1.2

321.03

346.66

nmol/l

1.17

208

1264

ILD medications: immunosuppressive drugs

329

2051

1.46

9.53

1.2

1.1

352.61

371.89

nmol/l

0.96

285

1753

Oxicams

145

454

1.82

9.51

1.2

392.50

337.72

nmol/l

1.80

113

344

Other heart diseases

226

923

1.60

9.48

1.2

1.1

395.05

405.65

nmol/l

0.34

201

863

Hypertension, essential

382

1508

1.43

9.46

1.2

1.1

371.72

382.28

nmol/l

0.43

324

1360

Diseases of the musculoskeletal system and connective tissue

267

866

1.55

9.38

1.2

1.1

381.90

385.72

nmol/l

0.10

241

744

Use of hypnotics and sedatives

569

2432

1.34

9.36

1.2

377.56

367.56

nmol/l

0.52

483

2066

Heart failure and coronary heart disease

246

1113

1.55

9.32

1.3

1.2

290.23

337.77

nmol/l

2.83

189

898

Pneumonia, organism unspecified

479

2413

1.36

9.15

1.2

1.1

345.33

376.79

nmol/l

2.21

398

2079

Deforming dorsopathies

155

913

1.70

9.04

1.2

1.1

340.12

371.80

nmol/l

1.31

142

764

Cerebrovascular diseases

401

1993

1.40

8.96

1.2

320.87

355.56

nmol/l

2.22

318

1634

GI-bleeding

199

1253

1.59

8.95

1.2

328.64

337.99

nmol/l

0.24

151

997

Disorders of other endocrine glands

246

1598

1.52

8.94

1.1

1.2

350.95

362.17

nmol/l

0.37

201

1355

Low back pain

407

1974

1.39

8.91

1.2

1.1

374.84

376.53

nmol/l

0.06

355

1675

Chronic pancreatitis

363

2.14

8.91

1.2

372.24

362.70

nmol/l

0.14

306

Coxarthrosis [arthrosis of hip](FG)

313

1478

1.46

8.88

1.2

1.1

347.44

365.66

nmol/l

0.78

250

1215

Hypertensive diseases

384

1533

1.42

8.87

1.2

1.1

381.62

383.20

nmol/l

0.05

331

1383

Hypertension

384

1533

1.42

8.87

1.2

1.1

381.62

383.20

nmol/l

0.05

331

1383

Benign neoplasm of other and ill-defined parts of digestive system

114

619

1.85

8.83

1.2

364.10

346.07

nmol/l

0.28

513

Any reimbursement code in KELA

267

879

1.53

8.79

1.1

386.55

406.18

nmol/l

0.77

244

819

Coeliac disease

352

2.15

8.78

1.3

1.1

324.28

377.38

nmol/l

1.70

315

Insulin, fast-acting

200

1267

1.58

8.75

1.2

323.54

360.49

nmol/l

1.75

138

1074

Unspecified urinary incontinence

302

2.24

8.69

1.3

1.2

322.49

366.47

nmol/l

1.07

256

Nonorganic sleeping disorders, excluding more controls

105

558

1.89

8.68

1.1

393.74

386.80

nmol/l

0.13

506

Acute tubulo-interstitial nephritis

341

2028

1.42

8.67

1.2

347.24

360.46

nmol/l

0.54

268

1727

Other bacterial intestinal infections, including avohilmo

145

852

1.71

8.59

1.2

336.56

353.01

nmol/l

0.42

116

716

Nausea and vomiting

154

896

1.68

8.57

1.2

325.56

354.25

nmol/l

0.90

112

727

Cardiovascular diseases (excluding rheumatic etc)

290

1123

1.48

8.52

1.1

399.38

409.47

nmol/l

0.36

264

1056

Familial hypercholesterolemia

499

1.94

8.51

1.3

1.2

302.28

336.68

nmol/l

0.84

397

Cough

216

1308

1.55

8.45

1.2

368.81

362.72

nmol/l

0.17

172

1103

Genitourinary diseases

265

880

1.51

8.43

1.2

1.1

376.71

384.55

nmol/l

0.23

232

735

Irregular menses

247

1231

1.51

8.43

1.1

380.50

399.98

nmol/l

0.83

230

1116

Benign neoplasm: Caecum

365

2.10

8.42

1.3

1.2

336.29

350.15

nmol/l

0.24

298

Senile cataract

321

1355

1.44

8.41

1.3

1.1

335.37

370.60

nmol/l

2.21

254

1154

Coxibs

159

490

1.71

8.33

1.2

1.1

380.25

343.82

nmol/l

1.18

131

378

Other headache syndromes

213

1381

1.54

8.32

1.2

1.1

412.19

378.51

nmol/l

1.57

190

1192

Heart failure and antihypertensive medication

121

432

1.83

8.32

1.2

1.1

316.53

364.32

nmol/l

1.78

379

Intestinal infectious diseases, including avohilmo, including avohilmo

618

2650

1.30

8.30

1.2

362.08

369.08

nmol/l

0.35

507

2253

Barrett oesophagus

112

3.07

8.29

1.2

1.1

327.65

374.43

nmol/l

0.56

Finngen Rheumatological endpoints

487

2062

1.34

8.22

1.2

1.1

360.60

381.49

nmol/l

1.32

417

1770

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

509

2556

1.33

8.20

1.2

1.1

344.86

378.17

nmol/l

2.63

422

2200

Pneumonias (Asthma/COPD co-morbidities)

517

2552

1.32

8.17

1.2

1.1

348.63

378.31

nmol/l

2.17

428

2201

Disturbances of skin sensation

151

910

1.67

8.15

1.2

1.1

343.33

385.37

nmol/l

1.79

134

807

All anxiety disorders

300

1618

1.44

8.15

1.2

1.1

380.86

389.42

nmol/l

0.31

270

1442

Caries of dentine

133

747

1.72

8.10

1.2

1.1

347.21

369.76

nmol/l

0.57

633

Myocardial infarction, without ST-elevation

239

1443

1.50

8.10

1.3

1.2

305.04

328.80

nmol/l

0.98

175

1130

Conduction disorders

168

828

1.63

8.08

1.3

1.2

315.75

341.26

nmol/l

0.86

137

667

Asthma, unspecified (mode), excluding more controls

271

1324

1.47

7.99

1.2

1.1

357.86

383.33

nmol/l

1.21

219

1159

Inflammatory bowel disease

163

1009

1.62

7.93

1.2

1.1

346.38

380.66

nmol/l

1.43

140

881

All pneumoniae

516

2549

1.32

7.84

1.2

1.1

348.18

378.70

nmol/l

2.27

425

2199

Transient ischemic attack

291

1618

1.44

7.80

1.3

1.2

306.33

342.54

nmol/l

2.45

235

1289

Cholecystectomy

392

2448

1.36

7.80

1.2

342.53

362.94

nmol/l

1.15

323

2052

Status post-ami

159

738

1.64

7.77

1.2

291.99

330.45

nmol/l

1.56

123

601

Other retinal disorders

351

1924

1.39

7.73

1.3

1.2

324.85

348.22

nmol/l

1.24

270

1576

Chronic diseases of tonsils and adenoids

376

1727

1.38

7.59

1.1

414.95

377.52

nmol/l

2.99

341

1502

AV-block

115

557

1.77

7.59

1.2

335.78

315.78

nmol/l

0.45

428

Anxiety (asthma-related co-morbidities)

292

1558

1.43

7.54

1.2

1.1

379.58

392.84

nmol/l

0.53

262

1396

Disturbance of activity and attention

287

2.15

7.49

1.1

430.64

409.49

nmol/l

0.35

277

Obesity related asthma

185

1197

1.55

7.49

1.2

1.1

375.80

369.53

nmol/l

0.16

154

1026

Arthrosis

365

1447

1.38

7.49

1.2

1.1

359.62

370.18

nmol/l

0.42

309

1220

Acute pancreatitis

112

638

1.76

7.47

1.2

323.15

353.11

nmol/l

0.84

525

Generalized anxiety disorder

431

1.93

7.39

1.2

1.1

393.21

406.49

nmol/l

0.23

407

Other or unspecified ileus, impaction or obstruction

108

611

1.78

7.37

1.2

328.51

348.45

nmol/l

0.47

489

Vitamin B12 deficiency anaemia

378

2.00

7.34

1.3

1.2

343.15

331.17

nmol/l

0.13

306

Other reaction to severe stress, and adjustment disorders

173

1107

1.57

7.32

1.2

1.1

385.14

391.85

nmol/l

0.16

149

1007

Cervical disc disorders

191

1251

1.53

7.32

1.2

1.1

344.31

371.48

nmol/l

1.05

161

1038

Factors influencing health status and contact with health services

135

394

1.72

7.31

1.2

1.1

374.70

387.96

nmol/l

0.23

119

345

Coxarthrosis, primary

330

1981

1.39

7.31

1.2

339.95

344.69

nmol/l

0.16

261

1608

Vascular dementia (undefined)

159

2.58

7.30

1.4

1.3

266.56

314.26

nmol/l

0.68

117

Visual disturbances and blindness

280

1976

1.42

7.30

1.2

347.24

358.00

nmol/l

0.37

240

1632

Other diseases of anus and rectum

166

1053

1.58

7.22

1.2

1.1

340.04

356.84

nmol/l

0.51

134

860

Other mental disorders due to brain damage and dysfunction and to physical disease

408

1.95

7.22

1.3

1.2

343.20

334.86

nmol/l

0.11

321

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

465

2058

1.32

7.20

1.2

1.1

352.59

376.63

nmol/l

1.38

386

1771

465

2058

1.32

7.20

1.2

1.1

352.59

376.63

nmol/l

1.38

386

1771

Neoplasms

370

1415

1.37

7.20

1.2

1.1

375.82

387.40

nmol/l

0.43

330

1234

Other diseases of pancreas

242

2.25

7.17

1.1

352.98

365.98

nmol/l

0.17

207

Post-traumatic stress disorder

223

2.30

7.16

1.1

425.42

417.77

nmol/l

0.09

215

Osteopathies and chondropathies

304

1995

1.40

7.13

1.2

333.48

362.27

nmol/l

1.47

241

1670

Glucagon-like peptide-1 (GLP-1) analogues

146

905

1.62

7.12

1.3

1.1

374.65

384.76

nmol/l

0.21

100

837

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

146

905

1.62

7.12

1.3

1.1

374.65

384.76

nmol/l

0.21

100

837

Influenza and pneumonia

529

2523

1.29

7.11

1.2

1.1

351.81

379.49

nmol/l

1.99

440

2181

Diseases of arteries, arterioles and capillaries

361

1946

1.36

7.10

1.2

333.03

345.90

nmol/l

0.52

265

1602

Implicit fungal Sepsis

3.06

7.06

1.3

1.2

341.84

397.57

nmol/l

0.43

Vocal cord dysfunction

287

2.06

7.04

1.1

394.09

385.67

nmol/l

0.12

265

Peripheral artery disease

254

1394

1.44

7.04

1.3

1.2

318.50

325.61

nmol/l

0.19

182

1104

Other systemic involvement of connective tissue (FG)

151

929

1.60

7.03

1.2

349.31

361.55

nmol/l

0.27

120

764

Symptoms and signs involving the skin and subcutaneous tissue

379

2670

1.34

7.01

1.2

1.1

342.65

371.16

nmol/l

2.06

322

2267

Temporomandibular joint disorders, including avohilmo

221

1457

1.47

7.01

1.1

428.90

386.65

nmol/l

2.73

195

1308

Insulin, fast-acting or short human

200

1337

1.50

6.97

1.2

323.54

358.42

nmol/l

1.60

138

1121

Hyperkinetic disorders

302

2.08

6.96

1.1

428.22

411.20

nmol/l

0.27

293

Unspecified haematuria

228

1269

1.47

6.92

1.2

353.90

349.87

nmol/l

0.10

165

1034

Paroxysmal tachycardia

109

520

1.75

6.88

1.1

368.12

389.65

nmol/l

0.44

478

Symptoms and signs concerning food and fluid intake

325

2.04

6.87

1.3

1.2

334.52

349.47

nmol/l

0.24

281

Cerebrovascular diseases (FINNGEN)

147

637

1.62

6.84

1.2

1.1

368.27

401.86

nmol/l

1.15

126

590

Other blood glucose lowering drugs, excl. Insulins

494

1.83

6.84

1.2

342.85

344.82

nmol/l

0.03

428

Intestinal stricture

179

1178

1.53

6.76

1.2

341.84

342.84

nmol/l

0.02

139

956

Spinal stenosis

276

1443

1.41

6.76

1.2

331.63

355.17

nmol/l

1.14

235

1169

Personality disorders, excluding more controls

112

656

1.71

6.75

1.1

353.04

406.62

nmol/l

2.00

613

Colectomy operation

102

584

1.76

6.75

1.2

333.42

345.93

nmol/l

0.22

477

Disorders of lens

331

1495

1.38

6.74

1.2

1.1

343.27

373.03

nmol/l

1.72

264

1279

Erysipelas, including avohilmo

373

2060

1.34

6.74

1.2

1.1

327.97

369.81

nmol/l

3.31

290

1747

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

138

2.40

6.72

1.1

342.69

377.67

nmol/l

0.45

128

Erysipelas

290

1799

1.39

6.69

1.2

328.79

358.55

nmol/l

1.47

212

1502

Other diseases of oesophagus

276

2.12

6.66

1.2

1.1

303.38

371.39

nmol/l

1.50

223

Thiazolidinediones

330

2.01

6.64

1.2

305.02

345.13

nmol/l

0.69

286

Diseases of the respiratory system

337

1229

1.38

6.63

1.2

1.1

374.42

373.22

nmol/l

0.03

289

1062

Budesonide

449

1.86

6.62

1.1

364.94

380.65

nmol/l

0.28

399

Use of pramipexole

129

792

1.64

6.59

1.2

334.19

342.55

nmol/l

0.19

111

644

L04AX Other immunosuppressants

274

1965

1.40

6.57

1.2

1.1

352.64

372.34

nmol/l

0.88

242

1690

Other bacterial intestinal infections

111

656

1.70

6.56

1.2

315.95

345.48

nmol/l

0.87

539

Iron deficiency anaemia secondary to blood loss (chronic)

106

619

1.72

6.55

1.2

304.80

336.59

nmol/l

0.90

500

Postmenopausal atrophic vaginitis

137

453

1.65

6.55

1.2

1.1

378.88

374.99

nmol/l

0.07

116

351

Carpal tunnel syndrome

321

2043

1.36

6.55

1.2

361.84

368.37

nmol/l

0.23

276

1719

Other specific joint derangements/joint disorders

348

1600

1.36

6.54

1.2

1.1

368.22

382.44

nmol/l

0.62

316

1380

Alzheimer’s disease (Early onset), excluding more controls

2.93

6.53

1.1

1.2

368.66

337.67

nmol/l

0.30

Retention of urine

192

1038

1.50

6.53

1.3

1.2

298.74

340.36

nmol/l

2.03

151

836

Primary hyperparathyroidism

361

1.95

6.47

1.1

300.35

364.32

nmol/l

2.16

305

Heart failure and bmi 25plus

199

891

1.49

6.43

1.3

1.2

313.94

337.44

nmol/l

0.63

160

718

Rheumatoid arthritis, including avohilmo

204

1396

1.47

6.39

1.2

338.76

355.79

nmol/l

0.57

167

1159

Unstable angina pectoris

204

1089

1.48

6.39

1.2

318.37

340.29

nmol/l

0.69

144

882

Diarrhoea and gastroenteritis of presumed infectious origin

363

2437

1.33

6.37

1.2

354.13

368.10

nmol/l

0.64

293

2075

Intestinal infectious diseases

486

2817

1.28

6.37

1.2

356.73

369.92

nmol/l

0.72

390

2404

Fungal Sepsis

108

2.81

6.33

1.3

1.2

341.84

396.16

nmol/l

0.43

Liquid cancers, including Hilmo

200

1200

1.47

6.33

1.2

352.22

343.40

nmol/l

0.22

159

974

Dementia due to Parkinsons disease, excluding more controls

3.88

6.28

1.3

1.1

326.36

336.61

nmol/l

0.06

Asthma (only as main-diagnosis), excluding more controls

337

1373

1.36

6.27

1.2

1.1

375.31

384.81

nmol/l

0.36

286

1206

Sequelae of cerebrovascular disease

211

1242

1.46

6.24

1.2

285.50

329.59

nmol/l

2.50

159

960

Dental caries

140

837

1.58

6.24

1.2

1.1

348.42

369.63

nmol/l

0.55

102

710

Asthma, unspecified (mode)

278

1446

1.39

6.22

1.2

1.1

356.55

377.45

nmol/l

0.92

224

1259

Second line medication for Crohn's disease

280

2035

1.38

6.21

1.2

1.1

353.02

374.33

nmol/l

1.01

247

1754

Tinnitus

124

766

1.63

6.20

1.2

1.1

351.59

371.18

nmol/l

0.54

114

648

Other and unspecified nerve root and plexus disorders, also in other diseases

108

644

1.68

6.20

1.2

1.1

331.93

378.49

nmol/l

1.86

556

Gout

149

821

1.56

6.19

1.3

1.2

299.12

336.42

nmol/l

1.39

112

644

Open wound of head

282

1929

1.38

6.16

1.2

348.99

358.83

nmol/l

0.32

215

1608

Other arthrosis

269

1292

1.40

6.15

1.2

1.1

390.34

370.15

nmol/l

0.82

224

1080

Extrapyramidal and movement disorders

215

1498

1.44

6.15

1.2

340.49

347.10

nmol/l

0.19

178

1222

Benign neoplasm: Transverse colon

333

1.97

6.15

1.3

1.2

310.27

356.37

nmol/l

1.24

276

Migraine with aura

116

707

1.65

6.11

1.1

377.08

395.69

nmol/l

0.45

107

648

Hypertensive diseases (excluding secondary)

231

935

1.44

6.08

1.1

414.24

406.75

nmol/l

0.21

210

872

Small fibre neuropathy

3.12

6.06

1.1

1.2

349.06

396.18

nmol/l

0.43

Dentofacial anomalies [including malocclusion]

329

1918

1.34

6.06

1.1

417.10

385.30

nmol/l

2.24

288

1706

Seropositive rheumatoid arthritis

137

869

1.57

6.01

1.2

328.89

357.15

nmol/l

0.89

113

712

Endometriosis

162

611

1.55

6.01

1.2

1.1

379.59

383.42

nmol/l

0.08

151

502

severe traumatic brain injury, does not include concussion

133

843

1.58

6.00

1.2

334.09

339.49

nmol/l

0.10

104

668

Triptan medication for migraine, min. 3 purchases

264

1422

1.39

5.97

1.1

432.29

395.67

nmol/l

2.33

250

1305

Acute pancreatitis (for exclusion)

112

682

1.65

5.96

1.2

323.15

351.85

nmol/l

0.80

560

Bacterial intestinal infections, IBD co-morbidities

113

690

1.65

5.95

1.2

313.12

347.64

nmol/l

1.11

566

Disorders of eyelid, lacrimal system and orbit

458

2622

1.28

5.93

1.2

367.80

363.84

nmol/l

0.14

391

2208

Other/unspecified dorsalgia

197

1343

1.45

5.92

1.2

341.22

366.88

nmol/l

0.74

156

1118

Injury, poisoning and certain other consequences of external causes

275

990

1.40

5.91

1.2

1.1

373.95

382.24

nmol/l

0.26

243

868

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

436

1.76

5.87

1.1

427.44

415.29

nmol/l

0.22

417

Glaucoma

304

1915

1.35

5.87

1.2

340.87

342.04

nmol/l

0.03

247

1542

Other pulmonary diagnosis

397

1515

1.31

5.85

1.2

1.1

381.34

378.80

nmol/l

0.07

339

1319

Visual disturbances

249

1799

1.39

5.81

1.2

351.87

359.24

nmol/l

0.22

213

1500

Degeneration of macula and posterior pole

268

1505

1.38

5.77

1.3

1.2

309.39

329.10

nmol/l

0.87

213

1184

Disorder of lipoprotein metabolism, unspecified

419

1.82

5.77

1.2

295.52

335.98

nmol/l

1.11

337

Vascular dementia

362

1.88

5.77

1.4

1.2

262.81

316.88

nmol/l

1.24

261

Trochanteric bursitis

464

1.78

5.71

1.3

1.1

363.13

357.97

nmol/l

0.08

394

Oesophageal obstruction

3.00

5.70

1.3

1.2

345.37

371.13

nmol/l

0.25

Rheumatism, unspecified

392

1.85

5.69

1.2

1.1

342.50

371.43

nmol/l

0.67

341

Dementia in Alzheimer disease

117

606

1.62

5.68

1.3

1.2

311.55

310.40

nmol/l

0.02

435

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

227

2.13

5.67

1.2

1.1

399.19

379.37

nmol/l

0.23

198

Pain in joint

276

1236

1.37

5.66

1.2

1.1

364.05

376.27

nmol/l

0.43

247

1048

Disorders of lacrimal system

236

1670

1.39

5.65

1.2

382.11

361.62

nmol/l

0.72

207

1394

Spondylosis

280

1610

1.36

5.64

1.2

340.61

367.90

nmol/l

1.37

228

1335

Cystitis

432

1998

1.29

5.64

1.2

372.97

370.38

nmol/l

0.08

374

1683

Benign neoplasm: Descending colon

195

2.22

5.63

1.5

1.2

337.05

363.51

nmol/l

0.37

165

Weight loss

337

1.91

5.62

1.3

1.2

346.77

358.97

nmol/l

0.18

288

Benign neoplasm: Sigmoid colon

106

647

1.65

5.62

1.3

1.2

313.05

348.65

nmol/l

1.06

516

Alzheimer’s disease (Atypical or mixed), excluding more controls

181

2.12

5.61

1.1

1.2

289.04

307.29

nmol/l

0.21

133

Candidiasis

483

1.75

5.55

1.2

1.1

352.61

374.41

nmol/l

0.41

425

Noninflammatory disorders of female genital tract

192

656

1.47

5.54

1.1

380.21

385.35

nmol/l

0.12

180

538

Candidiasis, including avohilmo

158

1060

1.50

5.54

1.2

1.1

360.05

365.46

nmol/l

0.12

136

918

IBD patients in KELA-register

111

688

1.62

5.53

1.2

1.1

361.97

392.45

nmol/l

0.91

620

COPD differential diagnosis

392

1507

1.31

5.51

1.2

1.1

376.73

378.74

nmol/l

0.06

335

1314

Atherosclerosis, excluding cerebral and coronary sclerosis

234

1320

1.40

5.50

1.2

308.93

322.47

nmol/l

0.43

164

1038

Asthma (only as main-diagnosis)

353

1498

1.32

5.47

1.2

1.1

376.10

379.09

nmol/l

0.10

299

1308

Other symptoms and signs involving the digestive system and abdomen

538

1.70

5.45

1.2

1.1

296.08

364.09

nmol/l

3.11

460

STROKE

260

1276

1.37

5.44

1.2

1.1

341.15

383.89

nmol/l

2.90

218

1132

Additional codes for the location of defect, injury or illness

160

2.33

5.43

1.1

1.2

320.49

393.63

nmol/l

1.24

142

Thyrotoxicosis, other and/or unspecified

103

630

1.64

5.42

1.1

375.51

373.96

nmol/l

0.02

549

ILD differential diagnosis

391

1507

1.30

5.40

1.2

1.1

377.07

378.74

nmol/l

0.05

334

1314

Other sleep disorders

328

1.90

5.38

1.1

402.42

378.97

nmol/l

0.37

278

Other diseases of upper respiratory tract

559

2345

1.24

5.35

1.2

380.33

358.19

nmol/l

1.59

475

1949

Other anxiety disorders

210

1268

1.41

5.35

1.1

375.43

390.84

nmol/l

0.53

191

1145

Osteoporosis

160

994

1.48

5.35

1.2

307.02

335.97

nmol/l

1.00

123

796

Inflammatory bowel disease, strict (require KELA)

111

695

1.60

5.32

1.2

1.1

361.97

387.83

nmol/l

0.72

627

Excluding asthma or asthma-COPD overlap

392

1515

1.30

5.31

1.2

1.1

377.47

378.80

nmol/l

0.04

336

1319

Amputation

351

1.86

5.30

1.2

358.73

319.87

nmol/l

0.71

279

Benign neoplasm: Stomach

323

1.90

5.30

1.3

1.2

369.90

358.67

nmol/l

0.09

274

Other noninfective gastroenteritis and colitis

134

877

1.53

5.28

1.2

360.19

357.46

nmol/l

0.06

114

738

Ischaemic heart disease, wide definition

368

1743

1.30

5.28

1.2

350.90

364.55

nmol/l

0.54

284

1499

Ischaemic Stroke, excluding all haemorrhages

293

1615

1.34

5.25

1.2

304.34

342.32

nmol/l

1.99

222

1285

Sulfasalazine

142

943

1.51

5.25

1.2

339.95

364.23

nmol/l

0.77

122

816

Stroke, excluding SAH

306

1665

1.33

5.23

1.2

307.84

344.60

nmol/l

1.95

230

1336

Paracetamol or NSAID medication

217

1.82

5.18

1.2

1.1

365.02

340.36

nmol/l

0.47

174

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

129

832

1.54

5.17

1.2

1.1

363.92

401.00

nmol/l

1.32

111

775

Peripheral artery operations in Hilmo

449

1.75

5.16

1.3

332.71

326.03

nmol/l

0.10

359

Major coronary heart disease event excluding revascularizations

298

1479

1.33

5.11

1.2

326.56

354.06

nmol/l

1.32

227

1231

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

571

1.65

5.11

1.2

1.1

381.21

394.23

nmol/l

0.18

518

Radiculopathy

541

1.67

5.10

1.2

302.01

345.10

nmol/l

1.24

434

Exclusions for E4_PCOS_CONSORTIUM

359

1728

1.30

5.10

1.2

1.1

381.88

384.07

nmol/l

0.07

315

1509

Disorders of synovium and tendon

255

1600

1.35

5.08

1.2

1.1

378.05

378.21

nmol/l

0.00

215

1357

Emergency coronary revascularization (for ACS)

419

1990

1.27

5.06

1.2

342.34

367.01

nmol/l

1.45

323

1692

Diseases of the skin and subcutaneous tissue

503

2021

1.25

5.06

1.2

1.1

365.09

370.57

nmol/l

0.21

418

1733

COPD/asthma/ILD related infections

512

2058

1.25

5.05

1.2

1.1

365.66

376.63

nmol/l

0.48

432

1771

COPD/asthma related infections

512

2058

1.25

5.05

1.2

1.1

365.66

376.63

nmol/l

0.48

432

1771

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

197

874

1.42

5.04

1.1

369.30

403.66

nmol/l

1.53

172

816

Vitamin deficiency, wide

141

2.36

5.00

1.3

1.1

399.46

386.69

nmol/l

0.11

126

Vitamin deficiency

141

2.36

5.00

1.3

1.1

399.46

386.69

nmol/l

0.11

126

Systemic connective tissue disorders

186

1319

1.41

4.93

1.2

347.63

356.57

nmol/l

0.22

153

1083

Percutaneous Coronary Intervention

377

1787

1.28

4.93

1.2

343.07

372.29

nmol/l

1.73

290

1543

Other systemic involvement of connective tissue

153

1048

1.47

4.90

1.2

348.36

352.65

nmol/l

0.08

121

860

Anaemia in chronic diseases classified elsewhere

3.03

4.85

1.2

1.1

371.67

361.43

nmol/l

0.05

Disorders of choroid and retina

413

2291

1.26

4.84

1.2

1.1

336.24

361.79

nmol/l

1.62

324

1912

Injuries to the knee and lower leg

599

2661

1.22

4.81

1.2

361.68

370.51

nmol/l

0.47

499

2263

Other and unspecified injuries of head

229

2.02

4.80

1.2

326.52

358.68

nmol/l

0.57

196

Abnormal weight loss

313

1.87

4.79

1.3

1.2

321.15

361.23

nmol/l

0.78

268

Other disorders of glucose regulation and pancreatic internal secretion

243

1.99

4.78

1.2

353.72

373.68

nmol/l

0.22

215

Tongue abnormality

170

2.19

4.75

1.3

1.2

355.27

383.98

nmol/l

0.32

152

Acetic acid derivatives and related substances

143

491

1.51

4.75

1.2

1.1

385.61

343.34

nmol/l

1.36

127

379

Nonorganic sleeping disorders

105

669

1.57

4.73

1.1

393.74

385.29

nmol/l

0.16

599

Other disorders of nervous system

191

2.11

4.67

1.2

1.1

313.25

380.46

nmol/l

1.09

165

Benign neoplasm: Rectum

609

1.60

4.67

1.4

1.2

316.21

344.72

nmol/l

0.69

491

Familial hypercholesterolemia, with ischemic heart disease

316

1.85

4.66

1.2

276.38

316.74

nmol/l

0.81

249

Orthopaedic devices associated with adverse incidents

3.27

4.64

1.6

1.2

321.35

371.72

nmol/l

0.48

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

342

2327

1.28

4.63

1.2

346.37

357.29

nmol/l

0.42

261

1939

Myocardial infarction

242

1256

1.35

4.61

1.2

321.39

348.95

nmol/l

1.14

184

1044

Stroke, including SAH

315

1744

1.30

4.61

1.2

310.54

349.75

nmol/l

2.23

237

1416

Any death

294

1571

1.31

4.61

1.2

325.42

356.85

nmol/l

1.70

237

1311

Asthma, excluding more controls

345

1373

1.29

4.59

1.2

1.1

381.44

384.81

nmol/l

0.10

295

1206

Complications of internal orthopaedic prosthetic devices, implants and grafts

126

842

1.50

4.59

1.3

1.2

341.22

341.58

nmol/l

0.01

101

657

Fracture of lower leg, including ankle

272

2033

1.32

4.59

1.2

352.27

368.00

nmol/l

0.64

225

1727

Fentanyl

390

1.75

4.58

1.3

1.2

306.93

340.24

nmol/l

0.66

300

Disorders of mineral metabolism

247

1.96

4.58

1.1

372.65

367.96

nmol/l

0.05

218

Other disorders of lacrimal gland

190

1373

1.39

4.55

1.2

371.44

363.37

nmol/l

0.23

170

1153

Spondyloarthritis

613

1.59

4.54

1.2

345.16

373.25

nmol/l

0.62

528

Artrosis, including avohilmo

414

1803

1.26

4.54

1.2

1.1

371.10

368.07

nmol/l

0.11

359

1521

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

490

2517

1.23

4.53

1.2

1.1

345.65

370.88

nmol/l

1.66

407

2125

Mandibular retrognathia

147

2.25

4.53

1.0

1.1

424.59

398.24

nmol/l

0.33

140

Myocardial infarction, strict

228

1192

1.36

4.52

1.2

311.44

347.67

nmol/l

1.67

169

989

Other cataract

206

1115

1.38

4.50

1.2

1.1

317.06

355.75

nmol/l

2.01

157

937

Covid-19 confirmed case

194

1409

1.38

4.47

1.3

1.2

324.02

347.48

nmol/l

0.89

165

1184

Behavioural syndromes associated with physiological disturbances and physical factors

451

2465

1.24

4.47

1.1

1.2

401.19

367.71

nmol/l

3.03

419

2066

Lumbar disc prolapse

307

1759

1.29

4.44

1.2

1.1

369.25

377.63

nmol/l

0.29

266

1484

Injuries to the hip and thigh

261

1779

1.32

4.42

1.2

338.09

341.95

nmol/l

0.09

209

1431

Implicit fungal Sepsis, including avohilmo

224

1.98

4.35

1.3

1.2

312.03

379.68

nmol/l

1.05

193

Polyarthrosis

110

649

1.53

4.35

1.2

300.76

351.98

nmol/l

2.41

524

Atrial fibrillation and flutter with reimbursement

109

443

1.55

4.35

1.3

1.1

400.11

393.62

nmol/l

0.12

401

Enterocolitis due to Clostridium difficile

398

1.72

4.32

1.2

298.19

344.24

nmol/l

1.08

327

Implicit viral Sepsis, including avohilmo

162

1149

1.41

4.29

1.2

346.19

347.10

nmol/l

0.02

125

938

Coronary revascularization (ANGIO or CABG)

371

1787

1.26

4.28

1.2

343.77

372.29

nmol/l

1.65

286

1543

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

240

1750

1.32

4.27

1.1

1.2

382.39

365.14

nmol/l

0.64

209

1495

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

508

2677

1.22

4.27

1.2

364.19

369.08

nmol/l

0.21

428

2272

Exposure to unspecified factor

504

2818

1.22

4.25

1.2

365.05

370.63

nmol/l

0.24

422

2396

Internal derangement of knee

172

1225

1.39

4.25

1.3

1.1

339.44

373.70

nmol/l

1.41

151

1039

Abnormal spermatozoa

363

1.74

4.24

1.1

1.2

309.30

331.91

nmol/l

0.39

287

Crohn disease

378

1.73

4.23

1.2

1.1

327.00

388.19

nmol/l

1.73

346

Female genital prolapse

142

540

1.47

4.21

1.2

1.1

318.51

375.58

nmol/l

2.39

125

426

Other disorders of skin and subcutaneous tissue

371

2503

1.25

4.21

1.2

346.18

361.23

nmol/l

0.72

301

2099

Other noninflammatory disorders of uterus, except cervix

110

480

1.53

4.19

1.2

1.1

338.66

372.31

nmol/l

0.80

376

Implicit viral Sepsis

112

746

1.51

4.18

1.2

316.09

348.40

nmol/l

0.86

599

Reimbursement for rheumatic diseases

274

2105

1.30

4.18

1.2

351.86

366.71

nmol/l

0.59

230

1776

Noninfectious colitis NAS

455

1.66

4.18

1.2

1.1

342.09

371.23

nmol/l

0.59

402

Allergic contact dermatitis

402

1.70

4.18

1.1

348.04

398.43

nmol/l

1.20

371

Viral Sepsis

112

747

1.50

4.16

1.2

316.09

349.03

nmol/l

0.88

600

Mycoses

137

951

1.44

4.16

1.2

1.1

354.80

365.72

nmol/l

0.23

112

813

Other general symptoms and signs

120

2.33

4.16

1.1

383.64

405.96

nmol/l

0.27

114

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

135

935

1.45

4.15

1.2

330.77

351.39

nmol/l

0.57

111

773

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

166

1193

1.40

4.15

1.1

1.2

375.29

366.70

nmol/l

0.22

136

1028

Coronary atherosclerosis

305

1497

1.29

4.15

1.2

358.90

358.47

nmol/l

0.01

244

1270

Total colectomy

103

2.45

4.14

1.0

1.1

329.89

388.39

nmol/l

0.70

Total colectomy operation

103

2.45

4.14

1.0

1.1

329.89

388.39

nmol/l

0.70

Other bullous disorders

2.83

4.13

1.2

323.46

374.80

nmol/l

0.45

Spondylolisthesis/Spondylolysis

565

1.58

4.13

1.2

1.1

331.60

369.68

nmol/l

1.18

466

Female infertility

120

479

1.50

4.12

1.1

397.70

400.90

nmol/l

0.06

114

419

Disorders of conjunctiva

403

2523

1.24

4.11

1.2

1.1

385.71

373.11

nmol/l

0.61

364

2143

Other and unspecified dermatitis

263

2030

1.30

4.08

1.2

1.1

371.74

369.46

nmol/l

0.06

215

1726

175

1090

1.38

4.07

1.3

1.2

288.91

313.97

nmol/l

0.94

136

818

Other/unspecified seropositive rheumatoid arthritis

137

957

1.44

4.04

1.2

328.89

350.93

nmol/l

0.63

113

789

Benign neoplasm: Rectum, anus and anal canal

105

696

1.51

4.03

1.3

1.2

317.92

346.76

nmol/l

0.73

563

Calcific aortic valvular stenosis, including rheumatic fever

172

1201

1.38

4.03

1.3

1.2

335.54

314.57

nmol/l

0.64

128

918

Endometriosis of ovary

439

1.64

4.03

1.2

1.1

400.89

388.98

nmol/l

0.19

364

Amputation of toe

238

1.90

4.01

1.2

341.23

335.27

nmol/l

0.06

190

Benign neoplasm: Colon, unspecified

132

918

1.44

3.99

1.2

315.40

340.83

nmol/l

0.69

738

Chronic sinusitis

197

1463

1.35

3.99

1.1

1.2

387.35

367.93

nmol/l

0.75

173

1250

Other and unspecified disorders of skin and subcutaneous tissue

183

2.04

3.99

1.2

1.1

316.22

377.81

nmol/l

1.02

160

Atrial fibrillation and flutter

129

569

1.47

3.97

1.2

1.1

404.75

401.40

nmol/l

0.06

112

522

Sleep disorders

429

2409

1.23

3.97

1.1

1.2

401.67

369.34

nmol/l

2.77

399

2027

Dementia in other diseases classified elsewhere

137

2.21

3.96

1.3

1.2

350.90

352.38

nmol/l

0.01

109

Heartburn

319

1.76

3.94

1.3

1.1

362.00

379.70

nmol/l

0.29

277

232

1.90

3.93

1.3

1.2

351.53

332.11

nmol/l

0.22

188

Follow-up care involving plastic surgery

112

2.34

3.93

1.1

448.42

386.22

nmol/l

0.96

105

Delirium, not induced by alcohol and other psychoactive substances

439

1.64

3.93

1.4

1.2

298.59

335.11

nmol/l

0.85

337

Lower back pain or/and sciatica

535

2770

1.20

3.92

1.2

1.1

369.01

369.55

nmol/l

0.02

462

2344

Psoriatic and enteropathic arthropathies

335

1.74

3.90

1.1

362.50

381.64

nmol/l

0.30

297

Right hemicolectomy

178

2.04

3.89

1.4

1.2

326.93

350.44

nmol/l

0.21

149

Injuries to the elbow and forearm

349

2399

1.25

3.89

1.2

346.32

372.83

nmol/l

1.56

282

2046

Exclusions for E4_PCOS_BROAD

534

1.58

3.89

1.1

361.13

379.87

nmol/l

0.34

479

Diseases of male genital organs

205

763

1.36

3.88

1.2

364.18

361.63

nmol/l

0.06

170

629

Use of levodopa decarboxylase inhibitor

505

1.59

3.84

1.2

336.03

323.83

nmol/l

0.20

391

132

862

1.43

3.84

1.2

283.12

316.15

nmol/l

1.08

104

632

Parkinson's disease, strict definition

513

1.59

3.84

1.2

306.78

324.61

nmol/l

0.34

402

Secondary hypertension

176

2.02

3.84

1.2

1.1

342.90

368.72

nmol/l

0.37

159

All influenza

130

910

1.43

3.80

1.2

1.1

317.23

362.14

nmol/l

1.87

105

752

Disorders of sclera, cornea, iris and ciliary body

262

2043

1.28

3.80

1.2

363.78

367.59

nmol/l

0.11

217

1733

Ulcerative colitis

114

779

1.47

3.79

1.2

352.30

378.77

nmol/l

0.76

680

Polyp of the female genital tract

142

563

1.43

3.79

1.2

1.1

378.19

381.06

nmol/l

0.06

128

450

Other CVD

121

837

1.45

3.78

1.2

334.46

333.44

nmol/l

0.02

646

Supplementary factors related to causes of morbidity and mortality classified elsewhere

150

1079

1.39

3.77

1.2

1.1

325.24

368.24

nmol/l

1.58

108

919

Purpura and other haemorrhagic conditions

445

1.62

3.77

1.3

1.2

326.67

352.11

nmol/l

0.47

377

Seronegative rheumatoid arthritis

384

1.67

3.76

1.2

1.1

359.05

354.51

nmol/l

0.06

319

Operations 2 for CAVS

170

1201

1.37

3.76

1.3

1.2

333.01

314.91

nmol/l

0.52

126

918

Calcific aortic valvular stenosis, diagnosis (helper)

170

1201

1.37

3.76

1.3

1.2

333.01

314.91

nmol/l

0.52

126

918

Seropositive rheumatoid arthritis, wide

137

971

1.42

3.76

1.2

328.89

350.33

nmol/l

0.61

113

803

Calcific aortic valvular stenosis

170

1202

1.37

3.74

1.3

1.2

333.01

315.32

nmol/l

0.51

126

919

Calcific aortic valvular stenosis, operated

170

1202

1.37

3.74

1.3

1.2

333.01

315.32

nmol/l

0.51

126

919

Restless leg syndrome

493

1.59

3.74

1.2

1.1

352.03

363.64

nmol/l

0.21

428

Ovarian cyst

154

628

1.41

3.73

1.1

378.74

387.15

nmol/l

0.18

134

517

Fissure and fistula of anal and rectal regions

108

733

1.48

3.73

1.2

1.1

337.97

376.32

nmol/l

1.14

627

Bronchitis, not specified as acute or chronic

259

1.82

3.71

1.2

384.33

362.37

nmol/l

0.26

227

Other enthesopathies

137

973

1.41

3.71

1.1

372.96

386.52

nmol/l

0.32

121

843

Duodenal ulcer

318

1.74

3.70

1.3

1.2

258.08

348.86

nmol/l

2.76

246

Unspecified fall

256

1961

1.28

3.68

1.2

335.54

357.12

nmol/l

0.92

207

1611

Osteoporosis with pathological fracture (FG)

275

1.79

3.66

1.2

303.42

352.03

nmol/l

0.87

213

Asthma (mode)

357

1507

1.25

3.65

1.2

1.1

377.91

378.74

nmol/l

0.02

303

1314

Dermatitis and eczema

548

2727

1.19

3.64

1.2

367.08

368.16

nmol/l

0.04

457

2316

Other ulcerative colitis

150

2.08

3.57

1.2

1.1

340.75

397.22

nmol/l

0.92

138

Focal brain injury

150

2.08

3.56

1.2

348.20

356.90

nmol/l

0.08

121

Hypotension

108

741

1.46

3.55

1.2

344.46

326.02

nmol/l

0.34

566

Major coronary heart disease event

391

1910

1.23

3.54

1.2

341.02

371.09

nmol/l

1.91

308

1635

Uterine polyps

132

541

1.43

3.54

1.1

392.90

383.72

nmol/l

0.19

117

431

Type of accident

141

1016

1.39

3.54

1.2

326.76

367.35

nmol/l

1.33

100

862

Biological medication for rheuma

500

1.57

3.53

1.1

386.53

393.49

nmol/l

0.12

461

Fenamates

309

1.61

3.53

1.1

384.85

358.01

nmol/l

0.46

236

Tonsillectomy and adenotomy

227

1214

1.30

3.52

1.1

406.79

400.37

nmol/l

0.18

215

1110

Other extrapyramidal and movement disorders in other diseases

126

892

1.42

3.51

1.1

1.2

340.29

351.91

nmol/l

0.28

113

742

Prolonged pregnancy

398

0.45

3.48

1.0

1.1

469.10

422.30

nmol/l

0.52

385

Type 1 diabetes

108

743

1.46

3.48

1.2

356.79

381.42

nmol/l

0.60

677

Malignant neoplasm of colon, including Hilmo

107

733

1.46

3.48

1.3

1.2

325.85

332.48

nmol/l

0.11

570

Thyroiditis, ILD-related definition

355

1.67

3.46

1.1

377.83

383.10

nmol/l

0.07

318

Pacemaker

197

1392

1.32

3.46

1.2

325.60

324.24

nmol/l

0.03

144

1077

Neuromuscular dysfunction of bladder

295

1.74

3.46

1.2

329.78

352.97

nmol/l

0.28

252

Hard cardiovascular diseases

381

1839

1.23

3.45

1.2

1.1

347.37

376.44

nmol/l

1.84

305

1598

Psoriatic arthropathies

266

1.77

3.43

1.1

375.47

371.14

nmol/l

0.05

235

Haemorrhoids and perianal venous thrombosis

159

1167

1.36

3.41

1.2

1.1

330.30

360.74

nmol/l

1.17

135

955

Malignant neoplasm of digestive organs, including Hilmo

221

1252

1.30

3.41

1.3

1.2

340.68

347.28

nmol/l

0.17

175

1018

Dermatitis

306

2410

1.24

3.41

1.2

1.1

373.73

369.22

nmol/l

0.13

252

2042

Epilepsy

141

1020

1.38

3.40

1.1

1.2

307.51

369.07

nmol/l

3.16

102

846

Diabetic maculopathy, excluding more controls

304

1.72

3.40

1.3

1.2

342.84

356.14

nmol/l

0.15

278

Vascular disorders of the intestines

216

1.86

3.40

1.1

1.2

275.99

333.70

nmol/l

1.27

172

Infections of the skin and subcutaneous tissue

267

2085

1.26

3.38

1.2

1.1

342.20

373.58

nmol/l

1.55

213

1786

Gilbert syndrome

7.14

3.38

1.1

1.2

320.86

437.70

nmol/l

—

Migraine with aura and triptan purchases

427

1.60

3.38

1.1

385.11

393.80

nmol/l

0.13

400

Coxarthrosis, primary, with hip surgery

232

1678

1.28

3.38

1.2

347.79

337.47

nmol/l

0.33

185

1338

Phobic anxiety disorders

334

1.68

3.37

1.2

1.1

372.58

405.43

nmol/l

0.56

317

Nontoxic single thyroid nodule

217

1.85

3.36

1.2

1.1

318.28

383.87

nmol/l

1.27

196

Anterior Iridocyclitis

660

1.47

3.35

1.2

1.1

368.32

366.11

nmol/l

0.04

568

Superficial injury of hip and thigh

595

1.50

3.35

1.3

1.2

344.00

339.58

nmol/l

0.07

481

Insomnia

416

2399

1.21

3.34

1.1

1.2

401.51

371.17

nmol/l

2.46

389

2027

Left hemicolectomy

2.74

3.33

1.5

1.2

343.73

355.32

nmol/l

0.06

Ischemic heart diseases

380

1855

1.22

3.33

1.2

344.54

373.15

nmol/l

1.71

296

1609

Episcleritis

141

2.07

3.32

1.3

1.1

374.33

403.53

nmol/l

0.28

131

5-aminosalicylic acid

645

1.48

3.32

1.2

1.1

384.46

380.08

nmol/l

0.08

572

Spondylopathies (FG)

414

1.60

3.30

1.2

1.1

379.26

388.59

nmol/l

0.12

372

Lesion of ulnar nerve

422

1.59

3.30

1.2

1.1

386.94

380.97

nmol/l

0.07

364

Asthma

357

1498

1.23

3.30

1.2

1.1

379.89

379.09

nmol/l

0.02

302

1308

Gonarthrosis

303

1371

1.25

3.29

1.2

1.1

344.25

366.36

nmol/l

1.04

255

1147

571

2461

1.18

3.29

1.2

358.67

368.40

nmol/l

0.50

474

2083

Parkinson's disease, including avohilmo

582

1.50

3.28

1.2

307.01

327.26

nmol/l

0.43

455

Personality disorders

112

787

1.43

3.27

1.1

353.04

401.32

nmol/l

1.73

723

Primary open-angle glaucoma

172

1247

1.33

3.26

1.3

1.2

327.70

322.22

nmol/l

0.13

135

954

Other (seronegative) rheumatoid arthritis, wide

673

1.46

3.25

1.2

340.31

352.68

nmol/l

0.24

562

Acute and subacute iridocyclitis

616

1.48

3.24

1.2

1.1

365.03

365.87

nmol/l

0.01

531

Injuries to the thorax

227

1777

1.28

3.24

1.2

338.97

355.30

nmol/l

0.60

191

1459

Parkinson's disease

560

1.51

3.23

1.2

301.16

328.23

nmol/l

0.61

436

Somnolence, stupor and coma

116

2.17

3.23

1.3

1.2

273.53

367.94

nmol/l

1.09

Anomalies of dental arch relationship, including avohilmo

491

1.51

3.20

1.1

443.85

394.37

nmol/l

1.27

456

Disorders of calcium metabolism

178

1.92

3.19

1.1

389.55

370.29

nmol/l

0.21

156

Streptococcal septicaemia, including avohilmo

280

1.72

3.18

1.3

1.2

317.20

340.05

nmol/l

0.29

239

Other bursopathies

387

1.61

3.18

1.2

1.1

373.06

363.70

nmol/l

0.13

312

Gout, FINNGEN

149

1097

1.35

3.18

1.3

1.2

299.12

332.49

nmol/l

1.22

112

865

Conjunctivitis

348

2300

1.22

3.17

1.2

1.1

385.85

375.81

nmol/l

0.42

323

1973

Diseases of salivary glands

153

1140

1.35

3.16

1.2

354.22

369.76

nmol/l

0.46

128

983

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

105

725

1.43

3.16

1.1

370.87

399.44

nmol/l

0.76

663

Collagenous colitis

296

1.70

3.15

1.1

1.2

389.57

376.05

nmol/l

0.17

258

therapeutic use

2.43

3.14

1.6

1.2

319.63

397.41

nmol/l

1.04

Ulcerative proctitis

172

1.93

3.14

1.2

1.1

377.11

410.94

nmol/l

0.41

160

Inflammatory diseases of prostate (prostatitis)

358

1.63

3.12

1.3

1.2

349.13

343.71

nmol/l

0.08

284

Abnormal findings on diagnostic imaging of other body structures

469

1.54

3.09

1.2

1.1

359.45

366.36

nmol/l

0.09

400

Intestinal adhesions without obstruction

253

1.75

3.08

1.2

1.1

314.05

363.14

nmol/l

0.99

215

Fracture of forearm

267

1925

1.25

3.08

1.2

335.76

371.54

nmol/l

2.05

212

1640

Papulosquamous disorders

181

1388

1.31

3.07

1.2

366.43

362.62

nmol/l

0.08

132

1193

Fibroblastic disorders

110

781

1.41

3.06

1.2

327.10

355.24

nmol/l

0.75

628

Cervicalgia

100

698

1.44

3.06

1.2

375.85

365.08

nmol/l

0.19

579

Female infertility, cervical, vaginal, other or unspecified origin

105

467

1.44

3.05

1.1

408.42

400.74

nmol/l

0.15

100

409

Allergic conjunctivitis

260

2006

1.25

3.05

1.2

1.1

401.40

380.70

nmol/l

0.93

249

1743

Other disorders of skin and subcutaneous tissue, not elsewhere classified

511

1.51

3.04

1.2

322.90

347.42

nmol/l

0.46

424

Other Crohn's disease

174

1.91

3.04

1.2

1.1

312.04

392.42

nmol/l

1.55

163

Impingement syndrome of shoulder

675

1.44

3.02

1.2

1.1

338.57

373.27

nmol/l

0.95

578

Crossbite

128

2.02

3.01

1.1

471.32

401.23

nmol/l

0.76

119

Other diseases of pericardium

113

2.14

3.00

1.2

1.1

310.30

354.59

nmol/l

0.50

Use of rasagiline

2.43

2.98

1.4

1.2

347.23

381.92

nmol/l

0.35

Asthma, including avohilmo

574

2717

1.16

2.97

1.2

380.83

366.24

nmol/l

0.92

488

2299

Urinary track infection

279

1122

1.25

2.95

1.1

387.37

395.98

nmol/l

0.24

252

994

Haemorrhage from respiratory passages

163

1096

1.32

2.93

1.2

347.83

341.11

nmol/l

0.15

134

888

Primary coxarthrosis, bilateral

149

1121

1.33

2.92

1.3

1.2

345.77

334.67

nmol/l

0.28

118

876

Explicit bacterial Sepsis, including avohilmo

349

1.61

2.92

1.3

1.2

315.21

355.67

nmol/l

0.72

289

Cardiac arrest

125

1.98

2.90

1.2

1.1

330.00

364.08

nmol/l

0.33

107

Elevated blood glucose level

243

1.74

2.90

1.1

1.2

408.31

365.94

nmol/l

0.73

220

Acquired absence of limb

4.16

2.90

1.2

373.00

385.06

nmol/l

—

Hyperparathyroidism

105

740

1.41

2.89

1.2

309.21

344.25

nmol/l

1.06

601

Diseases of tongue

221

1.77

2.89

1.3

1.1

343.88

353.19

nmol/l

0.09

193

Malignant neoplasm of colon

616

1.45

2.88

1.3

1.2

320.17

338.02

nmol/l

0.32

475

Arthropathies in other diseases classified elsewhere

2.26

2.87

1.3

1.2

345.40

374.46

nmol/l

—

Injuries to the neck

104

741

1.41

2.87

1.2

1.1

337.37

380.58

nmol/l

1.39

648

Inflammatory diseases of female pelvic organs

294

1640

1.23

2.86

1.2

1.1

385.28

383.57

nmol/l

0.05

275

1428

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

248

1910

1.24

2.86

1.2

1.1

399.32

381.71

nmol/l

0.73

238

1661

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

535

1.48

2.85

1.2

1.1

387.91

385.06

nmol/l

0.04

484

Gonarthrosis [arthrosis of knee](FG)

360

1719

1.21

2.85

1.2

1.1

346.73

371.34

nmol/l

1.39

301

1442

Synovial cyst of popliteal space [Baker]

222

1.77

2.85

1.3

1.1

374.15

374.75

nmol/l

0.01

186

Iron deficiency

2.31

2.84

1.2

1.0

396.42

410.85

nmol/l

0.10

Leisure time condition

626

1.44

2.84

1.2

309.85

360.32

nmol/l

1.42

541

Other/unspecified synovitis and tenosynovitis

329

1.62

2.82

1.2

1.1

347.49

388.04

nmol/l

0.76

283

Speech and linguistic disorders, excluding more controls

141

1.94

2.80

1.2

1.1

346.71

392.88

nmol/l

0.50

134

Diplopia

425

1.54

2.78

1.2

1.1

332.27

364.16

nmol/l

0.71

369

Disorders of speech understanding and production

2.18

2.77

1.2

1.1

301.25

381.34

nmol/l

1.00

Thrombocytopenia, unspecified

202

1.79

2.77

1.3

1.2

335.26

363.20

nmol/l

0.33

174

Lateral epicondylitis

370

1.57

2.77

1.2

1.1

375.49

403.92

nmol/l

0.49

329

Liquid cancers

148

1061

1.32

2.76

1.2

353.74

338.70

nmol/l

0.34

118

856

Iridocyclitis

105

755

1.39

2.76

1.2

1.1

356.98

361.22

nmol/l

0.08

639

Unspecified jaundice

145

1.94

2.75

1.1

1.2

328.81

371.37

nmol/l

0.40

121

Specific personality disorders

672

1.42

2.74

1.2

1.1

351.41

400.83

nmol/l

1.60

623

Benign neoplasm: Rectosigmoid junction

111

2.09

2.73

1.2

382.60

376.05

nmol/l

0.04

Propionic acid derivatives

133

492

1.36

2.73

1.2

1.1

368.85

343.00

nmol/l

0.65

116

380

Peripheral arterial reconstruction

640

1.43

2.72

1.2

304.35

318.25

nmol/l

0.26

487

Hypoglycaemia, other or unspecified

196

1.79

2.71

1.2

331.91

380.79

nmol/l

0.57

173

Other/unspecified rheumatoid arthritis

444

1.52

2.71

1.3

1.2

352.17

350.54

nmol/l

0.02

368

Streptococcal septicaemia

271

1.67

2.71

1.3

1.2

332.38

341.89

nmol/l

0.10

233

Chronic iridocyclitis

125

2.01

2.71

1.3

1.1

357.68

388.83

nmol/l

0.36

110

Gout, idiopatic and unspecified

125

929

1.35

2.69

1.3

1.2

300.80

330.97

nmol/l

0.93

722

Superficial injury of head

121

894

1.36

2.68

1.1

1.2

351.60

359.97

nmol/l

0.18

743

Viral pneumonia

421

1.53

2.68

1.1

1.2

331.88

351.56

nmol/l

0.31

356

Carbimazole or st.post thyroidectomy, condition for graves disease

684

1.41

2.67

1.1

386.88

380.87

nmol/l

0.11

608

Other diseases of liver

576

1.45

2.67

1.1

355.77

371.28

nmol/l

0.29

503

Diseases of liver

157

1207

1.30

2.67

1.1

1.2

352.65

359.98

nmol/l

0.17

125

1025

Seborrhoeic dermatitis

303

1.62

2.67

1.1

375.83

382.69

nmol/l

0.08

266

Fracture of femur

151

1039

1.31

2.67

1.2

329.73

322.56

nmol/l

0.12

127

784

Disorders of parathyroid gland

115

835

1.37

2.67

1.1

1.2

310.37

341.38

nmol/l

1.00

679

Symptoms and signs involving the nervous and musculoskeletal systems

274

2248

1.22

2.66

1.2

367.55

357.62

nmol/l

0.35

227

1875

Pneumocystosis, including avohilmo

2.82

2.65

1.0

1.1

296.29

372.50

nmol/l

—

Pneumocystosis

2.82

2.65

1.0

1.1

296.29

372.50

nmol/l

—

Other eating disorders

119

2.03

2.65

1.3

1.0

421.87

391.21

nmol/l

0.35

112

Seropositive rheumatoid arthritis, strict definition

495

1.48

2.65

1.2

1.1

300.65

362.10

nmol/l

2.02

423

Abrasion of teeth

159

1226

1.30

2.65

1.2

1.1

400.77

374.84

nmol/l

0.96

143

1065

Phlebitis and thrombophlebitis (not including DVT)

111

812

1.37

2.65

1.2

332.46

356.02

nmol/l

0.38

680

Hernia of abdominal wall, postoperative

565

1.44

2.64

1.2

1.1

314.83

364.78

nmol/l

1.55

461

Pediculosis, acariasis and other infestations, including avohilmo

504

1.47

2.63

1.1

380.06

395.13

nmol/l

0.25

459

Diseases of inner ear

261

2043

1.22

2.60

1.2

341.33

357.35

nmol/l

0.62

214

1685

Hallux valgus (acquired)

158

868

1.30

2.59

1.2

1.1

356.98

369.87

nmol/l

0.31

126

726

Palmar fascial fibromatosis [Dupuytren]

490

1.47

2.58

1.2

304.39

343.21

nmol/l

1.07

378

Panic disorder

409

1.52

2.57

1.1

388.55

398.74

nmol/l

0.17

388

Disorders of adult personality and behaviour

113

835

1.36

2.54

1.2

1.1

352.47

402.60

nmol/l

1.83

769

Pain associated with micturition

387

1.53

2.52

1.2

1.1

363.57

366.70

nmol/l

0.03

331

Benign leiomyoma with endometriosis

534

1.45

2.51

1.2

1.1

381.58

359.86

nmol/l

0.40

455

Enlarged lymph nodes

469

1.48

2.49

1.1

395.31

368.42

nmol/l

0.45

415

Hypo-osmolality and hyponatraemia

638

1.40

2.49

1.4

1.2

312.51

329.33

nmol/l

0.30

515

Superficial injury of thorax

527

1.45

2.48

1.2

335.06

357.35

nmol/l

0.46

442

Subjective visual disturbances

117

873

1.34

2.48

1.3

1.1

369.10

363.22

nmol/l

0.10

103

744

Acute renal failure

113

839

1.35

2.48

1.3

1.2

306.97

337.01

nmol/l

0.77

669

Unspecified kidney failure

373

1.53

2.47

1.3

1.2

245.71

326.45

nmol/l

2.85

295

Explicit bacterial Sepsis

341

1.56

2.47

1.3

1.2

327.51

354.07

nmol/l

0.40

283

Decubitus ulcer and pressure area

210

1.72

2.46

1.1

1.2

345.83

349.82

nmol/l

0.03

169

Circumscribed brain atrophy

2.48

2.46

1.3

1.2

244.00

349.65

nmol/l

1.50

Mouth breathing

161

1256

1.28

2.45

1.1

379.41

372.77

nmol/l

0.16

142

1081

Asthma (diagnoses ohter than nonallergic)

415

2872

1.17

2.45

1.2

366.59

368.48

nmol/l

0.06

349

2434

Myocardial infarction, with ST-elevation

629

1.40

2.44

1.2

320.63

327.09

nmol/l

0.09

487

Diseases of the myoneural junction and muscle

415

1.50

2.43

1.3

1.2

366.78

355.57

nmol/l

0.17

353

Non-ischemic cardiomyopathy

146

891

1.30

2.43

1.2

289.43

342.96

nmol/l

2.83

127

731

Enthesopathies of lower limb, excluding foot

714

1.38

2.43

1.1

370.03

380.42

nmol/l

0.21

616

Arthropathic psoriasis

335

1.56

2.42

1.2

1.1

379.10

373.81

nmol/l

0.06

304

Fall on same level involving ice and snow

268

2222

1.21

2.38

1.2

343.06

366.77

nmol/l

1.17

213

1892

Malignant neoplasm of digestive organs

194

1186

1.25

2.37

1.2

345.59

341.71

nmol/l

0.09

153

957

Disorders of magnesium metabolism

4.19

2.37

1.1

316.71

363.76

nmol/l

—

Other problems related to primary support group, including family circumstances

289

1.59

2.36

1.1

378.58

406.12

nmol/l

0.42

272

Protozoal diseases

2.27

2.35

1.1

1.2

289.33

378.90

nmol/l

—

Other hammer toe(s) (acquired)

522

1.41

2.34

1.2

371.83

341.78

nmol/l

0.59

412

Viral warts, including avohilmo

668

1.38

2.34

1.1

374.83

389.94

nmol/l

0.31

590

Postmenopausal osteoporosis with pathological fracture

253

1.63

2.30

1.2

313.59

339.80

nmol/l

0.32

210

Postmenopausal bleeding

121

474

1.34

2.30

1.2

1.1

379.39

371.39

nmol/l

0.13

100

366

Psoriasis

125

954

1.31

2.30

1.2

1.1

364.32

368.41

nmol/l

0.07

823

Thyrotoxicosis with diffuse goitre

404

1.49

2.30

1.1

422.86

386.70

nmol/l

0.80

363

Spinal instabilities

2.14

2.29

1.5

1.1

350.62

404.60

nmol/l

0.45

Abnormal findings on examination of blood, without diagnosis

222

1641

1.23

2.29

1.1

1.2

365.07

346.02

nmol/l

0.65

169

1360

Cervicocranial syndrome

332

1.54

2.29

1.1

389.98

375.08

nmol/l

0.19

283

Asthma, hospital admission 2, infections

279

2274

1.20

2.28

1.2

372.68

361.86

nmol/l

0.39

233

1911

Asthma-related infections

279

2274

1.20

2.28

1.2

372.68

361.86

nmol/l

0.39

233

1911

Scleritis and episcleritis

170

1.77

2.28

1.3

1.1

367.12

395.53

nmol/l

0.28

156

Asthma, hospital admissions , main diagnosis only

381

2841

1.17

2.28

1.2

369.56

368.63

nmol/l

0.03

320

2412

Disorders of ocular muscles, binocular movement, accommodation and refraction

205

1649

1.23

2.28

1.1

367.84

381.71

nmol/l

0.44

172

1442

Recurrent aphthous stomatitis , including avohilmo

479

1.44

2.27

1.3

1.1

351.34

367.28

nmol/l

0.26

416

Convulsions, not elsewhere classified

680

1.37

2.27

1.1

341.74

368.74

nmol/l

0.58

599

Meniscus derangement

241

1313

1.22

2.27

1.2

1.1

377.38

370.73

nmol/l

0.18

206

1100

Glomerular disorders in diseases classified elsewhere

349

1.52

2.26

1.3

1.2

353.00

362.70

nmol/l

0.12

295

Gout, unspecified

101

750

1.35

2.25

1.3

1.2

277.58

334.65

nmol/l

2.13

589

Substance abuse, excluding more controls

217

1479

1.23

2.25

1.2

1.1

344.60

374.23

nmol/l

1.31

171

1288

Bullous disorders

171

1.76

2.25

1.3

1.2

349.21

376.34

nmol/l

0.33

143

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

539

1.41

2.24

1.1

1.2

350.46

346.07

nmol/l

0.07

439

Thyrotoxicosis

118

898

1.32

2.23

1.2

376.03

368.67

nmol/l

0.14

776

Degeneration of the brain due to alcohol

2.36

2.22

1.2

1.1

213.89

370.75

nmol/l

—

Multiple myeloma and malignant plasma cell neoplasms

135

1.86

2.22

1.2

335.37

345.62

nmol/l

0.08

112

Psoriatic arthropathies, ICD10

303

1.56

2.21

1.1

375.47

375.07

nmol/l

0.00

274

Dislocation, sprain and strain of joints and ligaments at neck level

449

1.45

2.21

1.1

336.40

396.52

nmol/l

1.89

413

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

272

1.59

2.20

1.0

1.2

290.53

340.97

nmol/l

0.88

231

Speech disturbances, not elsewhere classified

312

1.54

2.18

1.2

352.42

351.30

nmol/l

0.01

265

Symptoms and signs involving speech and voice

157

1244

1.26

2.18

1.2

389.64

358.48

nmol/l

1.15

128

1045

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

475

1.44

2.18

1.2

1.1

373.45

385.36

nmol/l

0.19

431

Other and unspecified drugs and medicaments

257

1.60

2.17

1.1

349.55

384.48

nmol/l

0.44

230

Pneumonia due to other infectious organisms, not elsewhere classified

2.08

2.17

1.1

372.39

382.53

nmol/l

0.06

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

313

1.54

2.16

1.3

1.2

317.56

359.94

nmol/l

0.70

275

Chronic ulcer of skin, not elsewhere classified

219

1.65

2.15

1.2

339.63

336.34

nmol/l

0.03

182

Adenomyosis (Endometriosis of uterus)

369

1.49

2.15

1.3

1.1

343.86

377.35

nmol/l

0.64

290

Endometriosis ASRM stages 3,4

102

765

1.34

2.15

1.2

1.1

383.69

375.60

nmol/l

0.14

678

Sequelae of injuries, of poisoning and of other consequences of external causes

100

748

1.34

2.14

1.3

1.1

391.56

377.21

nmol/l

0.25

650

Use of galantamine

346

1.51

2.14

1.3

1.2

311.36

293.46

nmol/l

0.25

268

Thyroiditis

212

1.66

2.13

1.1

404.29

397.89

nmol/l

0.07

188

Ulcerative colitis (strict definition, require KELA)

495

1.42

2.11

1.2

1.1

377.60

382.62

nmol/l

0.07

449

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

275

1.57

2.11

1.1

343.73

390.75

nmol/l

0.70

247

Chronic lower respiratory diseases

566

2635

1.13

2.07

1.2

1.1

371.56

370.80

nmol/l

0.03

472

2249

Other postsurgical states

168

1.73

2.07

1.2

1.1

342.38

392.14

nmol/l

0.63

148

Schizophrenia

458

0.59

2.07

1.1

292.99

387.46

nmol/l

1.61

420

Gonarthrosis,primary

432

2266

1.15

2.06

1.2

343.75

361.75

nmol/l

0.98

356

1875

Other specified/unspecified systemic involvement of connective tissue

161

1.75

2.06

1.3

1.1

330.79

397.11

nmol/l

0.95

147

Asthma/COPD (KELA code 203)

451

2633

1.14

2.06

1.2

1.1

377.94

370.79

nmol/l

0.30

380

2247

Postprocedural endocrine and metabolic disorders, not elsewhere classified

382

1.47

2.05

1.1

414.21

380.61

nmol/l

0.58

348

Hyperplasia of prostate

149

660

1.27

2.04

1.2

348.23

347.57

nmol/l

0.01

113

534

Degenerative macular diseases

458

1.42

2.02

1.4

1.2

316.90

334.73

nmol/l

0.33

356

Colorectal cancer, including Hilmo

136

997

1.27

2.02

1.3

1.2

329.06

336.08

nmol/l

0.14

103

788

Other skin changes

730

1.33

2.02

1.3

1.2

358.81

348.21

nmol/l

0.20

602

Dementia due to Parkinson's disease

2.02

2.01

1.3

1.2

326.36

357.46

nmol/l

0.22

Sequelae of injuries of head

140

1.79

2.01

1.4

1.1

335.60

381.12

nmol/l

0.55

124

Deviated nasal septum

133

1044

1.27

2.00

1.2

1.1

351.62

362.42

nmol/l

0.24

106

877

Artificial joint operation, meniscal resection

432

2411

1.15

2.00

1.2

356.12

363.31

nmol/l

0.29

369

1997

Malignant melanoma, including Hilmo

649

0.66

2.00

1.1

1.2

356.59

347.43

nmol/l

0.12

516

Other noninflammatory disorders of vulva and perineum

255

1.57

2.00

1.3

1.1

380.12

394.86

nmol/l

0.15

217

Benign thyroid growths and nodules

149

1103

1.26

1.99

1.2

341.77

355.40

nmol/l

0.36

123

920

Disorders of skin appendages

207

1702

1.21

1.98

1.2

1.1

386.06

377.52

nmol/l

0.22

170

1492

Other disorders of conjunctiva

502

1.40

1.97

1.2

405.35

346.10

nmol/l

1.38

415

Bell's palsy

369

1.47

1.97

1.2

1.1

387.09

371.65

nmol/l

0.21

319

Osteomyelitis

194

1.66

1.96

1.1

1.2

367.70

362.19

nmol/l

0.04

163

Medical abortion

209

1368

0.83

1.96

1.1

1.2

383.07

378.47

nmol/l

0.12

182

1185

Amyloidosis

2.37

1.95

1.5

1.1

338.83

317.19

nmol/l

0.19

Dissociative [conversion] disorders

1.95

1.2

1.1

300.93

387.60

nmol/l

0.88

Other medical care

207

1436

1.21

1.94

1.2

339.01

353.29

nmol/l

0.42

163

1235

Other noninflammatory disorders of cervix uteri

120

1.84

1.93

1.4

1.1

326.57

380.72

nmol/l

0.54

Other and unspecified local infections of skin and subcutaneous tissue

298

1.52

1.92

1.3

1.1

341.53

376.83

nmol/l

0.47

265

Sequelae of tuberculosis

2.26

1.91

1.2

302.00

330.73

nmol/l

—

Protozoal diseases, including avohilmo

2.07

1.91

1.1

1.2

289.33

375.70

nmol/l

—

Bipolar affective disorders

514

1.38

1.90

1.2

1.1

347.52

403.79

nmol/l

1.73

476

Anti-inflammatory and antirheumatic products, non-steroids

126

492

1.29

1.90

1.3

1.1

364.18

343.00

nmol/l

0.53

110

380

Specific development disorders of speech and language

123

1.81

1.90

1.2

1.1

301.25

391.52

nmol/l

1.22

112

Dental operations

318

1399

1.17

1.89

1.2

348.27

359.96

nmol/l

0.45

264

1151

Other and unspecified nonorganic psychotic disorders

556

0.65

1.88

1.1

323.19

398.97

nmol/l

1.35

515

Ulcerative colitis, NAS

406

1.43

1.88

1.2

1.1

363.29

380.12

nmol/l

0.27

364

Chronic rhinitis, nasopharyngitis and pharyngitis

130

1028

1.27

1.88

1.2

1.1

380.22

363.73

nmol/l

0.41

117

892

208

1555

1.20

1.87

1.3

1.2

328.06

323.38

nmol/l

0.12

165

1207

Other metabolic disorders

415

1.43

1.87

1.1

408.26

383.61

nmol/l

0.39

379

Other diseases of lip and oral mucosa

182

1496

1.22

1.87

1.2

1.1

365.23

371.94

nmol/l

0.18

156

1277

Otalgia

236

1.57

1.86

1.1

412.00

381.33

nmol/l

0.45

209

Glomerular diseases

576

1.36

1.86

1.2

365.06

357.58

nmol/l

0.12

487

Other strabismus

668

1.33

1.86

1.2

1.1

382.60

385.59

nmol/l

0.04

594

Keratitis

154

1245

1.24

1.85

1.2

370.02

366.59

nmol/l

0.07

129

1063

Psoriasis (vulgaris), strict definition

1.95

1.85

1.2

1.1

340.45

412.67

nmol/l

0.56

Other menopausal disorders

110

471

1.30

1.84

1.1

412.90

387.39

nmol/l

0.61

100

383

Bacterial pneumoniae

186

1345

1.22

1.84

1.2

314.43

350.47

nmol/l

1.68

142

1108

Flat foot [pes planus] (acquired)

277

1.52

1.84

1.2

1.1

395.73

360.42

nmol/l

0.54

241

Leiomyoma of uterus

295

1413

1.17

1.83

1.2

1.1

377.67

376.50

nmol/l

0.03

257

1216

Other local infections of skin and subcutaneous tissue

318

1.48

1.83

1.3

1.1

334.58

378.32

nmol/l

0.66

282

Degeneration of nervous system due to alcohol

2.14

1.82

1.2

1.1

213.89

360.00

nmol/l

—

Gout, strict definition

656

1.33

1.82

1.3

1.2

319.82

330.08

nmol/l

0.18

513

Malignant neoplasm of bronchus and lung

620

0.70

1.81

1.2

286.50

322.18

nmol/l

0.73

488

Prolapse and hernia of ovary and fallopian tube

129

1.78

1.80

1.1

1.2

218.94

332.21

nmol/l

2.13

Sequelae of tuberculosis, including avohilmo

2.19

1.78

1.2

302.00

328.15

nmol/l

—

Stomatitis and related lesions

667

1.32

1.78

1.3

1.1

356.46

370.31

nmol/l

0.27

585

Disorders of vestibular function (Vertigo)

219

1793

1.19

1.78

1.2

347.39

356.85

nmol/l

0.28

178

1483

Disease of hard tissues of teeth, NOS

196

1235

0.83

1.77

1.2

1.1

360.14

360.55

nmol/l

0.01

182

1029

Other psoriatic arthropathies

296

1.49

1.77

1.1

379.06

377.72

nmol/l

0.01

268

Cyst of kidney

216

1.58

1.76

1.1

1.2

391.50

372.34

nmol/l

0.15

182

Redundant prepuce, phimosis and paraphimosis

505

1.37

1.76

1.2

318.07

364.35

nmol/l

1.08

414

Other disorders of kidney and ureter

429

1.40

1.76

1.2

339.34

355.79

nmol/l

0.22

360

Fistulae involving female genital tract

2.52

1.74

1.0

1.1

398.00

414.00

nmol/l

—

Asthma-related pneumonia

179

1476

1.21

1.74

1.2

342.01

347.61

nmol/l

0.13

148

1192

Asthma, hospital admissions 3, pneumonia

179

1476

1.21

1.74

1.2

342.01

347.61

nmol/l

0.13

148

1192

Asthma-related pneumonia or sepsis

179

1476

1.21

1.74

1.2

342.01

347.61

nmol/l

0.13

148

1192

Sicca syndrome [Sjögren]

281

1.50

1.74

1.1

343.63

380.97

nmol/l

0.48

244

Benign neoplasm of urinary organs

132

1.75

1.73

1.1

1.2

291.67

381.60

nmol/l

1.05

111

Alzheimer’s disease (Early onset)

178

1.64

1.73

1.1

1.2

368.66

331.49

nmol/l

0.39

140

Mental disorders, not otherwise specified

241

1.54

1.73

1.1

332.90

404.41

nmol/l

1.16

229

Azathioprine

422

1.40

1.73

1.3

1.1

342.46

382.49

nmol/l

0.75

377

Sciatica+with lumbago

223

1667

1.19

1.71

1.2

1.1

358.08

376.31

nmol/l

0.66

189

1409

Disorders resulting from impaired renal tubular function

1.89

1.71

1.3

1.1

214.67

394.87

nmol/l

4.44

COPD, hospital admissions 3, with asthma pneumonia sepsis

961

0.77

1.70

1.2

294.65

327.22

nmol/l

0.84

746

Type 1 diabetes, wide definition, subgroup 1

603

1.33

1.69

1.2

1.1

343.42

388.66

nmol/l

1.22

553

Other disorders of bladder

391

1.41

1.68

1.3

1.2

370.93

346.27

nmol/l

0.31

312

Non-allergic asthma (mode), excluding more controls

590

1.33

1.68

1.1

376.16

366.89

nmol/l

0.16

505

Abnormal findings on diagnostic imaging of lung

224

1798

1.18

1.67

1.2

339.95

343.12

nmol/l

0.08

169

1473

Multiple myeloma, including Hilmo

149

1.69

1.67

1.2

341.16

350.11

nmol/l

0.07

127

Other disorders of eyelid

214

1705

1.19

1.67

1.2

342.59

342.44

nmol/l

0.00

166

1381

Bacterial pneumonia, not elsewhere classified

178

1297

1.21

1.66

1.2

315.55

349.95

nmol/l

1.51

138

1066

Use of levodopa decarbox-comt-inhibitor

1.87

1.66

1.2

289.98

345.33

nmol/l

0.68

Coagulation defects, purpura and other haemorrhagic conditions

684

1.30

1.65

1.2

340.88

359.41

nmol/l

0.35

581

Cervicobrachial syndrome

719

1.30

1.65

1.1

360.67

379.78

nmol/l

0.41

618

Cellulitis

763

1.29

1.65

1.2

1.1

333.43

364.44

nmol/l

0.72

648

Atrophic disorders of skin

511

1.35

1.65

1.2

1.1

388.34

369.49

nmol/l

0.30

450

Reactive arthropathies

252

1.51

1.65

1.2

1.1

320.44

363.79

nmol/l

0.55

227

Colonic or urogenital fistula

115

915

1.26

1.63

1.2

1.1

343.97

369.60

nmol/l

0.67

776

Chronic laryngitis and laryngotracheitis

444

1.38

1.63

1.1

1.2

389.77

355.74

nmol/l

0.70

373

ILD medications: azathioprine

427

1.38

1.63

1.3

1.1

342.46

384.58

nmol/l

0.81

381

Other diseases of blood and blood-forming organs, wide

730

1.29

1.62

1.2

332.93

357.16

nmol/l

0.53

614

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

411

2835

1.13

1.62

1.2

1.1

378.33

369.96

nmol/l

0.36

363

2399

Inflammatory diseases of the central nervous system

237

1.52

1.62

1.4

1.1

362.28

377.72

nmol/l

0.18

214

Mixed hyperlipidaemia

1.85

1.62

1.3

1.1

384.23

361.21

nmol/l

0.17

Adhesive capsulitis of shoulder

505

1.35

1.61

1.1

340.31

369.84

nmol/l

0.58

424

Other secondary coxarthrosis

1.92

1.60

1.1

1.2

392.00

377.33

nmol/l

—

Vasomotor and allergic rhinitis

144

1151

1.22

1.59

1.2

1.1

370.93

379.88

nmol/l

0.21

124

1014

Striking against or struck by other objects

129

1042

1.24

1.59

1.2

1.1

382.66

382.32

nmol/l

0.01

116

907

Polymyalgia rheumatica

541

1.33

1.59

1.2

325.09

324.42

nmol/l

0.01

415

Glaucoma, exfoliation

447

1.37

1.58

1.4

1.2

318.23

317.79

nmol/l

0.00

339

Malignant neoplasm of respiratory system and intrathoracic organs

684

0.74

1.58

1.2

289.44

321.75

nmol/l

0.65

541

Torsion of ovary, ovarian pedicle and fallopian tube

2.21

1.57

1.1

376.36

393.11

nmol/l

0.11

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

473

1.36

1.57

1.2

308.53

362.14

nmol/l

1.31

397

Orchitis and epididymitis

231

1.52

1.56

1.3

1.2

330.43

332.63

nmol/l

0.02

180

Disorders of psychological development

244

1.48

1.55

1.2

1.1

351.13

402.64

nmol/l

0.75

231

Myeloid leukaemia

1.98

1.54

1.1

1.2

432.44

355.74

nmol/l

—

Other obstetric trauma

160

0.44

1.53

1.0

1.1

478.57

413.05

nmol/l

—

154

Spirochaetal infections, other/unspecified, including avohilmo

139

1139

1.22

1.53

1.2

1.1

382.65

366.89

nmol/l

0.40

130

980

Non-small cell lung cancer, including Hilmo

540

0.69

1.53

1.3

1.2

306.41

323.25

nmol/l

0.23

422

Malignant neoplasm of bronchus and lung, including Hilmo

693

0.74

1.52

1.2

304.61

321.64

nmol/l

0.30

539

193

1620

1.18

1.51

1.1

1.2

381.94

369.43

nmol/l

0.37

160

1384

Open wound of ankle and foot

307

1.44

1.51

1.2

1.1

293.82

385.48

nmol/l

2.48

271

Vitamin D deficiency

2.17

1.51

1.1

342.17

425.67

nmol/l

—

Pedal cyclist injured in transport accident

721

1.28

1.50

1.2

1.1

394.76

378.49

nmol/l

0.36

630

Hydronephrosis

400

1.38

1.50

1.2

348.70

348.19

nmol/l

0.00

337

Varicose veins

291

1917

1.15

1.49

1.2

338.00

358.75

nmol/l

0.98

236

1583

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

765

0.76

1.49

1.2

306.11

326.48

nmol/l

0.39

604

Ganglion

643

1.29

1.49

1.2

1.1

383.25

392.18

nmol/l

0.15

564

Glucosamine medication

217

1480

1.17

1.48

1.3

1.2

331.75

335.10

nmol/l

0.08

170

1161

Blepharochalasis

131

1072

1.22

1.48

1.1

1.2

353.89

338.48

nmol/l

0.34

871

Other viral diseases, including avohilmo

146

1196

1.21

1.47

1.1

373.34

391.38

nmol/l

0.53

127

1073

Injuries to the shoulder and upper arm

390

2679

1.12

1.46

1.2

373.80

363.34

nmol/l

0.43

333

2245

Other specified/unspecified arthritis

109

876

1.25

1.45

1.2

1.1

346.63

365.57

nmol/l

0.44

735

Other diseases of arteries and capillaries

293

1.44

1.45

1.2

366.97

363.92

nmol/l

0.03

250

Other factor of the environment

2.52

1.45

1.0

1.1

299.14

430.00

nmol/l

—

Transport accidents

192

1355

1.18

1.45

1.2

1.1

387.47

382.73

nmol/l

0.12

176

1178

Gonarthrosis, primary, with knee surgery

273

1851

1.15

1.44

1.2

338.63

354.12

nmol/l

0.61

225

1502

Malignant neoplasm of breast, ER-negative, including Hilmo

101

753

1.26

1.44

1.2

326.62

367.13

nmol/l

1.21

632

Primary gonarthrosis, bilateral

245

1775

1.16

1.43

1.3

1.2

334.47

354.31

nmol/l

0.78

193

1440

Malignant neoplasm of breast, HER-negative

706

1.27

1.43

1.2

332.29

364.61

nmol/l

0.80

588

Autoimmune hyperthyroidism

172

1.58

1.43

1.1

365.59

384.27

nmol/l

0.18

158

Primary open-angle glaucoma, strict

129

1056

1.22

1.42

1.2

334.43

324.05

nmol/l

0.23

103

803

Mycoses, including avohilmo

413

2813

1.12

1.42

1.2

1.1

371.12

372.16

nmol/l

0.04

369

2379

Other diseases of biliary tract

303

1.42

1.2

335.85

362.91

nmol/l

0.36

253

Other spirochaetal diseases, including avohilmo

140

1159

1.21

1.42

1.2

1.1

385.44

367.99

nmol/l

0.45

131

997

Lyme disease, including avohilmo

137

1132

1.21

1.42

1.2

1.1

384.42

365.30

nmol/l

0.51

128

973

Lyme disease

137

1132

1.21

1.42

1.2

1.1

384.42

365.30

nmol/l

0.51

128

973

conjunctival haemorrhage

237

1.48

1.41

1.2

345.96

364.07

nmol/l

0.20

200

Other disorders of adrenal gland

118

1.70

1.41

1.2

285.47

405.06

nmol/l

1.63

108

Benign lipomatous neoplasm

124

1015

1.22

1.41

1.2

324.25

359.81

nmol/l

1.17

862

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

881

0.77

1.41

1.1

1.2

320.33

342.30

nmol/l

0.39

717

Colon adenocarcinoma, helper endpoint

474

1.33

1.41

1.2

313.98

329.29

nmol/l

0.22

379

Benign neoplasm of other and unspecified endocrine glands

431

1.35

1.40

1.2

1.1

340.92

366.04

nmol/l

0.39

376

Oter anti-inflammatory and antirheumatic agents, non-steroids

425

1.27

1.40

1.3

1.2

373.30

331.74

nmol/l

1.05

318

Acute myeloid leukaemia and myelodysplastic syndromes

1.87

1.40

1.1

1.2

381.89

346.65

nmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

198

1079

1.18

1.40

1.2

1.1

342.74

386.72

nmol/l

2.35

176

932

Inguinal hernia

246

1415

1.16

1.40

1.2

348.71

364.41

nmol/l

0.57

217

1153

Malignant neoplasm of breast, including Hilmo

198

1079

1.18

1.40

1.2

1.1

342.74

386.72

nmol/l

2.35

176

932

Lichen sclerosus et atrophicus

363

1.38

1.40

1.2

1.1

407.38

365.80

nmol/l

0.69

311

Diabetic nephropathy, excluding more controls

463

1.30

1.39

1.3

1.2

333.02

365.57

nmol/l

0.60

347

Malignant neoplasm of breast

195

1069

1.18

1.39

1.1

343.90

387.08

nmol/l

2.24

173

922

Hallux rigidus

415

1.35

1.38

1.3

1.1

340.82

346.24

nmol/l

0.07

341

Raynaud syndrome

263

1.45

1.38

1.1

364.41

393.43

nmol/l

0.43

241

Myeloproliferative diseases

255

1.46

1.38

1.4

1.2

355.75

364.01

nmol/l

0.08

216

Myasthenia gravis

2.21

1.37

1.2

433.22

375.29

nmol/l

—

Hyperkalaemia

166

1.57

1.37

1.1

1.2

301.06

347.06

nmol/l

0.43

133

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

489

0.69

1.37

1.1

415.62

377.57

nmol/l

0.55

435

Infarction of spleen

2.98

1.36

1.0

1.2

224.60

360.42

nmol/l

—

Malignant neoplasm of head and neck

264

1.44

1.36

1.2

342.44

345.43

nmol/l

0.03

216

Non-small cell lung cancer

403

0.66

1.36

1.3

1.2

285.58

326.20

nmol/l

0.50

312

Fracture at wrist and hand level

133

1098

1.21

1.35

1.2

1.1

367.66

379.43

nmol/l

0.26

108

955

Other diseases of appendix

0.00

1.35

0.0

1.2

—

384.47

—

Alcohol abuse counselling and surveillance

0.00

1.34

0.0

1.1

—

407.78

—

Other acute lower respiratory infections

242

2007

1.15

1.34

1.2

352.27

357.37

nmol/l

0.14

189

1670

Skin changes due to chronic exposure to nonionizing radiation

192

1488

1.17

1.33

1.3

1.2

327.95

321.58

nmol/l

0.17

153

1148

Primary_lymphoid and hematopoietic malignant neoplasms

106

860

1.23

1.33

1.2

361.06

334.28

nmol/l

0.57

697

Malignant neoplasm, including Hilmo

390

2032

1.12

1.32

1.2

1.1

344.66

381.14

nmol/l

2.94

340

1742

Abnormal findings on diagnostic imaging of central nervous system

136

1.62

1.32

1.1

360.40

399.53

nmol/l

0.45

121

Malignant neoplasm of breast, HER2-negative

194

1069

1.17

1.32

1.1

343.39

387.08

nmol/l

2.27

172

922

Other symptoms and signs involving the nervous and musculoskeletal systems

182

1555

1.17

1.31

1.2

371.42

360.90

nmol/l

0.28

153

1311

Ulcerative colitis (strict definition, all Crohn cases excluded)

419

1.34

1.31

1.2

1.1

370.83

388.90

nmol/l

0.28

380

Event of undetermined intent

160

1.57

1.31

1.2

1.1

316.11

389.97

nmol/l

0.91

147

Hypertensive Renal Disease

1.74

1.31

1.4

1.2

303.08

335.07

nmol/l

0.22

Amyloidosis, other/unspecified

2.11

1.30

1.2

367.78

328.10

nmol/l

—

Non-allergic asthma (mode)

615

1.27

1.30

1.1

376.16

361.68

nmol/l

0.26

528

Strabismus

106

860

1.23

1.30

1.2

1.1

378.83

371.49

nmol/l

0.13

742

Any event in cancer register

408

2140

1.11

1.30

1.1

1.2

354.85

379.80

nmol/l

1.64

355

1840

Other spirochaetal diseases

137

1144

1.20

1.30

1.2

1.1

384.42

366.40

nmol/l

0.47

128

984

Other disorders of thyroid

2.37

1.29

1.5

1.2

203.13

398.93

nmol/l

—

Volume depletion

326

1.38

1.29

1.4

1.2

325.75

332.02

nmol/l

0.06

264

Personal history of malignant neoplasm

259

1.43

1.29

1.0

1.1

348.93

380.84

nmol/l

0.47

225

Infections with a predominantly sexual mode of transmission

111

907

1.22

1.28

1.1

431.58

400.53

nmol/l

0.80

102

843

Speech and linguistic disorders

185

1.51

1.28

1.2

1.1

346.71

395.54

nmol/l

0.54

172

Mixed conductive and sensorineural hearing loss

404

1.34

1.28

1.2

329.56

361.53

nmol/l

0.52

325

Ankylosing spondylitis, ICD10

227

1.46

1.26

1.2

1.1

348.14

375.27

nmol/l

0.34

207

Colorectal cancer

116

917

1.22

1.26

1.3

1.2

327.63

331.00

nmol/l

0.06

722

malignant neoplasm of female genital organs, including Hilmo

625

0.75

1.26

1.1

1.2

361.95

356.80

nmol/l

0.05

513

Pneumonitis due to solids and liquids

294

1.40

1.26

1.4

1.2

329.15

328.43

nmol/l

0.01

235

Asthma mixed form (mode), excluding more controls

159

0.50

1.24

1.1

1.2

396.75

347.20

nmol/l

—

142

Malignant neoplasm, wide definition

389

2035

1.11

1.24

1.2

1.1

344.81

380.89

nmol/l

2.88

339

1745

Other peripheral vertigo

295

1.39

1.24

1.2

1.1

343.55

366.47

nmol/l

0.27

247

Diseases of external ear

152

1288

1.18

1.23

1.1

1.2

348.57

358.40

nmol/l

0.21

119

1080

Hernia of abdominal wall

196

1695

1.16

1.23

1.2

337.65

358.44

nmol/l

0.74

164

1418

Malignant neoplasm of head and neck, including Hilmo

329

1.37

1.23

1.2

348.32

347.99

nmol/l

0.00

260

Other and unspecified effects of external causes

105

860

1.22

1.1

356.15

382.10

nmol/l

0.73

765

Superficial injury of lower leg

111

915

1.21

1.22

1.2

346.36

367.66

nmol/l

0.51

793

Open wound of forearm

279

1.40

1.22

1.2

283.27

372.61

nmol/l

1.95

244

Postviral fatigue syndrome

2.65

1.22

1.0

1.2

550.80

463.58

nmol/l

—

Fracture of lumbar spine and pelvis

112

922

1.21

1.22

1.3

1.2

321.20

331.46

nmol/l

0.20

724

Anorexia

2.18

1.22

1.1

480.75

417.56

nmol/l

—

COPD, hospital admission 2, with asthma infections

107

1117

0.82

1.21

1.2

306.45

331.74

nmol/l

0.66

875

Carcinoma in situ of other and unspecified digestive organs

116

1.65

1.21

1.0

1.2

308.67

376.31

nmol/l

0.50

Abnormal results of function studies

246

1.43

1.21

1.4

1.1

344.19

380.25

nmol/l

0.44

221

Pain in thoracic spine

479

1.30

1.19

1.2

1.1

325.59

380.97

nmol/l

1.21

409

Other and unspecified psoriasis

197

1.48

1.19

1.2

322.86

377.87

nmol/l

0.63

175

Amiodarone users

306

1.38

1.19

1.2

308.69

333.77

nmol/l

0.32

247

Panniculitis, unspecified

2.33

1.19

1.3

1.2

309.00

405.95

nmol/l

—

Colon adenocarcinoma

488

1.29

1.19

1.2

313.98

339.35

nmol/l

0.41

375

Malignant neoplasm

380

2004

1.11

1.18

1.2

1.1

345.62

378.28

nmol/l

2.42

331

1715

Other/unspecified reactive arthropathies

181

1.50

1.18

1.3

1.1

298.43

389.82

nmol/l

1.12

165

Lichen ruber planus, wide definition including periferal and oral lichen planus

756

1.23

1.18

1.1

413.68

356.39

nmol/l

1.57

642

Schizophrenia or delusion

1017

0.81

1.17

1.1

331.88

381.88

nmol/l

1.32

899

Other aneurysm

165

1.52

1.17

1.4

1.3

350.80

339.47

nmol/l

0.09

139

Actinic keratosis

186

1463

1.16

1.17

1.3

1.2

326.14

319.87

nmol/l

0.16

149

1126

Other disorders of white blood cells

149

1.55

1.17

1.1

1.2

334.56

382.59

nmol/l

0.60

134

Injuries to the abdomen, lower back, lumbar spine and pelvis

188

1606

1.15

1.16

1.3

1.2

344.73

352.75

nmol/l

0.20

153

1315

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

686

1.24

1.16

1.2

301.11

341.81

nmol/l

1.07

555

Dislocation of lens

2.06

1.15

1.1

309.88

330.66

nmol/l

—

Other shoulder lesions

274

1.39

1.15

1.2

1.1

344.00

382.55

nmol/l

0.56

245

malignant neoplasm of female genital organs

575

0.75

1.14

1.1

1.2

369.39

349.25

nmol/l

0.22

466

Nephrotic syndrome

1.85

1.13

1.2

442.00

376.00

nmol/l

—

Chronic apical periodontitis

438

2693

0.91

1.13

1.2

1.1

359.23

372.14

nmol/l

0.64

366

2293

Myeloproliferative diseases (CML excluded)

233

1.42

1.13

1.4

1.2

334.71

357.94

nmol/l

0.27

199

Lesion of lateral popliteal nerve

127

1.58

1.11

1.1

328.79

399.89

nmol/l

0.62

113

Fracture of rib(s), sternum and thoracic spine

137

1164

1.18

1.11

1.2

337.67

347.45

nmol/l

0.23

119

936

Type 1 diabetes, wide definition

653

1.24

1.11

1.2

1.1

344.43

382.16

nmol/l

0.96

599

Other disorders of bone

618

1.25

1.11

1.2

1.1

351.47

387.85

nmol/l

0.74

548

Other follicular disorders

217

1.43

1.11

1.2

1.1

339.42

393.84

nmol/l

0.62

205

Chronic periodontitis, including avohilmo

378

2658

0.91

1.11

1.2

1.1

370.06

367.39

nmol/l

0.09

291

2276

Lifestyle-related condition

2.28

1.11

1.0

1.1

299.14

411.80

nmol/l

—

Disorders of breast

214

1654

1.14

1.10

1.1

391.27

379.94

nmol/l

0.34

195

1439

Other complications of surgical and medical care, not elsewhere classified

311

1.35

1.09

1.1

369.80

376.48

nmol/l

0.07

275

Cutaneous abscess, furuncle and carbuncle

104

864

1.21

1.09

1.2

1.1

344.79

380.21

nmol/l

0.81

753

Adverse effects, not elsewhere classified

602

1.25

1.08

1.1

356.60

388.71

nmol/l

0.78

538

Ulcer of lower limb, not elsewhere classified

540

1.26

1.08

1.2

368.98

332.65

nmol/l

0.56

430

Malignant neoplasm

378

2006

1.10

1.07

1.2

1.1

345.24

378.21

nmol/l

2.46

329

1717

Coronary artery bypass grafting

113

700

1.20

1.07

1.3

1.2

339.56

325.40

nmol/l

0.26

570

Other symptoms and signs involving the urinary system

321

1.34

1.07

1.1

1.2

387.88

350.51

nmol/l

0.48

265

Injury of nerves at wrist and hand level

1.66

1.06

1.2

1.1

319.47

399.74

nmol/l

0.94

Haemorrhage, not elsewhere classified

105

1.63

1.06

1.3

1.2

408.64

343.69

nmol/l

0.60

Statin medication

285

1433

1.12

1.06

1.2

1.1

379.67

377.70

nmol/l

0.05

250

1262

Fall involving bed

121

1.58

1.05

1.1

1.2

282.33

350.04

nmol/l

0.77

Periodontitis

380

2660

0.91

1.05

1.2

1.1

369.39

367.47

nmol/l

0.06

293

2278

Embedded and impacted teeth

584

1.22

1.05

1.1

378.76

406.70

nmol/l

0.73

551

Plantar fascial fibromatosis

279

1.36

1.05

1.2

1.1

381.69

383.91

nmol/l

0.02

245

Schizophrenia, schizotypal and delusional disorders

1023

0.82

1.04

1.1

333.60

381.49

nmol/l

1.30

903

Appendectomy

265

2256

1.12

1.03

1.2

1.1

364.90

382.36

nmol/l

0.76

230

1959

Malignant neoplasm of bladder, including Hilmo

440

1.28

1.03

1.2

298.13

312.64

nmol/l

0.19

337

Herpesviral [herpes simplex] infections, including avohilmo

100

833

1.20

1.03

1.2

1.1

412.54

383.80

nmol/l

0.66

743

Hemiplegia

146

1.51

1.03

1.1

1.2

339.20

385.35

nmol/l

0.47

130

Other and unspecified diseases of blood and blood-forming organs

1.74

1.03

1.4

1.2

383.69

371.17

nmol/l

0.08

Valvular operations

455

1.28

1.03

1.3

1.2

340.73

334.99

nmol/l

0.08

365

Asthma mixed form (mode)

151

0.53

1.02

1.1

396.75

339.60

nmol/l

—

136

Other/unspecified disorders of vestibular function

122

1.56

1.02

1.4

1.1

367.33

378.21

nmol/l

0.06

105

Carcinoma in situ of skin

298

1.35

1.02

1.2

352.74

330.57

nmol/l

0.24

241

Bacterial pneumonia (organism specified)

205

1637

1.13

1.01

1.2

315.91

344.92

nmol/l

1.26

156

1326

Hypertrophy of breast in women and men

617

1.23

1.01

1.2

1.1

435.09

396.47

nmol/l

0.93

565

Excessive attrition of teeth

244

2154

1.12

1.01

1.2

1.1

406.64

380.89

nmol/l

1.27

214

1897

Ankylosing spondylitis

247

1.38

1.01

1.2

1.1

348.14

378.60

nmol/l

0.39

216

Other and unspecified visual disturbances

342

1.32

1.01

1.1

365.14

377.30

nmol/l

0.16

299

Ventral hernia

103

863

1.20

1.00

1.2

310.47

356.75

nmol/l

1.53

705

Horner syndrome

2.01

1.00

1.3

1.2

413.57

375.55

nmol/l

—

Undetermined asthma, excluding more controls

421

1.28

1.00

1.1

354.10

370.30

nmol/l

0.28

360

Nontoxic multinodular goitre

636

1.23

1.00

1.2

357.98

353.05

nmol/l

0.07

531

Persistent mood disorders

627

1.23

1.00

1.2

1.1

368.08

378.17

nmol/l

0.17

543

Sub-endpoint used in defining T1D endpoints

124

1039

1.18

1.00

1.2

352.44

364.43

nmol/l

0.26

878

Retained placenta and membranes, without haemorrhage

360

1.31

1.00

1.1

347.54

390.95

nmol/l

0.71

330

Malignant neoplasm of pancreas, including Hilmo

308

1.33

1.00

1.2

408.91

340.54

nmol/l

0.89

245

Voice disturbances

111

938

1.18

0.99

1.2

399.82

361.53

nmol/l

1.33

803

Spontaneous rupture of synovium and tendon

240

1.38

0.98

1.2

1.1

374.87

366.09

nmol/l

0.07

200

Unspecified acute lower respiratory infection

530

1.25

0.98

1.2

319.09

363.40

nmol/l

1.02

461

Benign neoplasm of meninges

327

1.32

0.97

1.1

334.00

367.19

nmol/l

0.47

277

Lagophthalmos

0.00

0.96

0.0

1.2

—

352.46

—

Cholecystitis

513

1.25

0.96

1.2

338.75

339.02

nmol/l

0.00

413

Lichen planus, including avohilmo

640

1.22

0.95

1.1

1.2

397.74

355.58

nmol/l

0.90

549

Cirrhosis of liver, NAS

149

1.48

0.95

1.4

1.2

273.67

358.16

nmol/l

1.06

128

Acute nasopharyngitis (common cold)

308

1.32

0.95

1.1

365.61

404.89

nmol/l

0.63

284

DVT of lower extremities

686

1.21

0.95

1.2

292.08

345.15

nmol/l

1.62

553

Sequelae of external causes of morbidity and mortality

109

924

1.18

0.95

1.2

377.05

359.62

nmol/l

0.34

766

Localized swelling, mass and lump of skin and subcutaneous tissue

131

1128

1.16

0.94

1.2

328.69

362.60

nmol/l

1.28

116

958

Disorder of thyroid, unspecified

1.90

0.94

1.6

1.2

211.57

388.81

nmol/l

—

Diseases of oral cavity, salivary glands and jaws

294

1366

1.11

0.94

1.3

1.2

359.40

355.75

nmol/l

0.10

247

1127

UC patients in KELA-register (code 208), prior to 1994

109

1.57

0.93

1.1

334.50

409.18

nmol/l

0.73

Atopic dermatitis

231

1643

1.12

0.93

1.1

392.62

389.69

nmol/l

0.08

211

1471

Benign lipomatous neoplasm of other sites/unspecified

277

1.34

0.93

1.2

319.27

354.83

nmol/l

0.52

238

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

119

1018

1.17

0.93

1.2

1.1

356.83

365.52

nmol/l

0.18

103

863

Later onset COPD

104

985

0.85

0.93

1.3

1.2

279.15

305.87

nmol/l

0.72

738

Spontaneous abortion

184

1084

1.14

0.93

1.1

380.23

391.22

nmol/l

0.31

173

981

Foreign body entering into or through eye or natural orifice

200

1.40

0.93

1.1

1.2

315.48

384.77

nmol/l

0.96

175

Cerebral palsy and other paralytic syndromes

356

1.29

0.92

1.1

1.2

343.21

368.30

nmol/l

0.33

311

409

1.27

0.92

1.2

1.1

456.94

384.99

nmol/l

1.23

372

Benign neoplasm: Skin of other and unspecified parts of face

365

1.29

0.92

1.2

381.89

355.55

nmol/l

0.29

304

Nonsuppurative otitis media

588

1.21

0.92

1.1

343.26

398.94

nmol/l

1.70

533

Nephropathy related operations

362

0.72

0.92

1.2

359.00

358.84

nmol/l

0.00

307

Calculus of kidney and ureter

123

1058

1.16

0.91

1.2

341.80

355.84

nmol/l

0.33

872

malignant neoplasm of male genital organs, including Hilmo

120

616

1.17

0.90

1.2

357.31

335.94

nmol/l

0.52

496

Other specified and unspecified disorders of eye and adnexa

103

0.48

0.89

1.2

495.20

382.77

nmol/l

—

L04AD Calcineurin inhibitors

278

0.68

0.89

1.2

336.36

381.60

nmol/l

0.40

255

Deep bite

237

1.34

0.89

1.1

435.89

382.78

nmol/l

0.74

222

Undetermined asthma

429

1.26

0.89

1.1

354.10

366.15

nmol/l

0.20

369

Immunodeficiency with predominantly antibody defects

1.70

0.89

1.3

1.1

308.08

390.52

nmol/l

0.94

Abnormal findings on antenatal screening of mother

230

0.65

0.88

1.1

385.13

421.29

nmol/l

0.41

224

Solid cancers, including Hilmo

376

2009

1.09

0.88

1.2

1.1

343.98

378.75

nmol/l

2.65

326

1720

Need for other prophylactic measures

154

0.58

0.88

1.0

1.1

388.64

399.27

nmol/l

—

139

Other obstetric conditions, not elsewhere classified

117

631

1.17

0.88

1.1

433.46

414.42

nmol/l

0.53

111

606

Immunodeficiencies

119

1.52

0.88

1.3

1.2

354.22

398.94

nmol/l

0.48

110

Injury of nerves and spinal cord at neck level

1.79

0.88

1.0

1.1

391.40

394.60

nmol/l

—

Other viral diseases, not elsewhere classified, including avohilmo

100

843

1.18

0.88

1.1

369.72

389.86

nmol/l

0.45

757

Injuries to the wrist and hand

446

2734

1.08

0.87

1.2

1.1

368.14

372.05

nmol/l

0.14

375

2338

Benign paroxysmal vertigo

126

1090

1.16

0.87

1.2

351.44

352.04

nmol/l

0.01

108

900

Examination and encounter for administrative purposes

186

1.40

0.87

1.1

382.74

384.49

nmol/l

0.01

147

Otitis externa, unspecified

351

1.28

0.87

1.2

1.1

362.00

387.40

nmol/l

0.32

315

Benign neoplasm: Adrenal gland

229

1.36

0.86

1.1

1.2

319.33

385.71

nmol/l

0.75

199

Other and unspecified rosacea

281

1.32

0.86

1.3

1.1

359.48

386.24

nmol/l

0.44

251

Urethritis and urethral syndrome

1.73

0.86

1.4

1.1

367.18

390.11

nmol/l

0.15

Pre-eclampsia

612

1.21

0.86

1.2

1.1

384.27

401.66

nmol/l

0.31

567

DVT of lower extremities and pulmonary embolism

187

1656

1.13

0.86

1.2

320.13

347.27

nmol/l

0.75

145

1335

Urticaria

114

980

1.16

0.86

1.1

388.15

377.07

nmol/l

0.24

881

Open wound of lower leg

522

1.23

0.85

1.3

1.2

325.92

363.34

nmol/l

0.71

445

Reactive arthropathies, FINNGEN

204

1.38

0.85

1.3

1.1

308.73

379.24

nmol/l

0.81

183

Presbycusis

579

1.21

0.84

1.3

1.2

288.73

328.23

nmol/l

1.08

428

Certolizumab pegol

1.79

0.84

1.0

1.1

416.13

406.05

nmol/l

—

Stenosis and insufficiency of lacrimal passages

309

1.30

0.83

1.1

1.2

364.71

353.92

nmol/l

0.14

263

Effects of foreign body entering through natural orifice

752

1.18

0.83

1.2

1.1

331.03

377.30

nmol/l

1.26

652

Superficial injury of wrist and hand

642

1.20

0.83

1.2

1.1

352.60

395.13

nmol/l

0.94

570

Conjunctivitis (acute, non atopic), including avohilmo

385

2516

0.92

0.82

1.2

1.1

375.43

369.29

nmol/l

0.23

346

2110

Dislocation, sprain and strain of joints and ligaments of knee

235

1919

1.11

0.82

1.1

390.75

387.07

nmol/l

0.11

208

1707

Other disorders of patella

480

1.23

0.81

1.3

1.1

366.42

397.72

nmol/l

0.51

438

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

223

1.35

0.81

1.2

322.09

346.46

nmol/l

0.25

179

Venous thromboembolism

241

2101

1.10

0.81

1.2

315.51

349.24

nmol/l

1.39

192

1717

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

105

902

1.17

0.81

1.1

370.87

400.22

nmol/l

0.81

829

Benign neoplasm: Cerebral meninges

302

1.29

0.81

1.1

1.2

337.72

370.84

nmol/l

0.45

254

Burns and corrosions

391

1.26

0.80

1.2

1.1

351.55

382.32

nmol/l

0.51

353

Acute sinusitis

218

1787

1.11

0.79

1.1

388.91

380.98

nmol/l

0.23

190

1573

Alcohol use disorder, ICD-based

157

1391

1.13

0.79

1.2

330.84

375.16

nmol/l

1.97

123

1188

Alcohol abuse, main dg, excluding more controls

383

1.25

0.79

1.2

1.1

354.38

385.21

nmol/l

0.47

343

Other peripheral vascular diseases

233

1.33

0.79

1.1

1.2

304.52

366.92

nmol/l

1.16

213

Disorders of refraction and accommodation

104

892

1.16

0.79

1.1

380.49

390.83

nmol/l

0.21

795

Fall on and from stairs and steps

111

961

1.16

0.78

1.2

340.09

360.91

nmol/l

0.53

809

Arteriovenous malformation of cerebral vessels

0.00

0.78

0.0

1.1

—

394.05

—

Urethral stricture

173

1.39

0.78

1.1

1.2

345.38

340.66

nmol/l

0.03

138

Demyelinating diseases of the central nervous system

251

1.32

0.78

1.0

1.1

377.38

397.11

nmol/l

0.19

235

Idiopathic gout

295

1.29

0.78

1.3

1.2

358.70

333.99

nmol/l

0.31

234

Allergic asthma (mode), excluding more controls

703

1.18

0.78

1.2

1.1

404.16

387.74

nmol/l

0.32

635

Abnormal involuntary movements

456

1.23

0.78

1.2

1.1

380.24

359.61

nmol/l

0.33

392

281

0.71

0.78

1.1

432.35

425.54

nmol/l

0.05

270

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

108

934

1.16

0.78

1.2

1.1

395.05

393.03

nmol/l

0.04

835

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

360

0.75

0.76

1.3

1.2

366.16

347.97

nmol/l

0.17

286

Other benign neoplasms of connective and other soft tissue

296

1.29

0.76

1.1

361.38

372.87

nmol/l

0.14

267

Disorders of muscles

296

1.29

0.76

1.2

1.1

276.64

372.46

nmol/l

2.42

255

Cardiodefibrillation

147

1298

1.13

0.76

1.2

324.53

336.09

nmol/l

0.28

113

1021

Visual field defects

270

1.30

0.76

1.1

1.2

301.54

355.24

nmol/l

0.91

233

Trigger finger

431

1.23

0.75

1.3

1.1

360.74

385.36

nmol/l

0.36

378

Hypertrophy of breast

540

1.21

0.75

1.2

1.1

455.37

400.45

nmol/l

1.46

497

Rosacea

413

1.24

0.75

1.2

1.1

356.05

381.94

nmol/l

0.45

373

Atypical virus infections of central nervous system

2.10

0.75

1.4

1.1

185.60

415.58

nmol/l

—

Atypical virus infections of central nervous system, including avohilmo

2.10

0.75

1.4

1.1

185.60

415.58

nmol/l

—

Alcoholic liver disease

306

1.28

0.75

1.2

315.70

352.89

nmol/l

0.56

261

Arterial embolism and thrombosis

192

1.36

0.74

1.1

1.2

291.29

334.80

nmol/l

0.56

158

Retinal detachments and breaks

150

1332

1.13

0.74

1.2

354.85

346.53

nmol/l

0.20

121

1080

Persons encountering health services in other circumstances

158

1393

1.12

0.74

1.2

1.1

340.69

372.30

nmol/l

1.24

145

1184

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

113

618

1.15

0.73

1.1

430.93

413.69

nmol/l

0.46

107

594

Exposure to other specified factors

338

2682

1.08

0.73

1.2

1.1

366.87

376.35

nmol/l

0.40

293

2306

Acute bronchitis

181

1595

1.11

0.73

1.2

359.00

354.89

nmol/l

0.09

140

1317

Other diseases of the respiratory system

772

1.17

0.73

1.2

327.01

331.36

nmol/l

0.07

602

Other respiratory disorders and diseases

772

1.17

0.73

1.2

327.01

331.36

nmol/l

0.07

602

Chondropathies

460

1.22

0.73

1.2

1.1

323.49

383.13

nmol/l

1.23

416

Non-small cell lung cancer, adenocarcinoma

219

0.68

0.73

1.2

285.40

344.85

nmol/l

—

181

Other injuries of lower limb, level unspecified

2.01

0.73

1.0

1.2

313.00

338.00

nmol/l

—

Thoracic aortic aneurysm

433

1.23

0.73

1.2

371.10

338.90

nmol/l

0.52

353

Other/unspecified enthesopathies, not elsewhere classified

263

1.30

0.73

1.1

1.2

351.68

369.46

nmol/l

0.20

219

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

159

1.39

0.72

1.2

317.94

334.39

nmol/l

0.13

126

Pre-eclampsia or eclampsia

653

1.18

0.72

1.2

1.1

382.69

400.07

nmol/l

0.31

606

Outcome of delivery

316

0.80

0.72

1.1

403.34

420.77

nmol/l

0.26

297

Appendicitis, broad definition

302

2497

1.08

0.71

1.2

1.1

374.22

378.04

nmol/l

0.12

261

2151

Glaucoma secondary to other eye disorders

117

1.46

0.71

1.2

460.25

357.94

nmol/l

0.91

100

Other disorders of penis

237

1.31

0.71

1.2

314.29

347.11

nmol/l

0.33

189

Thyroiditis, unspecified

1.76

0.71

1.3

1.2

392.43

388.44

nmol/l

—

Allergic asthma (mode)

710

1.17

0.71

1.2

1.1

404.16

383.63

nmol/l

0.42

641

Superficial injury of ankle and foot

362

1.24

0.71

1.3

1.1

364.01

391.86

nmol/l

0.40

331

Maternal care for known or suspected disproportion

134

1.42

0.71

1.2

1.1

451.47

421.88

nmol/l

0.26

128

Conjunctivitis (acute, non atopic)

105

910

1.15

0.71

1.2

1.1

340.32

376.59

nmol/l

1.17

794

Viral pneumonia (unknown virus, not influenza)

177

1.36

0.70

1.0

1.1

369.75

392.23

nmol/l

0.20

158

Urolithiasis

130

1150

1.13

0.70

1.2

339.00

352.45

nmol/l

0.33

948

Hydrocele

345

1.25

0.70

1.2

295.67

336.83

nmol/l

0.61

262

Other predominantly sexually transmitted diseases, not elsewhere classified

490

1.21

0.70

1.1

413.70

403.10

nmol/l

0.13

462

Psoriasis vulgaris

591

1.19

0.70

1.2

344.49

371.87

nmol/l

0.49

511

All influenza (not pneumonia)

454

1.21

0.69

1.3

1.1

316.67

366.94

nmol/l

1.22

401

Acute appendicitis

281

2402

1.09

0.69

1.2

1.1

376.17

379.75

nmol/l

0.11

242

2085

Solid cancers

363

1976

1.08

0.69

1.1

347.99

377.53

nmol/l

1.97

313

1691

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

178

1.35

0.68

1.2

353.12

355.12

nmol/l

0.01

142

Protein-energy malnutrition of moderate and mild degree

1.86

0.68

1.6

1.1

202.14

363.41

nmol/l

—

Beningn neoplasm: Meninges, unspecified

1.67

0.68

1.0

1.2

368.14

372.56

nmol/l

—

MS-disease / Multiple Sclerosis

213

1.32

0.68

1.0

1.1

387.65

395.85

nmol/l

0.06

202

Lichen planus

446

1.21

0.68

1.1

1.2

389.74

353.27

nmol/l

0.49

379

Open wound of wrist and hand

167

1451

1.11

0.68

1.2

1.1

362.43

377.62

nmol/l

0.44

143

1254

Vascular dementia (subcortical)

127

1.42

0.68

1.6

1.2

303.17

334.82

nmol/l

0.17

Umbilical hernia

100

872

1.15

0.67

1.2

1.1

372.21

371.42

nmol/l

0.01

736

Other superficial mycoses, including avohilmo

311

1.26

0.67

1.1

462.06

396.76

nmol/l

1.49

289

Dialysis, with operation codes

374

0.77

0.67

1.2

324.74

362.52

nmol/l

0.45

314

Necrosis of pulp, including avohilmo

228

2061

1.09

0.67

1.2

1.1

366.91

384.35

nmol/l

0.69

185

1827

Complications of labour and delivery

197

1206

0.91

0.67

1.1

403.44

389.98

nmol/l

0.42

184

1084

Injuries to the ankle and foot

292

2304

1.08

0.66

1.2

1.1

364.02

382.09

nmol/l

0.76

247

2017

Malignant neoplasm of oral cavity

1.49

0.66

1.1

1.2

311.47

382.25

nmol/l

—

Tularaemia

1.79

0.66

1.4

1.1

373.40

380.73

nmol/l

—

Foreign body on external eye

384

1.23

0.66

1.1

349.50

390.74

nmol/l

0.63

341

Bronchitis

495

2792

1.06

0.66

1.2

354.30

370.09

nmol/l

0.92

411

2373

Perichondritis of external ear

1.60

0.65

1.1

1.2

350.00

375.46

nmol/l

—

Respiratory insufficiency

285

1.26

0.65

1.3

1.2

280.85

333.48

nmol/l

0.99

227

Other and unspecified injuries of lower leg

215

1.30

0.65

1.1

377.00

405.40

nmol/l

0.28

197

Non-small cell lung cancer, adenocarcinoma, helper endpoint

213

0.70

0.64

1.2

285.40

345.04

nmol/l

—

174

Neovascular glaucoma

120

1.42

0.64

1.2

460.25

368.16

nmol/l

0.79

104

Malignant neoplasm of liver and intrahepatic bile ducts

1.48

0.64

1.1

1.2

323.89

343.55

nmol/l

—

Urticaria and erythema

140

1253

1.12

0.64

1.1

381.29

373.56

nmol/l

0.17

111

1099

malignant neoplasm of male genital organs

115

610

1.14

0.64

1.2

362.28

334.42

nmol/l

0.73

491

Otitis externa

774

1.15

0.63

1.1

355.92

376.46

nmol/l

0.36

664

Other disorders of the genitourinary system

441

1.20

0.63

1.3

1.1

317.06

353.75

nmol/l

0.84

376

Injury of unspecified body region

216

1.30

0.63

1.1

353.61

369.38

nmol/l

0.13

192

Missing teeth due to accident, extraction or parodontitis

266

2194

1.08

0.63

1.2

367.01

357.07

nmol/l

0.33

223

1815

Acute upper respiratory infections

476

2685

1.06

0.63

1.2

367.75

365.98

nmol/l

0.06

407

2262

Pregnancy with abortive outcome

245

1387

0.92

0.62

1.1

1.2

365.08

377.77

nmol/l

0.43

215

1201

Adenocarcinoma and papilloma adenocarcinoma of rectum

347

0.78

0.62

1.3

1.2

366.16

349.87

nmol/l

0.15

278

Malignant neoplasm of oral cavity, including Hilmo

121

1.41

0.62

1.2

1.1

303.20

374.45

nmol/l

0.55

107

Allergic rhinitis

106

923

1.13

0.62

1.2

1.1

383.47

396.62

nmol/l

0.28

852

Infections with a predominantly sexual mode of transmission, including avohilmo

138

1131

1.12

0.62

1.1

439.11

400.93

nmol/l

1.34

129

1041

1.59

0.62

1.1

365.90

448.14

nmol/l

—

Divergent concomitant strabismus

208

1.30

0.62

1.0

1.1

361.25

396.26

nmol/l

0.36

192

Alcohol use disorder, Swedish definition

212

1765

1.09

0.61

1.2

350.42

368.15

nmol/l

0.61

168

1499

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

226

1.29

0.61

1.1

399.14

413.77

nmol/l

0.18

216

Presbyopia

226

1.29

0.61

1.1

401.42

395.95

nmol/l

0.05

211

Primary angle-closure glaucoma

130

1.39

0.61

1.2

331.08

325.38

nmol/l

—

108

COPD, early/later onset

162

1500

0.91

0.61

1.2

320.41

332.30

nmol/l

0.31

121

1202

Gender identity disorders

0.00

0.60

0.0

1.2

—

412.00

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

167

1502

1.10

0.60

1.2

339.49

373.19

nmol/l

1.30

130

1281

Degenerative myopia

0.00

0.60

0.0

1.1

—

341.38

—

Ulcerative rectosigmoiditis

227

1.28

0.59

1.1

341.12

396.32

nmol/l

0.83

206

Contact with sharp object, undetermined intent

1.54

0.59

1.1

404.00

417.48

nmol/l

—

Other and unspecified glaucoma

245

1.27

0.59

1.1

1.2

387.96

335.34

nmol/l

0.57

200

Pruritus

408

1.20

0.59

1.2

1.1

378.23

382.36

nmol/l

0.05

363

Diseases of appendix

302

2514

1.07

0.59

1.2

1.1

374.22

377.45

nmol/l

0.10

261

2165

Sequelae of injuries of neck and trunk

1.53

0.59

1.3

1.1

347.73

396.50

nmol/l

0.29

Agranulocytosis

345

1.22

0.58

1.2

1.1

356.03

373.46

nmol/l

0.18

299

Benign neoplasm of mouth and pharynx

336

1.22

0.58

1.2

327.56

366.95

nmol/l

0.81

297

Pre-eclampsia or poor fetal growth

106

936

1.13

0.58

1.2

1.1

392.09

405.06

nmol/l

0.29

870

Other and unspecified tonsillitis

114

843

1.12

0.58

1.1

405.46

415.73

nmol/l

0.22

104

783

Other diseases of pleura

198

1577

1.09

0.58

1.3

1.2

321.32

335.20

nmol/l

0.42

161

1250

Other specified/unspecified necrotizing vasculopathies

1.72

0.58

1.0

1.2

279.33

369.30

nmol/l

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

249

2101

1.08

0.57

1.1

395.23

381.78

nmol/l

0.49

220

1844

Ingrowing nail

132

1.37

0.57

1.2

1.1

424.77

400.48

nmol/l

0.15

122

224

1846

1.08

0.56

1.2

354.74

367.25

nmol/l

0.39

173

1578

Small cell lung cancer

0.58

0.56

1.2

1.3

186.20

340.52

nmol/l

—

Small cell lung cancer, including Hilmo

0.58

0.56

1.2

1.3

186.20

340.52

nmol/l

—

Tularaemia, including avohilmo

1.46

0.56

1.4

1.2

413.75

387.38

nmol/l

—

Fracture of skull and facial bones

680

1.15

0.56

1.2

1.1

325.94

371.36

nmol/l

1.39

583

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

535

1.17

0.55

1.1

1.2

306.65

319.12

nmol/l

0.17

405

Perforation of tympanic membrane

302

1.23

0.55

1.3

1.1

377.04

383.55

nmol/l

0.05

265

Other disorders starting during childhood or adolecense, excluding more controls

1.54

0.55

1.2

1.1

464.20

417.32

nmol/l

—

Clear cell adenocarcinoma of kidney

142

1.34

0.54

1.1

1.2

338.23

367.54

nmol/l

0.27

119

Acute peritonitis

186

1.29

0.54

1.3

1.1

333.79

368.29

nmol/l

0.43

158

Other arthritis (FG)

120

1079

1.11

0.54

1.2

1.1

344.85

368.67

nmol/l

0.65

100

900

Malignant neoplasm of prostate, including Hilmo

114

601

1.12

0.53

1.2

349.28

331.01

nmol/l

0.43

482

Retinal breaks without detachment

506

1.17

0.53

1.3

1.2

383.53

356.04

nmol/l

0.49

430

Squamous cell neoplasms and carcinomas of the skin

432

1.18

0.53

1.2

295.68

315.66

nmol/l

0.26

324

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

433

1.18

0.52

1.1

342.73

375.18

nmol/l

0.51

381

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

591

1.15

0.52

1.1

430.31

404.61

nmol/l

0.42

557

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

461

1.17

0.52

1.2

1.1

327.82

405.39

nmol/l

2.07

429

Endometriosis diagnosis and infertility diagnosis occurring together

314

1.21

0.51

1.1

413.50

415.37

nmol/l

0.02

297

Congenital malformations, deformations and chromosomal abnormalities

218

1915

1.08

0.51

1.1

395.64

382.71

nmol/l

0.43

192

1688

Gingivitis and periodontal diseases

423

2307

0.95

0.51

1.2

372.48

363.03

nmol/l

0.42

359

1947

Other chronic obstructive pulmonary disease, including avohilmo

198

1758

0.92

0.51

1.2

336.50

341.01

nmol/l

0.11

149

1424

Fracture of shoulder and upper arm

149

1358

1.10

0.51

1.2

379.19

350.83

nmol/l

0.78

119

1108

Abnormal findings in secretions and smears from cervix uteri vagina vulva

167

1339

0.92

0.51

1.1

397.71

397.42

nmol/l

0.01

155

1217

Malignant neoplasm of bladder

251

1.24

0.50

1.2

305.36

323.92

nmol/l

0.18

187

Lung cancer and mesothelioma

587

0.87

0.50

1.2

1.1

310.93

333.92

nmol/l

0.42

475

Ascites

216

1.25

0.49

1.1

302.84

367.53

nmol/l

1.09

186

Diabetic retinopathy, excluding more controls

113

568

1.11

0.49

1.2

344.69

378.90

nmol/l

0.87

441

Carcinoma in situ of skin of other and unspecified parts of face

345

0.81

0.48

1.1

1.2

380.91

308.10

nmol/l

0.87

268

Glomerulonephritis

289

1.21

0.48

1.1

1.2

384.40

370.65

nmol/l

0.18

257

Diabetic nephropathy

653

1.14

0.48

1.3

1.2

333.02

339.29

nmol/l

0.09

469

Other pleural conditions

363

1.19

0.48

1.1

1.2

333.92

329.05

nmol/l

0.05

284

COPD, hospital admissions

163

1491

0.92

0.48

1.3

1.2

318.75

331.66

nmol/l

0.34

122

1194

Pulmonary heart disease, diseases of pulmonary circulation

137

1251

1.10

0.47

1.2

333.13

339.87

nmol/l

0.10

106

1001

Abnormal blood-pressure reading, without diagnosis

128

1.33

0.47

1.0

1.2

361.73

384.31

nmol/l

0.13

112

COPD, hospital admissions 1, only main diagnosis

124

1171

0.91

0.47

1.2

326.38

327.52

nmol/l

0.02

919

Viral infections characterized by skin and mucous membrane lesions

166

1529

1.09

0.47

1.2

340.46

368.79

nmol/l

1.14

141

1296

Focal epilepsy, strict definition

672

1.13

0.47

1.1

1.2

313.36

357.67

nmol/l

1.26

559

Erythema intertrigo

1.48

0.47

1.2

515.30

408.33

nmol/l

—

Contusion of toe(s) without damage to nail

1.47

0.47

1.1

350.50

424.50

nmol/l

—

Malignant neoplasm of pancreas

245

1.23

0.46

1.2

452.48

346.07

nmol/l

1.31

200

Alcohol withdrawal state with delirium

182

1.27

0.46

1.0

1.2

343.71

364.29

nmol/l

0.14

161

Abnormal findings on examination of urine, without diagnosis

120

1.34

0.46

1.1

1.2

376.18

375.66

nmol/l

0.00

103

Later onset COPD, excluding more controls

606

1.12

0.46

1.2

291.50

319.23

nmol/l

0.63

476

Dilated cardiomyopathy

364

0.82

0.46

1.2

355.84

342.89

nmol/l

0.11

290

Early onset COPD

707

0.88

0.45

1.2

369.78

365.80

nmol/l

0.05

590

Benign mammary dysplasia

477

1.15

0.45

1.2

332.40

353.89

nmol/l

0.30

411

Small cell lung cancer, helper endpoint

0.59

0.45

1.2

1.3

186.20

324.09

nmol/l

—

Acute appendicitis, with complications

656

1.13

0.45

1.2

402.37

363.92

nmol/l

0.80

559

Abnormalities of gait and mobility

431

1.16

0.45

1.2

353.64

339.79

nmol/l

0.18

349

Other hearing loss

122

1078

1.10

0.44

1.3

1.2

293.90

337.14

nmol/l

1.93

108

847

Diagnoses used for exclusion with ILD

101

913

1.11

0.44

1.3

1.2

346.06

348.99

nmol/l

0.05

743

Other disorders of veins

168

1530

1.08

0.44

1.2

346.34

364.79

nmol/l

0.54

130

1298

Complications predominantly related to the puerperium

780

1.12

0.44

1.1

387.32

406.18

nmol/l

0.37

728

Malignant neoplasm of urinary organs, including Hilmo

423

1.16

0.43

1.3

1.2

321.51

344.00

nmol/l

0.32

329

Other benign neoplasms of skin

157

1451

1.08

0.43

1.2

364.78

352.29

nmol/l

0.32

134

1198

Diabetic retinopathy

163

934

1.08

0.43

1.2

339.24

353.05

nmol/l

0.31

115

686

Impacted teeth

443

1.14

0.43

1.2

1.1

362.27

411.00

nmol/l

1.20

427

Malignant neoplasm of rectum

350

0.83

0.43

1.3

1.2

343.93

353.46

nmol/l

0.09

280

Nonsuppurative otitis media, including avohilmo

109

857

1.10

0.42

1.1

362.51

396.21

nmol/l

1.00

772

Diseases of middle ear and mastoid

217

1658

1.07

0.42

1.1

370.63

381.29

nmol/l

0.34

177

1455

Poisoning by medicine

631

1.13

0.42

1.2

1.1

313.57

398.09

nmol/l

2.99

578

Subarachnoid haemorrhage

371

0.83

0.42

1.4

1.2

336.16

346.64

nmol/l

0.10

304

Problems related to lifestyle

285

1.19

0.42

1.2

1.1

318.84

390.86

nmol/l

1.25

264

Acute appendicitis, no complications

207

1924

1.07

0.42

1.2

1.1

367.15

384.22

nmol/l

0.62

180

1690

Benign neoplasm of other and unspecified sites

0.64

0.42

1.0

1.2

354.67

384.73

nmol/l

—

Poisoning by drugs, medicaments and biological substances

707

1.12

0.42

1.2

1.1

318.22

397.23

nmol/l

2.98

646

Sequelae of injuries of upper limb

267

1.20

0.42

1.2

1.1

372.09

390.92

nmol/l

0.16

242

Pregnancy examination and test

304

0.86

0.42

1.1

433.76

423.13

nmol/l

0.16

287

Hepatocellular carcinoma

1.43

0.42

1.0

1.2

283.60

324.89

nmol/l

—

Other and unspecified myopathies

304

1.19

0.42

1.2

371.33

345.45

nmol/l

0.32

253

Retinal vascular disorders

453

1.15

0.41

1.2

324.90

330.59

nmol/l

0.07

352

Retinal vascular occlusion

444

1.15

0.41

1.2

324.90

328.89

nmol/l

0.05

346

Malignant neoplasm of rectum, including Hilmo

445

0.85

0.41

1.3

1.2

354.67

346.17

nmol/l

0.08

351

Atopic dermatitis, strict definition with reimbursement

863

1.10

0.41

1.2

1.1

394.27

409.73

nmol/l

0.32

803

Disorders of continuity of bone

286

1.19

0.41

1.3

1.1

340.78

387.08

nmol/l

0.63

260

Tuberculosis, IBD comorbidity

239

0.79

0.41

1.1

1.3

366.64

341.23

nmol/l

0.18

191

L04AA Selective immunosuppressants

680

1.12

0.41

1.1

345.77

379.43

nmol/l

0.74

600

Injuries to unspecified part of trunk, limb or body region

314

1.18

0.41

1.1

354.21

367.02

nmol/l

0.13

271

Embedded teeth, including avohilmo

222

1.22

0.41

1.0

1.1

378.93

412.33

nmol/l

0.45

210

Glaucoma suspect

151

1398

1.08

0.40

1.2

350.24

345.16

nmol/l

0.11

129

1121

Pregnancy, childbirth and the puerperium

111

635

0.91

0.40

1.2

351.42

359.40

nmol/l

0.15

527

Superficial injury of abdomen, lower back and pelvis

549

1.13

0.40

1.2

1.1

361.31

368.05

nmol/l

0.09

479

Major anomalies of jaw size

1.31

0.39

1.0

1.1

479.63

398.36

nmol/l

—

Wet age-related macular degeneration

740

1.11

0.39

1.2

304.92

315.15

nmol/l

0.19

545

Corneal ulcer

607

1.12

0.39

1.3

1.1

384.46

376.53

nmol/l

0.11

532

Use of antiglaucoma preparations and miotics

288

1.18

0.39

1.3

1.2

414.78

320.35

nmol/l

1.95

225

Distal bite

1.33

0.38

1.1

448.89

420.63

nmol/l

—

Vestibular neuronitis

279

0.82

0.37

1.2

1.1

352.11

371.88

nmol/l

0.19

242

Procedures for purposes other than remedying health state

1.31

0.37

1.0

1.2

400.56

414.36

nmol/l

—

Nontoxic goitre/thyroid nodule

118

1088

1.09

0.37

1.2

342.27

356.62

nmol/l

0.31

915

Artificial joint re-operation

225

1.20

0.37

1.3

1.2

303.38

351.23

nmol/l

0.82

190

Nasal polyp

591

1.12

0.36

1.0

1.2

320.93

350.20

nmol/l

0.65

494

Diabetic maculopathy

433

1.13

0.36

1.3

1.2

342.84

349.93

nmol/l

0.07

314

Certain disorders involving the immune mechanism

601

1.12

0.36

1.2

365.53

370.10

nmol/l

0.07

520

Other fall from one level to another

715

1.10

0.36

1.2

1.1

318.44

370.16

nmol/l

1.67

617

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

206

1308

1.06

0.35

1.2

291.28

351.89

nmol/l

4.47

167

1068

Fibrosis and cirrhosis of liver

226

1.20

0.35

1.4

1.2

254.67

365.32

nmol/l

1.90

200

Focal epilepsy

735

1.10

0.35

1.1

1.2

318.74

361.51

nmol/l

1.21

615

Suppurative and necrotic conditions of lower respiratory tract

168

0.77

0.35

1.2

329.77

355.41

nmol/l

0.19

142

Special screening examination for neoplasms

162

1.24

0.35

1.1

368.77

407.28

nmol/l

0.27

144

0.62

0.35

1.2

345.40

352.33

nmol/l

—

COPD related to multimorbidity

147

1331

0.93

0.35

1.3

1.2

311.02

326.88

nmol/l

0.44

108

1051

Foreign body in respiratory tract

135

1.26

0.35

1.2

1.1

417.27

397.00

nmol/l

0.11

121

Other disorders of pigmentation

126

1.27

0.35

1.2

1.1

263.90

392.04

nmol/l

—

110

Other viral diseases

896

1.09

0.35

1.1

375.05

391.50

nmol/l

0.34

805

Peritonsillar abscess

565

1.12

0.35

1.1

372.09

384.55

nmol/l

0.17

509

Viral and other specified intestinal infections

602

0.89

0.34

1.1

364.39

381.44

nmol/l

0.23

543

Periapical abscess

172

1615

1.07

0.34

1.2

1.1

345.15

378.08

nmol/l

1.36

138

1399

Benign neoplasm: Choroid

181

1.22

0.34

1.2

390.91

385.43

nmol/l

0.06

156

Diseases of peritoneum

339

1.15

0.34

1.2

340.12

357.89

nmol/l

0.24

289

Malignant neoplasm of prostate

109

594

1.09

0.34

1.2

352.29

330.15

nmol/l

0.53

475

Inflammation of lacrimal passages (acute and unspecified)

1.34

0.34

1.5

1.2

709.00

370.42

nmol/l

—

Inflammatory disorders of breast

188

0.80

0.33

1.2

1.1

383.87

408.39

nmol/l

0.21

175

Puerperal sepsis

359

1.14

0.33

1.1

358.87

385.73

nmol/l

0.28

329

Intussusception

1.28

0.32

1.0

1.1

362.67

416.34

nmol/l

—

Insulin, fast-acting (human)

434

0.87

0.32

1.1

368.73

382.83

nmol/l

0.16

394

Schizoaffective disorder

198

0.81

0.32

1.0

1.1

270.33

396.71

nmol/l

—

188

Other malignant neoplasms of skin (=non-melanoma skin cancer)

197

1263

1.06

0.32

1.2

297.86

347.77

nmol/l

3.02

162

1028

Other disorders of the musculoskeletal system and connective tissue

512

1.11

0.31

1.2

353.82

355.55

nmol/l

0.02

438

Alcohol dependence

858

1.08

0.31

1.2

316.14

365.92

nmol/l

1.72

725

Cystic kidney disease, including avohilmo

0.73

0.31

1.0

1.2

405.71

378.11

nmol/l

—

Other disorders of cornea

305

1.15

0.30

1.2

338.66

370.96

nmol/l

0.53

267

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.30

0.30

1.0

1.1

374.86

380.83

nmol/l

—

Alzheimer’s disease (Atypical or mixed)

507

1.11

0.30

1.1

1.3

286.00

311.50

nmol/l

0.36

367

Erosion of teeth , including avohilmo

830

1.08

0.30

1.1

436.43

388.72

nmol/l

1.31

737

Malignant neoplasm of oesophagus

1.34

0.30

1.1

1.2

330.80

353.07

nmol/l

—

Diseases of pulp and periapical tissues and dental caries

323

1587

1.04

0.30

1.2

349.26

357.10

nmol/l

0.28

263

1319

Hepatocellular carcinoma, including Hilmo

1.29

0.30

1.2

248.71

348.71

nmol/l

—

Dermatographic urticaria

203

1.18

0.29

1.1

384.37

393.37

nmol/l

0.07

189

Retinal detachment with retinal break

441

0.88

0.29

1.2

380.00

351.95

nmol/l

0.32

362

Maternal care for known or suspected malpresentation of fetus

420

0.90

0.29

1.1

394.96

421.65

nmol/l

0.47

404

Acute upper respiratory infections of multiple and unspecified sites

303

2303

0.96

0.29

1.2

360.47

371.54

nmol/l

0.44

259

1969

Focal epilepsy, mode (most common among epilepsy diagnosis)

630

1.10

0.29

1.1

1.2

311.16

357.80

nmol/l

1.22

530

Graves ophthalmopathy, strict

1.23

0.29

1.0

1.1

374.86

400.21

nmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

162

1326

1.06

0.29

1.2

1.1

388.40

399.81

nmol/l

0.31

142

1219

Type1 diabetes, definitions combined, early onset

129

0.77

0.28

1.0

1.1

370.50

419.84

nmol/l

—

124

Other congenital malformations of the digestive system

1.28

0.28

1.1

339.33

404.28

nmol/l

0.45

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

364

1.13

0.28

1.2

318.72

343.02

nmol/l

0.33

286

Benign neoplasm: salivary glands, exclude unknown (D119)

270

1.15

0.28

1.2

370.96

380.80

nmol/l

0.10

234

Colorectal adenocarcinoma

804

1.08

0.28

1.2

328.95

331.63

nmol/l

0.04

629

Erectile dysfunction

248

0.85

0.28

1.0

1.3

314.60

318.90

nmol/l

0.03

183

Benign neoplasm of ovary

585

0.91

0.27

1.2

1.1

319.55

358.88

nmol/l

0.84

503

Pyothorax

116

0.77

0.27

1.1

1.2

388.89

356.42

nmol/l

—

Excessive earwax

263

2283

1.04

0.27

1.2

354.19

358.63

nmol/l

0.13

243

1874

Acute and transient psychotic disorders

322

0.87

0.27

1.2

1.1

304.08

388.56

nmol/l

1.47

295

Malignant neoplasm of eye, brain and central nervous system

119

0.76

0.27

1.2

298.89

385.00

nmol/l

—

108

Other chronic obstructive pulmonary disease

161

1391

0.95

0.27

1.2

321.56

335.17

nmol/l

0.36

120

1114

Tuberculosis, wide, including avohilmo

258

0.85

0.27

1.0

1.3

391.60

337.50

nmol/l

0.43

208

Toxic effects of substances chiefly nonmedicinal as to source

328

1.13

0.26

1.1

390.34

388.44

nmol/l

0.02

300

Viral agents as the cause of diseases classified to other chapters, including avohilmo

1.20

0.26

1.0

1.1

387.00

393.05

nmol/l

—

Carcinoma in situ of skin of lower limb, including hip

0.69

0.26

2.0

1.1

401.40

354.08

nmol/l

—

Idiopathic pulmonary fibrosis

272

1.14

0.26

1.1

1.2

278.54

331.06

nmol/l

0.73

211

Maternal care related to the fetus and amniotic cavity and possible delivery problems

146

905

0.95

0.25

1.1

406.66

411.57

nmol/l

0.12

140

842

ILD, hospital admission 2, with pulmonary infections

341

0.88

0.25

1.1

1.2

284.67

337.21

nmol/l

0.77

272

Corns and callosities

192

0.83

0.25

1.3

1.2

286.81

384.63

nmol/l

2.24

171

Caries of dentine, including avohilmo

350

1853

0.96

0.25

1.2

341.07

364.49

nmol/l

1.35

284

1556

Tuberculosis, wide

256

0.86

0.25

1.0

1.3

391.60

338.13

nmol/l

0.43

206

Inguinal of femoral hernia, unilateral

1.22

0.25

1.1

1.2

414.00

373.98

nmol/l

—

Inguinal hernia, unilateral

1.22

0.25

1.1

1.2

414.00

373.98

nmol/l

—

Femoral hernia, unilateral

1.22

0.25

1.1

1.2

414.00

373.98

nmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

234

0.85

0.25

1.5

1.2

329.73

318.82

nmol/l

0.08

185

Toxic effect of contact with venomous animals

114

1.23

0.25

1.0

1.1

420.79

397.42

nmol/l

0.22

103

229

1908

1.04

0.25

1.2

358.25

366.47

nmol/l

0.23

178

1633

Rubella [German measles]

1.20

0.25

1.1

1.2

454.33

413.40

nmol/l

—

Rubella [German measles], including avohilmo

1.20

0.25

1.1

1.2

454.33

413.40

nmol/l

—

Other diseases of intestine

483

1.10

0.24

1.1

346.12

368.18

nmol/l

0.34

403

Other inflammation of eyelid, including avohilmo

166

1580

1.05

0.24

1.1

419.26

381.95

nmol/l

1.77

151

1376

Pulmonary embolism

121

1141

1.06

0.24

1.2

339.84

341.35

nmol/l

0.02

912

283

1.13

0.24

1.3

1.2

332.71

335.57

nmol/l

0.03

228

Malignant neoplasm of corpus uteri, including Hilmo

350

0.88

0.24

1.0

1.2

342.04

357.07

nmol/l

0.17

276

Benign neoplasm: Parotid gland

236

1.15

0.24

1.2

382.86

378.54

nmol/l

0.04

205

L02BX Other hormone antagonists and related agents

180

0.83

0.24

1.1

1.2

447.60

314.75

nmol/l

—

133

Chronic suppurative otitis media, including avohilmo

212

0.85

0.24

1.1

377.54

376.58

nmol/l

0.01

187

Gonococcal infection, including avohilmo

0.71

0.24

1.5

1.1

432.50

407.99

nmol/l

—

Substance abuse

217

1932

1.04

0.24

1.2

1.1

344.60

371.93

nmol/l

1.19

171

1655

Dental caries, including avohilmo

328

1738

0.97

0.23

1.2

343.61

360.57

nmol/l

0.80

269

1446

COPD (mode)

117

860

1.06

0.23

1.2

1.1

321.18

345.40

nmol/l

0.60

708

Pulmonary heart disease

121

1143

1.06

0.23

1.2

339.84

340.24

nmol/l

0.00

918

Suppurative and unspecified otitis media

107

1006

0.94

0.23

1.0

1.1

365.40

395.69

nmol/l

0.84

909

Premature rupture of membranes

486

0.92

0.23

1.1

369.19

413.81

nmol/l

1.12

466

Failed induction of labour

171

1.17

0.23

1.3

1.1

407.80

412.68

nmol/l

0.05

165

Nail disorders

237

1.14

0.23

1.2

1.1

462.25

383.43

nmol/l

0.86

212

Acute poliomyelitis

1.28

0.23

1.4

1.2

185.60

373.09

nmol/l

—

Acute poliomyelitis, including avohilmo

1.28

0.23

1.4

1.2

185.60

373.09

nmol/l

—

Bicipital tendinitis

125

0.80

0.23

1.0

1.2

310.10

387.25

nmol/l

—

106

Burn and corrosion of wrist and hand

0.76

0.22

1.6

1.1

377.00

404.36

nmol/l

—

Congenital deformities of feet, including avohilmo

0.76

0.22

1.1

391.29

406.15

nmol/l

—

Labour and delivery complicated by umbilical cord complications

153

1.18

0.22

1.1

351.01

384.72

nmol/l

0.34

145

Dermatophytosis

448

1.09

0.22

1.2

360.65

353.15

nmol/l

0.08

377

Atopic dermatitis, strict definition

835

1.07

0.22

1.2

1.1

397.70

402.92

nmol/l

0.09

774

Shoulder region

1.22

0.22

1.2

1.1

428.02

405.32

nmol/l

—

Other condition

458

1.09

0.22

1.2

1.1

348.11

376.57

nmol/l

0.36

402

Acute suppurative otitis media

681

0.93

0.21

1.0

1.1

401.04

410.17

nmol/l

0.14

635

Acute alcohol intoxication

844

0.94

0.21

1.2

320.66

368.27

nmol/l

1.13

715

Pregnancy hypertension

144

1226

1.05

0.21

1.2

1.1

391.38

399.81

nmol/l

0.20

131

1128

Tracheo-bronchomalasia

0.00

0.21

0.0

1.1

—

409.58

—

Cleft lip and cleft lip and palate

0.00

0.21

0.0

1.2

—

476.67

—

Ulcerative colitis (strict) with PSC

0.00

0.21

0.0

1.3

—

422.33

—

COPD

169

1433

0.96

0.21

1.2

322.68

336.68

nmol/l

0.38

125

1151

Use of rivastigmine

728

1.07

0.21

1.3

382.95

307.56

nmol/l

1.82

540

Impacted cerumen

402

1.10

0.20

1.1

1.2

337.13

347.38

nmol/l

0.11

330

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

234

1752

1.04

0.20

1.1

376.97

383.31

nmol/l

0.19

205

1545

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.20

0.0

1.2

—

422.21

—

Acute epiglottitis

1.25

0.20

1.0

1.1

271.73

369.98

nmol/l

—

Peroneal tendinitis

1.23

0.20

1.0

1.1

392.67

436.34

nmol/l

—

Chronic tubulo-interstitial nephritis

113

0.80

0.20

1.1

262.33

365.58

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

117

1230

0.95

0.20

1.2

1.1

378.48

354.61

nmol/l

0.65

105

1017

Other and unspecified disorders of vitreous body

162

1518

1.04

0.20

1.2

410.32

354.24

nmol/l

2.62

142

1268

Unspecified mental disorder

141

1347

1.05

0.19

1.1

357.94

379.86

nmol/l

0.58

104

1185

Venous complications and haemorrhoids in pregnancy

1.18

0.19

1.0

420.00

429.67

nmol/l

—

Other specified/unspecified deforming dorsopathies

1.16

0.19

1.3

1.1

427.17

467.57

nmol/l

—

Mental and behavioural disorders due to psychoactive substance use

223

1972

1.04

0.19

1.2

1.1

346.27

371.94

nmol/l

1.07

173

1695

Viral and other specified intestinal infections, including avohilmo

866

0.94

0.19

1.1

367.92

383.08

nmol/l

0.29

778

Tobacco use

137

1.17

0.18

1.2

1.1

263.38

385.42

nmol/l

—

125

L02BG Aromatase inhibitors

103

1070

0.95

0.18

1.1

1.2

340.29

367.91

nmol/l

0.78

902

Pleural plaque

328

1.10

0.18

1.4

1.2

281.47

317.03

nmol/l

0.71

235

Other maternal disorders predominantly related to pregnancy

192

1245

0.96

0.18

1.1

407.44

399.60

nmol/l

0.22

176

1147

Graves ophthalmopathy

1.13

0.17

1.0

1.1

374.86

393.95

nmol/l

—

Other congenital malformations of circulatory system

0.76

0.17

1.0

1.1

477.00

394.48

nmol/l

—

Bursitis of shoulder

0.76

0.17

1.0

1.2

387.40

414.31

nmol/l

—

Basal cell carcinoma

188

1237

1.04

0.17

1.2

308.20

345.73

nmol/l

1.77

160

1005

Vasomotor rhinitis (mode)

205

1.12

0.17

1.2

1.1

367.39

380.21

nmol/l

0.11

184

Vasculitis limited to skin, not elsewhere classified

0.73

0.17

1.0

1.2

296.60

388.81

nmol/l

—

Polycystic kidney disease

0.71

0.16

1.0

1.1

434.20

402.33

nmol/l

—

Herpesviral [herpes simplex] infections

388

1.08

0.16

1.1

370.37

380.43

nmol/l

0.11

346

Contraceptive management

136

912

1.04

0.16

1.1

440.18

409.01

nmol/l

1.15

130

834

Other and unspecified vascular occlusions

340

1.09

0.16

1.1

1.2

324.65

328.90

nmol/l

0.05

268

Extracorporeal dialysis

158

1.14

0.16

1.2

294.62

367.20

nmol/l

0.81

135

Dental pulpitis, including avohilmo

338

2217

0.98

0.16

1.1

375.53

385.91

nmol/l

0.41

278

1964

Hodgkin lymphoma, hilmo

1.13

0.16

1.4

1.1

370.88

403.60

nmol/l

—

Abdominal aortic aneurysm (AAA)

357

0.92

0.16

1.2

1.3

279.40

315.41

nmol/l

0.49

263

Memory loss

283

1.10

0.15

1.2

370.80

348.40

nmol/l

0.22

226

Follicular lymphoma, hilmo

111

1.17

0.15

1.1

1.2

339.38

355.38

nmol/l

—

Ménière disease

312

1.09

0.15

1.1

1.2

323.16

363.65

nmol/l

0.48

262

Systemic lupus erythematosus, unspecified

1.14

0.15

1.4

1.2

374.08

402.75

nmol/l

—

Other juvenile arthritis

1.10

0.15

1.1

413.22

413.25

nmol/l

—

Preterm labour and delivery

789

0.95

0.15

1.1

402.62

396.54

nmol/l

0.09

728

Transient global amnesia

265

0.91

0.15

1.0

1.2

358.12

354.73

nmol/l

0.02

217

Suicide or other Intentional self-harm

732

1.05

0.14

1.2

1.1

341.96

391.40

nmol/l

1.30

665

Diabetes mellitus in pregnancy

102

677

0.96

0.14

1.1

418.84

416.08

nmol/l

0.05

651

Cluster headache, strict

0.79

0.14

1.0

1.1

486.14

403.49

nmol/l

—

Cardiomyopathy

542

0.94

0.14

1.2

1.1

368.81

345.02

nmol/l

0.31

438

Poor fetal growth

357

0.92

0.14

1.1

407.33

421.44

nmol/l

0.19

344

All dysplastic lesions of the cervix uteri, vagina or vulva

917

0.96

0.14

1.1

407.73

402.42

nmol/l

0.09

852

Gestational [pregnancy-induced] hypertension

781

1.05

0.14

1.1

421.84

405.52

nmol/l

0.33

728

Cluster headache, wide

0.83

0.13

1.0

1.1

497.13

402.33

nmol/l

—

Malignant neoplasm of brain

0.82

0.13

1.0

1.2

323.75

403.05

nmol/l

—

Sarcoidosis

412

1.07

0.13

1.2

1.1

360.50

371.86

nmol/l

0.15

363

Other ill-defined and unspecified causes of mortality

344

1.08

0.13

1.2

311.36

322.82

nmol/l

0.10

274

Other and unspecified urticaria

627

1.05

0.13

1.1

388.56

381.34

nmol/l

0.11

565

Recurrent dislocation of patella

138

0.87

0.13

1.2

1.1

421.33

405.83

nmol/l

0.09

132

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

109

0.82

0.13

1.1

450.33

378.81

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis

306

1.08

0.13

1.1

1.2

331.92

334.39

nmol/l

0.02

241

Injury of muscle and tendon at lower leg level

458

0.94

0.13

1.1

399.03

372.70

nmol/l

0.43

397

Acute alcohol intoxication, ICD10

611

0.95

0.12

1.2

1.1

338.01

380.78

nmol/l

0.66

531

Intracerebral haemorrhage

472

1.06

0.12

1.1

1.2

346.85

327.77

nmol/l

0.25

367

Lung diseases due to external agents

492

1.06

0.12

1.4

1.2

316.41

333.25

nmol/l

0.27

386

Diseases of pulp and periapical tissues, including avohilmo

451

2371

0.98

0.12

1.2

1.1

365.99

370.40

nmol/l

0.17

369

2021

Mental and behavioural disorders due to alcohol

184

1706

1.03

0.12

1.2

350.80

371.93

nmol/l

0.67

141

1461

Delivery, wide proxy

123

675

0.97

0.12

1.2

366.06

372.76

nmol/l

0.13

110

568

Benign neoplasm of other and unspecified female genital organs

114

1.14

0.11

1.5

1.1

430.23

394.62

nmol/l

0.21

104

SLE, ICD10

1.16

0.11

1.4

1.2

330.43

406.29

nmol/l

0.70

SLE, strict definition

1.16

0.11

1.4

1.2

330.43

406.29

nmol/l

0.70

Vitreous haemorrhage

337

1.07

0.11

1.2

457.72

355.85

nmol/l

1.78

281

Other otitis externa (chronic)

201

1.10

0.11

1.0

1.1

427.80

385.67

nmol/l

0.32

181

Medicines for HER+ breast cancer

135

1295

0.97

0.11

1.1

1.2

348.30

371.68

nmol/l

0.72

114

1102

Alcohol abuse, main dg

455

1.06

0.11

1.2

1.1

354.38

376.10

nmol/l

0.30

401

Basal cell carcinoma, including Hilmo

193

1275

1.02

0.11

1.2

302.49

349.77

nmol/l

2.74

163

1040

Brain meningioma

167

0.90

0.10

1.1

1.2

322.20

390.97

nmol/l

—

146

Mental and behavioural disorders due to sedatives or hypnotics

167

0.90

0.10

1.2

1.1

325.71

394.98

nmol/l

—

157

Secondary uncertain malignant neoplasm

495

0.95

0.10

1.1

1.2

358.53

341.15

nmol/l

0.25

397

Chronic periodontitis, complicated

207

2061

0.98

0.10

1.2

1.1

354.73

366.27

nmol/l

0.35

155

1746

Malignant neoplasm of corpus uteri

321

0.93

0.10

1.0

1.2

351.63

353.53

nmol/l

0.02

256

Infective dermatitis

358

1.06

0.10

1.1

367.86

376.41

nmol/l

0.09

314

Zoster [herpes zoster], including avohilmo

212

2002

1.02

0.10

1.3

1.2

360.64

351.77

nmol/l

0.26

181

1642

Caries of enamel

376

2420

1.02

0.10

1.1

402.11

375.35

nmol/l

1.85

340

2084

Sequelae of injuries of lower limb

261

1.07

0.10

1.2

1.1

479.35

385.94

nmol/l

1.24

238

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.09

0.09

1.2

179.80

395.69

nmol/l

—

Long labour

629

1.04

0.09

1.0

1.1

429.42

400.43

nmol/l

0.59

596

Melanocytic naevi of trunk

391

0.95

0.09

1.2

1.1

388.26

382.25

nmol/l

0.06

347

Laparoscopic left hemicolectomy

1.04

0.09

1.0

1.2

430.20

396.50

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.04

0.09

1.0

1.1

306.80

407.22

nmol/l

—

Malignant neoplasm of skin

201

1388

0.98

0.09

1.2

298.17

355.58

nmol/l

4.22

168

1143

Malignant neoplasm of urinary organs

350

1.06

0.09

1.2

334.93

335.25

nmol/l

0.00

275

Benign neoplasm of major salivary glands

311

1.06

0.09

1.2

373.76

366.86

nmol/l

0.07

269

COPD-related respiratory insufficiency

419

1.05

0.09

1.3

1.2

278.07

330.11

nmol/l

0.83

327

Keratoconus

1.11

0.09

1.2

1.1

324.00

411.68

nmol/l

—

Disorders of optic nerve, not elsewhere classified

1.09

0.09

1.3

1.2

488.83

381.60

nmol/l

—

Benign neoplasm: Vulva

1.07

0.08

1.3

1.2

506.00

374.74

nmol/l

—

IgA nephropathy (IgA glomerulonephritis)

1.07

0.08

1.0

1.1

406.50

401.13

nmol/l

—

Non-follicular lymphoma

302

1.06

0.08

1.1

1.2

334.85

344.18

nmol/l

0.08

247

Aggressive periodontitis

1.03

0.08

1.2

347.33

398.57

nmol/l

—

Effects of other external causes

0.81

0.08

1.0

1.1

273.80

402.77

nmol/l

—

Other and unspecified vasculitis limited to skin

0.78

0.08

1.0

1.2

296.60

389.20

nmol/l

—

Golimumab

1.14

0.08

1.1

394.90

418.01

nmol/l

—

Gestational diabetes (for exclusion)

119

798

1.03

0.08

1.1

429.98

410.61

nmol/l

0.51

106

765

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.05

0.08

1.1

391.71

402.72

nmol/l

—

Abnormal serum enzyme levels

108

1016

1.03

0.07

1.2

385.18

339.81

nmol/l

1.20

829

Dronedarone medication

0.81

0.07

1.2

1.1

373.83

317.34

nmol/l

—

Sequelae with surgical and medical care as external cause

727

1.03

0.07

1.2

393.15

351.13

nmol/l

0.89

601

Ill-defined and unknown causes of mortality

372

1.05

0.07

1.2

309.70

323.11

nmol/l

0.12

297

Brain meningioma, including Hilmo

174

0.92

0.07

1.1

1.2

310.73

393.71

nmol/l

0.82

153

Gonococcal infection

0.80

0.07

1.5

1.1

432.50

404.99

nmol/l

—

Sequelae of infectious and parasitic diseases

225

1.07

0.07

1.1

1.2

312.73

364.54

nmol/l

0.46

199

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

173

1.08

0.07

1.2

1.1

363.42

404.81

nmol/l

0.43

162

Male infertility

1.04

0.07

1.4

1.1

412.13

408.69

nmol/l

—

ILD, hospital admissions 3, with pneumonia sepsis

286

0.94

0.07

1.1

1.2

294.82

331.09

nmol/l

0.43

227

Nonalcoholic fatty liver disease

284

1.06

0.07

1.1

379.04

389.34

nmol/l

0.09

259

Other keratitis

343

1.05

0.07

1.2

1.1

426.61

385.25

nmol/l

0.54

309

Exposure to other and unspecified animate mechanical forces

1.03

0.07

1.0

1.1

335.50

410.89

nmol/l

—

Cystic kidney disease

0.85

0.07

1.0

1.1

405.71

387.68

nmol/l

—

Schizophrenia or delusion, excluding more controls

832

0.97

0.07

1.1

331.88

383.51

nmol/l

1.37

737

Cardiomyopathies, Primary/intrinsic

356

0.95

0.06

1.2

364.83

346.67

nmol/l

0.17

287

Acute bronchiolitis

0.86

0.06

1.3

1.1

362.89

402.00

nmol/l

—

Ptosis of eyelid

376

0.96

0.06

1.4

1.2

367.58

346.80

nmol/l

0.22

306

Disorders of vitreous body and globe

202

1881

1.02

0.06

1.2

405.10

353.61

nmol/l

2.70

171

1557

Diabetic retinopathy, strict definition

603

0.97

0.06

1.2

374.12

353.26

nmol/l

0.29

438

Other disorders of eye and adnexa

463

1.04

0.06

1.3

1.1

362.38

382.86

nmol/l

0.27

412

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

247

1.05

0.05

1.1

428.19

400.16

nmol/l

0.27

235

In situ neoplasms

168

1656

1.01

0.05

1.2

376.00

346.58

nmol/l

1.00

136

1352

L02BA Anti-estrogens

566

0.97

0.05

1.2

1.1

373.32

368.54

nmol/l

0.06

495

Non-Hodgkin lymphoma, all, including Hilmo

465

1.03

0.05

1.1

1.2

347.18

346.71

nmol/l

0.00

375

Other diseases of hard tissues of teeth

253

1325

0.99

0.05

1.3

1.2

357.09

355.96

nmol/l

0.03

218

1101

Other disorders of optic [2nd] nerve and visual pathways

169

1.07

0.05

1.2

403.17

378.26

nmol/l

0.23

151

Congenital malformations of heart and great arteries

313

0.96

0.04

1.1

387.92

386.24

nmol/l

0.01

286

Disorders of vitreous body

195

1832

1.01

0.04

1.2

405.80

354.67

nmol/l

2.57

166

1517

Single spontaneous delivery

145

777

0.99

0.04

1.2

354.44

379.03

nmol/l

0.70

126

673

Hypertrophic scar

140

0.93

0.04

1.1

342.15

396.95

nmol/l

0.49

131

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.10

0.04

1.0

1.1

372.70

385.08

nmol/l

—

Juvenile arthritis (FINNGEN)

101

1.09

0.04

1.2

1.1

433.91

413.51

nmol/l

0.12

Suggestive for eosinophilic asthma

281

0.96

0.04

1.0

1.2

382.50

366.31

nmol/l

0.19

245

Injury of eye and orbit

408

1.03

0.03

1.2

1.1

396.17

386.97

nmol/l

0.09

366

Other viral diseases, not elsewhere classified

565

1.02

0.03

1.2

1.1

369.17

382.82

nmol/l

0.18

506

Maternal care for other conditions predominantly related to pregnancy

630

1.02

0.03

1.1

412.93

414.89

nmol/l

0.03

604

Follicular cysts of skin and subcutaneous tissue

593

0.98

0.03

1.3

1.2

355.00

366.93

nmol/l

0.15

509

Sequelae of infectious and parasitic diseases, including avohilmo

230

1.04

0.03

1.1

1.2

312.73

359.67

nmol/l

0.40

204

Tubulo-interstitial nephritis, not specified as acute or chronic

230

1.04

0.03

1.0

1.2

352.22

357.30

nmol/l

0.03

196

Zoster [herpes zoster]

713

0.98

0.03

1.4

1.2

314.82

343.52

nmol/l

0.65

575

Injury of muscle and tendon at wrist and hand level

391

0.97

0.03

1.2

1.1

376.01

388.97

nmol/l

0.14

343

Secondary and unspecified malignant neoplasm of lymph nodes

280

1.04

0.03

1.1

1.2

383.00

348.82

nmol/l

0.44

234

Methotrexate

449

1.02

0.03

1.1

1.2

349.36

359.04

nmol/l

0.11

388

Macular pucker

539

1.02

0.03

1.3

1.2

344.13

331.20

nmol/l

0.18

425

Other interstitial pulmonary diseases

551

0.98

0.03

1.1

1.2

312.28

336.26

nmol/l

0.36

433

Cardiomyopathy (excluding other)

370

0.97

0.03

1.2

370.23

352.68

nmol/l

0.17

298

Persistent delusional disorders

229

0.96

0.03

1.1

395.06

375.87

nmol/l

0.16

204

Other sexually transmitted chlamydial diseases, including avohilmo

239

0.96

0.02

1.0

1.1

482.91

405.66

nmol/l

1.63

229

Cluster headache, strict, including avohilmo

128

0.94

0.02

1.0

1.1

496.17

393.69

nmol/l

0.83

120

D07AA Corticosteroids, weak (group I)

459

1.02

0.02

1.1

404.17

389.50

nmol/l

0.19

414

Myocardial infarction, unclassifiable

850

0.99

0.02

1.3

1.2

295.89

318.54

nmol/l

0.51

633

Melanocytic naevi

107

1058

1.01

0.02

1.1

397.05

372.27

nmol/l

0.59

917

Inguinal hernia, bilateral

321

1.03

0.02

1.2

367.96

335.63

nmol/l

0.46

246

Interstitial lung disease

550

0.98

0.02

1.1

1.2

312.28

335.96

nmol/l

0.36

434

Interstitial lung disease endpoints

550

0.98

0.02

1.1

1.2

312.28

335.96

nmol/l

0.36

434

Malignant neoplasm of skin, including Hilmo

217

1443

1.01

0.02

1.2

302.21

357.71

nmol/l

4.05

179

1194

Paralytic strabismus

198

0.96

0.02

1.2

370.77

370.53

nmol/l

0.00

170

Superficial injury of shoulder and upper arm

399

0.98

0.02

1.2

1.1

393.03

370.62

nmol/l

0.28

350

Tuberculosis

212

1.04

0.02

1.1

1.3

396.92

330.26

nmol/l

0.49

169

SLE (Finngen)

1.08

0.02

1.4

1.1

351.07

395.82

nmol/l

—

Early onset COPD, excluding more controls

610

1.02

0.02

1.2

1.1

369.78

361.62

nmol/l

0.11

523

ILD, hospital admissions

539

0.98

0.02

1.1

1.2

311.02

337.04

nmol/l

0.39

425

False labour

602

0.99

0.02

1.1

388.43

421.36

nmol/l

0.98

575

Carcinoma in situ of cervix uteri

308

0.97

0.02

1.1

442.64

408.02

nmol/l

0.40

292

L02BB Anti-androgens

318

0.97

0.01

1.1

1.3

375.90

307.00

nmol/l

0.96

231

Nontraumatic intracranial haemmorrhage

771

1.01

0.01

1.2

336.32

342.23

nmol/l

0.09

599

Superficial injury of forearm

297

0.98

0.01

1.1

385.30

393.53

nmol/l

0.07

274

Pleural effusion

577

0.99

0.01

1.3

1.2

345.58

339.06

nmol/l

0.08

447

Pneumonia due to Streptococcus pneumoniae

104

1.06

0.01

1.1

260.00

374.52

nmol/l

—

Perineal laceration during delivery

417

0.99

0.00

1.0

1.1

404.17

409.26

nmol/l

0.07

399

Pyogenic arthritis

194

1.03

0.00

1.3

1.1

282.10

355.14

nmol/l

—

169

Burns and corrosions of external body surface, specified by site

304

1.02

0.00

1.3

1.1

364.85

382.18

nmol/l

0.19

276

ILD, hospital admissions 1, main diag only

474

1.01

0.00

1.1

1.2

289.92

338.74

nmol/l

0.95

375

Seborrhoeic keratosis

916

0.99

0.00

1.2

358.44

341.42

nmol/l

0.34

745

Other inflammation of eyelid

463

0.99

0.00

1.3

1.1

382.41

360.69

nmol/l

0.32

388

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

124

1225

1.00

0.00

1.2

1.1

382.17

398.54

nmol/l

0.37

107

1113

Fracture of foot, except ankle

807

1.00

0.00

1.2

1.1

364.20

378.21

nmol/l

0.26

716

Care involving dialysis

218

1.01

0.00

1.1

1.2

335.69

359.93

nmol/l

0.22

195

Contact with nonpowered hand tool

105

1.05

0.00

1.4

1.2

374.45

401.04

nmol/l

0.13

Malignant neoplasm of breast, ER-positive, including Hilmo

127

942

1.00

0.00

1.1

346.52

386.29

nmol/l

1.49

107

805

Other sexually transmitted chlamydial diseases

155

1.03

0.00

1.1

1.0

503.56

418.62

nmol/l

1.44

148

Maltreatment syndromes

119

1.01

0.00

1.1

365.09

411.54

nmol/l

0.44

112

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

255

1.02

0.00

1.1

428.19

401.81

nmol/l

0.26

243

Hypertrophic disorders of skin

149

1.01

0.00

1.1

366.07

397.12

nmol/l

0.25

139

Kela-code for severe mental illness

121

1205

1.00

0.00

1.1

353.61

377.85

nmol/l

0.59

1054

Substance use, excluding alcohol

605

0.99

0.00

1.2

1.1

305.06

393.79

nmol/l

3.43

546

Aortic aneurysm

821

1.00

0.00

1.2

347.44

322.84

nmol/l

0.50

656

Other respiratory diseases principally affecting the interstitium

665

1.01

0.00

1.1

1.2

328.13

336.60

nmol/l

0.12

518

Cluster headache, wide,, including avohilmo

134

0.97

0.00

1.0

1.1

502.15

401.62

nmol/l

0.91

125

Melanocytic naevi of other and unspecified parts of face

166

1.02

0.00

1.1

391.06

395.77

nmol/l

0.03

150

Hydrocephalus

254

0.98

0.00

1.3

1.2

327.76

351.82

nmol/l

0.24

209

ILD-related respiratory insufficiency

102

0.98

0.00

1.0

1.2

290.70

347.45

nmol/l

—

Malignant neoplasm of thyroid gland, including Hilmo

242

0.99

0.00

1.2

1.1

357.53

392.77

nmol/l

0.35

216

Dermatophytosis, including avohilmo

248

2431

1.00

0.00

1.2

1.1

363.73

369.89

nmol/l

0.19

227

2062

Delivery

148

777

1.00

0.00

1.1

1.2

361.67

379.03

nmol/l

0.44

129

673

Other coagulation defects

219

1.00

0.00

1.2

1.1

377.50

388.74

nmol/l

0.09

199

Malignant neoplasm of endocrine gland, including Hilmo

261

1.00

0.00

1.2

1.1

347.76

390.69

nmol/l

0.50

232

Aneurysms, operations, SAH

574

0.99

0.00

1.3

1.2

382.18

344.51

nmol/l

0.64

477

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

256

1.02

0.00

1.1

361.79

390.90

nmol/l

0.28

231

Inguinal or femoral hernia, bilateral

325

1.02

0.00

1.2

367.96

336.86

nmol/l

0.44

250

Systemic lupus erythematosus

1.03

0.00

1.4

1.2

351.07

406.13

nmol/l

—

Haemorrhage in early pregnancy

853

1.00

0.00

1.1

390.01

396.95

nmol/l

0.12

789

Malignant neoplasm of breast, HER-positive

127

942

1.00

0.00

1.1

346.52

386.29

nmol/l

1.49

107

805

Complications specific to multiple gestation

0.00

0.0

1.1

—

453.88

—

Femoral hernia, bilateral

0.00

0.0

1.4

—

305.13

—

Eccrine sweat disorders

0.00

0.0

1.0

—

336.40

—

Viral agents as the cause of diseases classified to other chapters

1.02

0.00

1.0

1.1

339.00

399.43

nmol/l

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

396.71

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

516.20

—

Malignant neoplasm of other and ill-defined sites

0.00

-0.00

0.0

1.5

—

318.00

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.6

—

486.40

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

470.50

—

Embolism and thrombosis of abdominal aorta

0.00

-0.00

0.0

1.5

—

311.18

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.4

—

484.80

—

Papilloedema, unspecified

0.93

-0.00

1.0

1.2

396.20

377.61

nmol/l

—

Precocious puberty

0.00

-0.00

0.0

1.4

—

357.00

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.1

—

366.00

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.2

—

506.60

—

Maxillary prognathism

0.00

-0.00

0.0

1.3

—

468.50

—

Chronic drug-induced interstitial lung disorders

0.00

-0.00

0.0

1.0

—

418.50

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.1

—

402.57

—

Aortic arch syndrome [Takayasu]

0.00

-0.00

0.0

1.2

—

280.60

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

405.60

—

Other specified disorders of kidney and ureter

0.90

-0.00

1.3

1.1

400.88

378.40

nmol/l

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

434.67

—

Malignant neoplasm of vagina, including Hilmo

0.00

-0.00

0.0

1.3

—

359.11

—

Malignant neoplasm of oesophagus, including Hilmo

110

1.00

-0.00

1.3

1.2

312.91

350.75

nmol/l

0.33

Malignant neoplasm of tonsil and base of tongue

0.96

-0.00

1.6

1.2

235.84

395.33

nmol/l

—

Ovarian dysfunction, other/unspecified

0.00

-0.00

0.0

1.1

—

462.63

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.6

—

409.20

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.3

—

330.50

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.1

—

405.38

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.0

—

416.00

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

1.2

—

493.17

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.0

—

371.00

—

Ectopic testis

0.00

-0.00

0.0

1.2

—

473.60

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.0

—

425.20

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

1.4

—

463.00

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.2

—

385.17

—

Complications of anaesthesia during labour and delivery

0.00

-0.00

0.0

1.0

—

432.00

—

Other infestations

0.00

-0.00

0.0

1.4

—

398.00

—

Complications of anaesthesia during pregnancy

0.00

-0.00

0.0

1.2

—

488.60

—

Cleft lip and palate

0.00

-0.00

0.0

1.3

—

480.75

—

Congenital varicose veins

0.00

-0.00

0.0

1.5

—

453.67

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.2

—

361.17

—

Cutaneous lupus erythematosus

1.00

-0.00

1.2

384.17

389.73

nmol/l

—

Other disorders involving the immune mechanism, not elsewhere classified

0.91

-0.00

1.1

391.71

402.50

nmol/l

—

Colour vision deficiencies

0.00

-0.00

0.0

1.3

—

428.50

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Folate [Moles/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS